The search for a connection between changes in the indicators of the pro-oxidant system of brain structures and the thyroid gland as a target organ is an urgent issue. The goal is to investigate the features of the pro-oxidant system against the background of experimental hyperthyroxinemia and to evaluate the age-related changes of malondialdehyde and diene conjugates in brain structures. Among Wistar rats (n=50) intact animals ("control", Σ=20) and experimental animals (under simulated hyperthyroxinemia, Σ=30) were selected for observation. The principle of the model of experimental hyperthyroxinemia lies in the addition of levothyroxine in a dosage of 20 μg/day (manufactured by "Berlin-Chemie AG", Germany) in the form of tablets with subsequent grinding at 9 o'clock in the morning with food. On day 14, hyperthyroxinemia in the animals was found, while the thyroxine level in the peripheral blood was >10 μg/dL in the first 48 hours and further, being >25 μg/dL (the results were verified in the laboratory, confirmed by immunoenzymatic method with the participation of the "Humarlander" test system). After functional testing in rats, highly specific parameters (malondialdehyde, diene conjugates) in the cortex, trunk, and hippocampus were further recorded and evaluated. The humane treatment of animals is certified by the local protocol of the meeting of the commission of the Dnipro State Medical University No. 10 dated 21.06.2023, bioethical principles and rules are taken into account during the experimental research. In the presented work, the results of the biochemical method were used to discuss the importance of the pro-oxidant system at the stage of protection against manifestations of stress and anxiety. Functional dependence on the accumulation of intermediate and final products of lipid peroxidation in the structures of the brain during the study of the state of the pro-oxidant system was found; the age-related dynamics of the activity of malondialdehyde and diene conjugates from young to middle-aged rats under conditions of experimental hyperthyroxinemia was observed; age-related changes contribute to a certain depletion of the activity of pro-oxidant compounds in response to stress as a principle of nervous system protection.

Key words: pro-oxidant system, thyroid processes, hyperthyroxinemia, age-related changes, rats

1. Riabukha OI. [Some aspects of thyroid impact on the body state in normal and pathology conditions]. Aktualni problemy suchasnoi medytsyny. Visnyk uk­rainskoi medychnoi stomatolohichnoi akademii. 2018;18(3):324-30. Ukrainian.
2. Tsai K, Leung AM. Subclinical Hyperthyroidism: A Review of the Clinical Literature. Endocr Pract. 2021;27(3):254-60. doi: https://doi.org/1016/j.eprac.2021.02.002
3. Liu YC, Yeh CT, Lin KH. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Pro­gres­sion and Anti-Apoptosis. Int J Mol Sci. 2019;20(20):4986. doi: https://doi.org/3390/ijms20204986
4. Tang M, Huang H, Li S, Zhou M, Liu Z, Huang R, et al. Hippocampal proteomic changes of susceptibility and resilience to depression or anxiety in a rat model of  chronic   mild stress. Transl Psychiatry. 2019;9(1):260. doi: https://doi.org/10.1038/s41398-019-0605-4
5. Rodynskyi OH, Demchenko OM, Zaichen­ko OYu. [The role of thyroid hormones in shaping the adaptive response of rats in early ontogeny]. Dnipro: LIRA; 2020. 178 p. Ukranian. Available from: https://repo.dma.dp.ua/6749/1/Тези%20%282%29%20Збірник%201-2%20жовтня%202020Д%20Н%20УС.%20171-173.pdf
6. Lanzolla G, Marcocci C, Marinò M. Oxidative Stress in Graves Disease and Graves Orbitopathy. Eur Thyroid J. 2020;9(Suppl 1):40-50. doi: https://doi.org/10.1159/000509615
7. Sirenko VA, Pavlova OO. [Іnfluence of prolonged stress of female rats on indicators oxidant-antioxidant homeostasis of the sub-gastic tissue glands and blood in their offspring]. Grail of Science. 2022;(16):514-8. Ukranian. doi: https://doi.org/10.36074/grail-of-science.17.06.2022.084
8. Noushad S, Ahmed S, Ansari B, Mustafa UH, Sa­leem Y, Hazrat H. Physiological biomarkers of chronic stress: A systematic review. Int J Health Sci (Qassim). 2021;15(5):46-59.Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434839/
9. Begni V, Sanson A, Pfeiffer N, Brandwein C, Inta D, et al. Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity. PLOS ONE. 2020;15(10):e0240439. doi: https://doi.org/10.1371/journal.pone.0240439
10. Strilchuk LM. [Malondialdehyde and its role in the pathogenesis of unstable forms of coronary heart disease]. Medytsyna sohodni i zavtra. 2020;87(2):20-5. Ukranian. doi: https://doi.org/10.35339/msz.2020.87.02.02
11. Ketsa OV, Marchenko MM. [Іntensity of lipid peroxidation in the microsomal fraction of rat liver under the effects of sodium benzoate and ascorbic acid]. Naukovyi visnyk Chernivetskoho universytetu. Biolohiia (Biolohichni systemy). 2022;14(2):93-9. Ukranian. doi: https://doi.org/10.31861/biosystems2022.02.093
12. Kras SI, Tarasiuk SI. [Fabric specificity of func­tioning antioxidant system and peroxidation lipids in Amur carp of different age groups]. Ukr Biochem J 2011;83(4):77-83. Ukrainian. 
13. Wei J. The adoption of repeated measurement of variance analysis and Shapiro-Wilk test. Front Med. 2022;16(4):659-60.
    doi: https://doi.org/1007/s11684-021-0908-8
14. Vrbin CM. Parametric or nonparametric statistical tests: Considerations when choosing the most appropriate option for your data. Cytopathology. 2022;33(6):663-7. doi: https://doi.org/1111/cyt.13174
15. Perme MP, Manevski D. Confidence intervals for the Mann-Whitney test. Stat Methods Med Res. 2019;28(12):3755-68. doi: https://doi.org/10.1177/0962280218814556
16. Pripp AH. Pearsons eller Spearmans korrelasjons koeffisienter [Pearson's or Spearman's correlation coefficients]. Tidsskr Nor Laegeforen. 2018;138(8). Norway. doi: https://doi.org/10.4045/tidsskr.18.0042
17. White NM, Balasubramaniam T, Nayak R, Bar­nett AG. An observational analysis of the trope "A p-value of < 0.05 was considered statistically significant" and other cut-and-paste statistical methods. PLoS One. 2022;17(3):e0264360. doi: https://doi.org/1371/journal.pone.0264360
18. Mas-Bargues C, Escrivá C, Dromant M, Borrás C, Viña J. Lipid peroxidation as measured by chroma­tographic determination of malondialdehyde. Human plasma reference values in health and disease. Arch Biochem Biophys. 2021;709:108941. doi: https://doi.org/10.1016/j.abb.2021.108941
19. Baghcheghi Y, Hosseini M, Beheshti F, Sal­mani H, Anaeigoudari A. Thymoquinone reverses learning and memory impairments and brain tissue oxidative damage in hypothyroid juvenile rats. Arq Neuropsiquiatr. 2018;76(1):32-40. doi: https://doi.org/10.1590/0004-282X20170182
20. Huaiyu S, Jiaai L, Buajieerguli M, et al. Cir­cula­ting malondialdehyde level in patients with epilepsy: A meta-analysis. Seizure. 2022;99:113-9. doi: https://doi.org/1016/j.seizure.2022.05.015
21. Pan Q, Zhang Y, Zhang W, Hu Y, Chen Z, Liu A, et al. The Prevalence of Euthyroid Hypertriiodo­thyro­ninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics. Endocr Pract. 2021;27(3):236-40. doi:https://doi.org/10.1016/j.eprac.2020.09.004
22. Denefil OV, Medynskyi MI. [Effect of stress on the development of lipid peroxide oxidation in rats with different motor activity]. Visnyk medychnykh i bio­lohichnykh doslidzhen. 2022;1(11):28-33. Ukranian. doi: https://doi.org/11603/bmbr.2706-6290.2022.1.12968
23. Jîtcă G, Fogarasi E, Ősz BE, Vari CE, Tero-Ves­can A, Miklos A, et al. A Simple HPLC/DAD Method Validation for the Quantification of Malondialdehyde in Rodent's Brain. Molecules. 2021;26(16):5066. doi: https://doi.org/10.3390/molecules26165066
24.  

Look through:

Voichenko Ya.S. Dnipro State Medical University, Dnipro, Ukraine 
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-7371-1298 

Rodynskyi O.H. Dnipro State Medical University, Dnipro, Ukraine 
https://orcid.org/0000-0002-8011-6104

Voichenko Ya.S., Rodynskyi O.H. Clinical course of pro-oxidant processes in brain structures in rats under conditions of experimental hyperthyroxinemia in age-related dynamics. Medicni perspektivi. 2023;28(3):4-11. DOI: https://doi.org/10.26641/2307-0404.2023.3.288923

Clinical course of pro-oxidant processes in brain structures in rats under conditions of experimental hyperthyroxinemia in age-related dynamics

The drug "Warfarin sodium" refers to anticoagulants of indirect action. It contains only one substance - warfarin sodium, the toxicological indicator of which have been studied in many countries. Therefore, the range of indicators for DL₅₀ of warfarin sodium is very large. However, warfarin sodium has not yet been studied in Ukraine, its maximum permissible concentration in the air of the work area has not been established. Significant volumes of production and use of the drug “Warfarin sodium” on the territory of Ukraine necessitate the clarification of its main toxicological indicators and the establishment of the maximum allowable concentration in the air of the working area, which includes several stages. The first of them is the purpose of this work, namely: to establish DL₅₀ upon intragastric administration of the drug "Warfarin sodium" to two species of animals in the conditions of an acute experiment. Experimental animals (60 non-linear white rats and 70 non-linear white mice) were divided into 9 groups. Six groups were injected with the drug "Warfarin sodium" in different doses: the first group (female rats) – 58 mg/kg per animal, the second (also female rats) – 29 mg/kg, the third (male rats) – 323 mg/kg, the fourth (also male rats) – 161.5 mg/kg, the fifth (mice of both sexes) – 374 mg/kg, the sixth (also mice of both sexes) – 187 mg/kg. Three control groups (the first – 6 male rats, the second – 6 female rats, the third – 14 mice) received distilled water. As a result, the mortality rates of experimental animals were obtained, on the basis of which, using the probit analysis method, the toxicity indicator of DL₅₀ was determined: for female rats – 15.85 mg/kg, male rats – 398.11 mg/kg and mice –645.65 mg/kg. The established DL₅₀ for male rats after intragastric administration of the drug "Warfarin sodium" may indicate an increase in their resistance to the drug, and this determines the expediency of periodic repeated acute experiments in order to verify the relevance of previously established DL₅₀ of sodium warfarin. According to DL₅₀ upon intragastric administration to female rats, which are the most sensitive species of animals to it, warfarin sodium belongs to highly hazardous substances.

Key words: warfarin sodium, anticoagulants, toxicological indicator, DL₅₀, intragastric administration

1. Elango K, Javaid A, Khetarpal BK, et al. The Ef­fects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review. Cells. 2021;10(4):773. doi: https://doi.org/10.3390/cells10040773
2. Gulati S, Gulati A. Anticoagulant rodenticide poisoning. Indian J Med Spec. 2018;9(3):150-3. doi: https://doi.org/10.1016/j.injms.2018.04.010
3. Assessment report Warfarin product type 14 (rodenticides). Directive 98/8/EC concerning the placing biocidal product on the market. Inclusion of active substances in annex I or IA to Directive 98/8/EC. European Chemicals Agency, Ireland; 2009. 61 p. Available from: https://circabc.europa.eu/sd/a/5bcfe8f9-228c-4bff-a347-556018a9af30/2009-09-16%20BPD%20Warfarin%20AR.pdf
4. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Bio­technology Information; 2004. PubChem Compound Summary for CID 16204922, Warfarin Sodium; [cited 2023 Apr 01]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Warfarin-Sodium
5. Warfarin sodium. Certificate of quality control department. Cadila Healthcare Limited [Internet]. 2018 [cited 2023 Jun 21]. Available from: https://www.zyduscadila.com/
6. [On approval of guidelines "Justification of the maximum permissible concentrations of drugs in the air of the working area and the atmospheric air of populated areas". Order of the MH of Ukraine dated 2005 Oct 21 No. 544] [Internet]. 2005 [cited 2023 Jun 21]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v0544282-05#Text
7. [On the approval of methods for conducting research on the specific activity, safety, quality (efficacy) of disinfectants and their testing in practice. Order of the MH of Ukraine dated 2020 Sept 03 No. 2024] [Internet]. 2020 [cited 2023 Jun 21]. Ukrainian. Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-03092020--2024-pro-zatverdzhennja-metodiv-provedennja-doslidzhen-specifichnoi-aktivnosti-bezpechnosti-jakosti-efektivnosti-dezinfekcijnih-zasobiv-ta-ih-viprobuvannja-na-praktici
8. [On approval of hygienic regulations for the permissible content of chemical and biological substances in the air of the working area. Order of the MH of Ukraine dated 2020 Jul 14 No. 1596] [Internet]. 2020 [cited 2023 Jun 21]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0741-20#Text
9. Smith AJ. Guidelines for planning and conducting high-quality research and testing on animals. Lab Anim Res. 2020;21. doi: https://doi.org/10.1186/s42826-020-00054-0
10. Erhirhie EO, Ihekwereme CP, Ilodigwe EE. Ad­vances in acute toxicity testing: strengths, weaknesses and regulatory acceptance. Interdiscip Toxicol. 2018;11(1):5-12. doi: https://doi.org/10.2478/intox-2018-0001
11. Halmi MI, Rahim MB, Othman AR. Estimation of LC50 and its Confidence Interval for the Effect of Ferrous Sulphate on Catla catla. JEMAT. 2018;6(1):21-3. doi: https://doi.org/10.54987/jemat.v6i1.402
12. [On the approval of the Methodological Guidelines "Justification of the permissible exposure limits (PELs) of chemical substances in the atmospheric air of populated areas". Order of the MH of Ukraine dated 2004 Oct 07 No. 485]. [Internet]. 2004 [cited 2023 Jun 21]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v0485282-04#Text 
13. Dutta S, Sharma PK, Misra AK, et al. A Case Report on Warfarin Induced Skin Necrosis: Drug-drug Interaction or Inappropriate Therapy. J Pharm Sci Therap. 2018;4(1):230-3. doi: https://doi.org/10.18314/jpt.v4i1.1445
14. Nsaful J, Adjei YO, Dedey F, et al. Warfarin-induced skin necrosis: a rare condition. Ghana Med J. 2020;54(4):269-73. doi: https://doi.org/10.4314/gmj.v54i4.10
15. Dearden JC, Hewitt M. Prediction of Human Lethal Doses and Concentrations of MEIC Chemicals from Rodent LD50 Values: An Attempt to Make Some Re­paration. Altern Lab Anim. 2021;49(1-2):10-21. doi: https://doi.org/10.1177/0261192921994754 

Look through:

Hlavachek D.O. State Institution “O.M. Marzіeiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-0512-6927

Kondratenko O.Ye. State Institution “O.M. Marzіeiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
https://orcid.org/0000-0002-9504-7228

Hlavachek D.O., Kondratenko O.Ye. Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment. Medicni perspektivi. 2023;28(3);12-18. DOI: https://doi.org/10.26641/2307-0404.2023.3.288925

Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment

The attention of scientists to the role of the epigenome in the development of human diseases is associated with the discovery of new non-coding RNA molecules of the epigenome that affect gene expression with changes in protein function and the development of diseases. The study analyzed current scientific data on the effect of oxidative stress induced by cadmium on the regulatory mechanisms of the epigenome, resulting in the development of pathological changes in the body. The results of the study showed that cadmium manifests its toxicity by oxidizing micro RNAs and long RNAs that regulate gene expression without changing DNA/histone complexes. It has been shown that epigenetic disorders under the influence of cadmium-induced oxidative stress can be transmitted to offspring without changing the genotype, and these aberrant changes in non-coding RNA expression patterns are associated with aging, cancer, neurodegenerative, cardiovascular diseases, etc. Circulating micro RNAs that are sensitive to oxidative stress are reported to be potential biomarkers of cardiovascular diseases, including myocardial infarction, hyper­trophy, ischemia/reperfusion, and heart failure. Many studies are aimed at using microRNAs for therapeutic purposes. The complete expression profile of microRNAs in human atherosclerotic plaques was studied, and the mechanisms affecting their formation were identified. Specific microRNAs and reactive oxygen species were identified as potential biomarkers in human malignancies, which expands the possibilities of their use as therapeutic targets. Unlike micro RNAs, the expression of long RNAs has tissue and species specificity, making them important candidates for specific disease markers. The role of these RNAs in carcinogenesis is being actively studied. A large number of them are disrupted at various types of cancer and may play an im­portant role in the onset, metastasis, and therapeutic response of cancer. Thus, oxidative stress induced by cad­mium affects non-coding RNAs, which disrupts the regulatory mechanisms of the epigenome and affects the deve­lopment of cardiovascular, oncological, pulmonary and other human diseases. The search for the impact of non-coding RNAs on the epigenome is constantly growing and has great scientific and practical prospects in medicine.

Key words: cadmium, oxidative stress, non-coding RNAs of the epigenome, development of cancer and cardiovascular diseases

1. Yan L-J, Allen DC. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism. Biomolecule.2021;11:1575. doi: https://doi.org/10.3390/biom11111575
2. Sweef O, Yang C, Wang Z. The Oncogenic and Tumor Suppressive Long Non-Coding RNA–microRNA–Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer. Biomedicine. 2022;10(10):2334. doi: https://doi.org/10.3390/biomedicines10102334
3. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular Cancer.2011;10:38.
   doi: https://doi.org/10.1186/1476-4598-10-38
4. Krol J, Loedige I, Filipowicz W. The widesp­read regulation of microRNA biogenesis, function and decay. Nature Reviews Genetics. 2010;11(9):597-610. doi: https://doi.org/10.1038/nrg2843
5. Sufianov A, Begliarzade S, Kudriashov V, Nafi­kova R, Ilyasova T, Liang Y. Role of міРНК in vascular development. Non-coding RNA Research. 2023;8(1):1-7. doi: https://doi.org/10.1016/j.ncrna.2022.09.010
6. Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nature Reviews Genetics.2016;17:47-62. doi: https://doi.org/10.1038/nrg.2015.10
7. Fromm B, Billipp T, Peck LE, Johansen M, Tar­ver JE, King BL, et al. A Uniform System for the Anno­tation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome. Annual Review of Genetics. 2015;49:213-42.
   doi: https://doi.org/10.1146/annurev-genet-120213-092023
8. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Research. 2009;19:92-105. doi: https://doi.org/10.1101/gr.082701.108
9. Wang JX, Gao J, Ding SL, Wang K, Jiao JQ, Wang Y, et al. Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w. Molecular Cell. 2015;59(1):50-61. doi: https://doi.org/10.1016/j.molcel.2015.05.003
10. Yu C, Yang C, Song X, Li J, Peng H, Qiu M, et al. Long Non-coding RNA Expression Profile in Broiler Liver with Cadmium-Induced Oxidative Damage. Biological Trace Element Research. 2021;199:3053-61. doi: https://doi.org/10.1007/s12011-020-02436-w
11. Wallace DR, Taalab YM, Heinze S, Lova­ković T, Pizent B, Renieri A, et al. Toxic-Metal-Induced Alteration in miRNA. Expression Profile as a Proposed Mechanism for Disease Development. Cells. 2020;9:901. doi: https://doi.org/10.3390/cells9040901
12. Li H, Fagerberg B, Sallsten G, Borné Y, Hed­blad B, Engström G, et al. Smoking-induced risk of future cardiovascular disease is partly mediated by cadmium in tobacco: Malmö Diet and Cancer Cohort Study. Environ­mental 2019;18(1):56. doi: https://doi.org/10.1186/s12940-019-0495-1
13. D’Oria R, Schipani R, Leonardini A, Natalic­chio A, Perrini S, Cignarelli A, et al. The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor. Oxidative Medicine and Cellular Longevity. 2020;2020:5732956. doi: https://doi.org/10.1155/2020/5732956
14. Toro R, Pérez-Serra A, Mangas A, Campuzano O, Sarquella-Brugada G, Quezada-Feijoo M, et al. MiR-16-5p Suppression Protects Human Cardiomyocytes against En­doplasmic Reticulum and Oxidative Stress-Induced Injury. International J of Molecular Sciences. 2022;23:1036. doi: https://doi.org/10.3390/ijms23031036
15. Handy DE, Castro R, Loscalzo J. Epigenetic mo­difications: basic mechanisms and role in cardiovascular disease. Circulation.2011;123(19):2145-56. doi: https://doi.org/10.1161/CIRCULATIONAHA.110.956839
16. Climent M, Viggian G, Chen YW, Coulis G, Cas­taldi A. MicroRNA and ROS Crosstalk in Cardiac and Pul­monary Diseases. International J of Molecular Sciences. 2020;21(12):4370. doi: https://doi.org/10.3390/ijms21124370
17. Alonso-Villa E, Bonet F, Hernandez-Torres F, Campuzano Ó, Sarquella-Brugada G, Quezada-Feijoo M, et al. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity. International J of Mo­lecular Sciences. 2022;23(21):13573. doi: https://doi.org/10.3390/ijms232113573
18. Kura B, Szeiffova Bacova B, Kalocayova B, Sy­kora M, Slezak J. Oxidative Stress-Responsive Mic­roRNAs in Heart Injury. International J of Molecular Sciences.2020;21:358. doi: https://doi.org/10.3390/ijms21010358
19. Aavik Einari, Henri Lumivuori, Olli Leppänen, Wirth T, Häkkinen S-K, Bräsen J-H, et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reacti­vation at imprinted locus 14q32 involving induction of a miRNA cluster. European Heart J. 2015;36(16):993-1000. doi: https://doi.org/10.1093/eurheartj/ehu437
20. Costantino S, Paneni F. The Epigenome in Athero­sclerosis. Handb Exp Pharmacol. 2022;270:511-35. doi: https://doi.org/10.1007/164_2020_422
21. Tong K, Tan KE, Lim YY, Tien XY, Wong PF. CircRNA-miRNA interactions in atherogenesis. Molecular and Cellular Biochemistry. 2022;477(12):2703-33. doi: https://doi.org/10.1007/s11010-022-04455-8
22. Carbonell T, Gomes AV. MicroRNA in the regu­la­tion of cellular redox status and its implications in myocardial ischemia-reperfusion injury. Redox Biology. 2020;36:101607. doi: https://doi.org/10.1016/j.redox.2020.101607
23. Jeffries MA. The Development of Epigenetics in the Study of Disease Pathogenesis. Advances in Expe­rimental Medicine and Biology. 2020;1253:57-94. doi: https://doi.org/10.1007/978-981-15-3449-2_2
24. Martinez-Zamudio R, Ha HC. Environmental epi­genetics in metal exposure. Epigenetics. 2011;6:820-7. doi: https://doi.org/10.4161/epi.6.7.16250
25. Ren C, Ren L, Yan J, Bai Z, Zhang L, Zhang H, et al. Cadmium causes hepatopathy by changing the status of DNA methylation in the metabolic pathway. Toxicology Letters.2021;340:101-13. doi: https://doi.org/10.1016/j.toxlet.2020.12.009
26. Mortoglou M, Buha Djordjevic A, Djordjevic V, Collins H, York L, Mani K, et al. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma. Archives of Toxicology. 2022;96:467-85. doi: https://doi.org/10.1007/s00204-021-03196-9
27. Hernández-Cruz EY, Arancibia-Hernández YL, Loyola-Mondragón DY, Pedraza-Chaverri J. Oxidative Stress and Its Role in Cd-Induced Epigenetic Modi­fications: Use of Antioxidants as a Possible Preventive Strategy. 2022;2(2):177-212. doi: https://doi.org/10.3390/oxygen2020015
28. Liu Y, Qiang W, Xu X, Dong R, Karst AM, Liu Z, et al. Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells. Oncotarget.2015;6:38983-98. doi: https://doi.org/10.18632/oncotarget.5493
29. Fernandez M, Miguel V, Lamas S. Role of redo­ximiRs in fibrogenesis. Redox Biology. 2016;7:58-67. doi: https://doi.org/10.1016/j.redox.2015.11.006
30. Meseguer S, Martinez-Zamora A, Garcia-Aru­mi E, et al. The ROS-sensitive microRNA-9/9 controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome. Human Molecular Genetics.2015;24:167-84. doi: https://doi.org/10.1093/hmg/ddu427
31. Lan J, Huang Z, Han J, Shao J, Huang C. Redox re­gulation of microRNAs in cancer. Cancer Letters. 2018;418:250-9. doi: https://doi.org/10.1016/j.canlet.2018.01.010
32. Lin YH. MicroRNA Networks Modulate Oxi­dati­ve Stress in Cancer. International J of Molecular Sciences. 2019;20(18):4497. doi: https://doi.org/10.3390/ijms20184497
33. Haque MM, MuraleDP, Lee  Role of microRNA and Oxidative Stress in Influenza A Virus Pathogenesis. International J of Molecular Sciences. 2020;21(23):8962. doi: https://doi.org/10.3390/ijms21238962
34. He R, Xie X, Lv L, Huang Y, Xia X, Chen X, et al. Comprehensive investigation of aberrant microRNAs expression in cells culture model of MnCl2-induced neurodegenerative disease. Biochemical and Biophysical Research 2017;486:342-8. doi: https://doi.org/10.1016/j.bbrc.2017.03.041
35. Wen Q, Verheijen M, Wittens MM, Czuryło J, Engelborghs S, Hauser D, et al. Lead-exposure associated міРНК in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes. Scientific Reports.2022;12(1):15966. doi: https://doi.org/10.1038/s41598-022-20305-5
36. Wang PS, Wang Z, Yang C. Dysregulations of long non-coding RNAs – The emerging “lnc” in environ­mental carcinogenesis. Seminars in Cancer Biology. 2021;76:163-72. doi: https://doi.org/10.1016/j.semcancer.2021.03.029
37. Ren C, Ren L, Yan J, Bai Z, Zhang L, Zhang H, et al. Cadmium causes hepatopathy by changing the status of DNA methylation in the metabolic pathway. Toxicology Letters.2021;340:101-13. doi: https://doi.org/10.1016/j.toxlet.2020.12.009
38. Miguel V, Lamas S, Espinosa-Diez C. Role of non-coding-RNAs in response to environmental stressors and consequences on human health. Redox Biology. 2020;37:101580. doi: https://doi.org/10.1016/j.redox.2020.101580
39. Po-Shun W, Zhishan W, Chengfeng Y. Dysre­gulations of long non-coding RNAs – The emerging “lnc” in environmental carcinogenesis. Seminars in Cancer Biology.2021;76:163-72. doi: https://doi.org/10.1016/j.semcancer.2021.03.029
40. Ramírez-Moya J, Wert-Lamas L, Riesco-Eiza­guirre G, Santisteban P. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness. Oncogene. 2019;38:5486-99. doi: https://doi.org/10.1038/s41388-019-0804-8
41. He J, Jiang BH. Interplay between reactive oxygen species and microRNAs in cancer. Current Pharmacology Reports.2016;2:82-90. doi: https://doi.org/10.1007/s40495-016-0051-4
42. Tan W, Liu B, Qu S, Liang G, Luo W, Gong C. MicroRNAs and cancer: Key paradigms in molecular therapy.Oncology  2018;15:2735-42. doi: https://doi.org/10.3892/ol.2017.7638
43. Manić L, Wallace D, Onganer PU, Taalab YM, Farooqi AA, Antonijević B, et al. Epigenetic mechanisms in metal carcinogenesis. Toxicology Reports. 2022;9:778-87. doi: https://doi.org/10.1016/j.toxrep.2022.03.037
44. Waalkes M. Cadmium carcinogenesis in review. J ofInorganic  2000;79:241-4. doi: https://doi.org/10.1016/S0162-0134(00)00009-X
45. Grioni S, Agnoli C, Krogh V, Pala V, Rinaldi S, Vinceti M, et al. Dietary cadmium and risk of breast cancer subtypes defined by hormone receptor status: A prospective cohort study. International J of Cancer. 2019;144:2153-60. doi: https://doi.org/10.1002/ijc.32039
46. Kim TH, Kim JH, Kim Le, Suh MD, Kim WD, Yeon JE, et al. Exposure assessment and safe intake gui­delines for heavy metals in consumed fishery products in the Republic of Korea. Environmental Science and Pollution Research. 2020;27:33042-51. doi: https://doi.org/10.1007/s11356-020-09624-0
47. Wang Y, Mandal AK, Son Y-O, Pratheeshku­mar P, Wise JT, Wang L, et al. Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane. Toxicology and Applied Pharmacology. 2018;353:23-30. doi: https://doi.org/10.1016/j.taap.2018.06.003
48. Wang Z, Wu J, Humphries B, Kondo K, Jiang Y, Shi X, et al. Upregulation of histone-lysine methyltrans­ferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transfor­mation. Toxicology and Applied Pharmacology. 2018;342:22-30. doi: https://doi.org/10.1016/j.taap.2018.01.022
49. Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology. 2020:1-23. doi: https://doi.org/10.1038/s41580-020-00315-9
50. Tsagakis I, Douka K, Birds I, Aspden JL. Long non-coding RNAs in development and disease: conservation to mechanisms. The J of pathology. 2020;250(5):480-95. doi: https://doi.org/10.1002/path.5405
51. Rinn JL, Chang HY. Long noncoding RNAs: mo­lecular modalities to organismal functions. Annual Review of Biochemistry. 2020;89:283-308. doi: https://doi.org/10.1146/annurev-biochem-062917-012708
52. Huang Q, Lu Q, Chen B, Shen H, Liu Q, Zhou Z, et al. LncRNA-MALAT1 as a novel biomarker of cad­mium toxicity regulates cell proliferation and apoptosis. Toxicology 2017;6(3):361-71. doi: https://doi.org/10.1039/C6TX00433D
53. Zhou Z, Huang Z, Chen B, Lu Q, Cao L, Chen W. LncRNA-ENST00000446135 is a novel biomarker of cad­mium toxicity in 16HBE cells, rats, and Cd-exposed wor­kers and regulates DNA damage and repair. Toxicology Research.2020;9(6):823-34. doi: https://doi.org/10.1093/toxres/tfaa088
54. Brzóska MM, Borowska S, Tomczyk M. Antioxi­dants as a Potential Preventive and Therapeutic Strategy for Cadmium. Current Cancer Drug Targets. 2016;17:1350-84. doi: https://doi.org/10.2174/1389450116666150506114336
55. Bishop KS, Ferguson LR. The interaction between epigenetics, nutrition and the development of cancer. Nutrients.2015;7:922-47. doi: https://doi.org/10.3390/nu7020922
56. García-Guede А, Vera O, Ibáñez-de-Caceres I. When Oxidative Stress Meets Epigenetics: Implications in Cancer Development. Antioxidants. 2020;9:4684. doi: https://doi.org/10.3390/antiox9060468
57. Yoshioka Y, Ohishi T, Nakamura Y, Fukutomi R, Miyoshi N. Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs. Molecules. 2022;27(12):3816. doi: https://doi.org/10.3390/molecules27123816

Look through:

Ostrovska S.S. “European Medical University” LLC, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-0373-3491

Dychko Ye.N. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0001-6633-4028

Shumna T.Ye. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0003-0557-6714

Titov G.I. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0002-5460-0728

Trushenko O.S. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0002-1719-1451

Gerasymchuk P.G. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0001-9698-1912

Burega I.Y. “European Medical University” LLC, Dnipro, Ukraine 
https://orcid.org/0000-0001-6425-4286

Ostrovska S.S., Dychko Ye.N., Shumna T.Ye., Titov G.I., Trushenko O.S., Gerasymchuk P.G., Burega I.Y.  The role of oxidized non-coding RNAs of the epigenome in the development of human diseases (literature review). Medicni perspektivi. 2023;28(3):19-27.
DOI: https://doi.org/10.26641/2307-0404.2023.3.288926

The role of oxidized non-coding RNAs of the epigenome in the development of human diseases (literature review)

This review article provides a summary and update on the role of epigenetic mechanisms in predisposition and progression of diabetes, analyzes the data concerning the cause-and-effect relationship between epigenetic changes and the emergence of distinct metabolic phenotypes. Extensive genetic research has enabled the isolation of a group of genes associated with a high risk of developing diabetes. However, numerous data point to the key role of so-called epigenetic modifications in the interaction between genes and the environment, which arise during ontogenesis based on the existing genotype under the influence of external factors. These modifications do not affect the primary DNA sequence, but influence gene expression through chemical modification and alteration of the secondary structure of DNA molecules and chromatin. Epigenetic mechanisms can program pathological phenotypes in subsequent generations. The main molecular mechanisms of epigenetic modifications are DNA methylation, histone and miRNA modification. Changes in the expression of genes that ensure the synthesis of key enzymes and regulatory molecules lead to disruption in the main signaling metabolic pathways. Deregulation of genes responsible for inflammatory, atherosclerotic and other pathological processes, in particular, leads to endothelial dysfunction and development of diabetic complications, such as cardiovascular diseases, diabetic nephropathy, retinopathy, neuropathy. Hyperglycemia, oxidative stress, inflammatory factors are known as mediators in the pathogenesis of type 2 diabetes and its complications. Since epigenetic modifications are reversible, the methylation process can be influenced by exercise, dietary, lifestyle changes and pharmacological agents such as methyl group donors. For example, S-adenosylmethionine, through participation in methylation reactions, can modulate the folate cycle function and production of homocysteine, an endothelium-toxic substance. Thus, the study of molecular modifications in chromatin structure and the features of activation and inhibition of various signaling pathways is a pressing task, the resolution of which will enable a deeper understanding of the pathogenesis of diabetes and the development of approaches to correct metabolic disorders.

Key words: type 2 diabetes, epigenetic modifications, gene expression, DNA methylation

1. Korpachev VV, Prybyla OV, Korpacheva-Zi­nych OV, Kushnareva NM, Gurina NM, Kovalchuk AV. [Anthropometric, hormonal and biochemical markers of metabolic phenotype in patients with type 2 diabetes]. [Internet]. Universum: medicine and pharmacology: electron scientific magazine. 2016 [cited 2023 Apr 17];1-2(24). Russian. Availablefrom: https://7universum.com/pdf/med/1-2(24)/Korpachev.pdf
2. Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019 Jul;571(7766):489-99. doi: https://doi.org/10.1038/s41586-019-1411-0
3. Glotka LI. [Role of genetic and epigenetic factors in formation of obesity and cardiometabolic disorders in boys]. Ukrainian Journal of Pediatric Endocrinology. 2020;4:4-7. Ukrainian. doi: https://doi.org/10.30978/UJPE2020-4-4
4. Savelyeva-Kulik NA. [Obesity and diabetes: reversible epigenetics and lifestyle – the key to success?]. Ukrainian medical journal. 2019;05:02. Russian. doi: https:// doi.org/www.umj.com.ua.02.05.2019
5. Wang L, Dong C, Lu C, Li S, Fu L, Cong B. A stu­dy of strong nucleosomes in the human genome. Science. 2022 Jun 13;25(7):104593. doi: https://doi.org/10.1016/j.isci.2022.104593
6. Hale PJ, López-Yunez AM, Chen JY. Genome-wide meta-analysis of genetic susceptible genes for Type 2 Diabetes. BMC Syst Biol. 2012;6(Suppl 3):S16. doi: https://doi.org/10.1186/1752-0509-6-S3-S16
7. DeForest N, Majithia AR. Genetics of Type 2 Diabetes: Implications from Large-Scale Studies. Curr Diab Rep. 2022 May;22(5):227-35. doi: https://doi.org/10.1007/s11892-022-01462-3
8. Wu Y, Tian H, Wang W, Li W, Duan H, Zhang D. DNA methylation and waist-to-hip ratio: an epigenome-wide association study in Chinese monozygotic twins. J Endocrinol 2022 Dec;45(12):2365-76. doi: https://doi.org/10.1007/s40618-022-01878-4
9. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown F, Bruemmer D, et al. on behalf of the American Diabetes Association. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19-S40. doi: https://doi.org/10.2337/dc23-S007
10. Dashti M, Nizam R, Hebbar P, Jacob S, Sumi E, Channanath A, et al. Differentially methylated and expres­sed genes in familial type 1 diabetes. Sci Rep. 2022;12:11045. doi: https://doi.org/10.1038/s41598-022-15304-5
11. Piko P, Werissa NA, Fiatal S, Sandor J, Adany R. Impact of genetic factors on the age of onset for type 2 diabetes mellitus in addition to the conventional risk factors. JPers  2020;11(1):6. doi: https://doi.org/10.3390/jpm11010006
12. Touré M, Samb A, Sène M, Thiam S, Mané CA, et al. Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females. BMC Med Genomics. 2022;15(1):186. doi: https://doi.org/10.1186/s12920-022-01337-2
13. Ling CJ, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29:1028-44. doi: https://doi.org/10.1016/j.cmet.2019.03.009
14. Ling CJ. Epigenetic regulation of insulin action and secretion – role in the pathogenesis of type 2 diabetes. Intern 2020 Aug;288(2):158-67. doi: https://doi.org/10.1111/joim.13049
15. Suárez R, Chapela SP, Álvarez-Córdova L, Bau­tista-Valarezo E, Sarmiento-Andrade Y, Verde L, et al. Epigenetics in Obesity and Diabetes Mellitus: New Insights. Nutrients. 2023;15(4):811. doi: https://doi.org/10.3390/nu15040811
16. Parveen N, Dhawan S. DNA Methylation Patter­ning and the Regulation of Beta Cell Homeostasis. Front Endocrinol (Lausanne). 2021;12:651258. doi: https://doi.org/10.3389/fendo.2021.651258
17. Maden SK, Walsh B, Ellrott K, Hansen KD, Thompson RF, Nellore A. recountmethylation enables flexible analysis of public blood DNA methylation array data. Bioinform Adv. 2023 Feb 20;3(1):vbad020. doi: https://doi.org/10.1093/bioadv/vbad020
18. Zatterale F, Raciti GA, Prevenzano I, Leone A, Campitelli M, De Rosa V, et al. Epigenetic Reprogram­ming of the Inflammatory Response in Obesity and Type 2 Diabetes. Biomolecules. 2022 Jul 14;12(7):982. doi: https://doi.org/10.3390/biom12070982
19. Akbari M, Hassan-Zadeh V. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes. Inflammopharmacology. 2020 Apr;28(2):345-62. doi: https://doi.org/10.1007/s10787-019-00663-9
20. Wang X, Yang W, Zhu Y, Zhang S, Jiang M, Hu J, et al. Genomic DNA methylation in diabetic chronic complications in patients with type 2 diabetes mellitus. Front 2022;13:896511. doi: https://doi.org/10.3389/fendo.2022.896511
21. Zhang H, Han X, Wang M, Hu Q, Li S, Wang M, et al. The association between genomic DNA methylation and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. J Diabetes Res. 2019;2019:2494057. doi: https://doi.org/10.1155/2019/2494057
22. Vaiserman A, Lushchak O. Developmental ori­gins of type 2 diabetes: Focus on epigenetics. Ageing Res Rev. 2019 Nov;55:100957. doi: https://doi.org/10.1016/j.arr.2019.100957
23. Novak A, Bowman P, Kraljevic I, Tripolski M, Houghton JA, De Franco E, et al. Transient Neonatal Diabetes: An Etiologic Clue for the Adult Diabetologist. Can J Diabetes. 2020 Mar;44(2):128-30. doi: https://doi.org/10.1016/j.jcjd.2019.05.002
24. Khan AI. Do second generation sequencing tech­niques identify documented genetic markers for neonatal diabetes mellitus? Heliyon. 2021 Aug 30;7(9):e07903. doi: https://doi.org/10.1016/j.heliyon.2021.e07903
25. Tolstikova OO, Aharkov SF. [Modern views on metabolic syndrome in children and adolescents]. Likarska sprava.2019;5-6:27-39.  doi: https://doi.org/10.31640/JVD.5-6.2019(3)
26. Meyre D, Andress EJ, Sharma T, Snippe M, Asif H, Maharaj A, et al. Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-meta­bolic complications. Sci Rep. 2019 Nov 20;9(1):17123. doi: https://doi.org/10.1038/s41598-019-53388-8
27. Mansour A, Mousa M, Abdelmannan D, Tay G, Hassoun A, Alsafar H. Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses. Front Endocrinol (Lausanne). 2023 Mar 23;14:1143067. doi: https://doi.org/10.3389/fendo.2023.1143067
28. Reznikov OG, Sachynska OV, Falіush OA, Lyma­ryeva AA, Perchyk IG. [Endocrine disruptors — prenatal factors of reproductive health disorders]. Endokrynologia. 2023;28(1):21-35. Ukrainian. doi: https://doi.org/10.31793/1680-1466.2023.28-1.21
29. Kern B, Podkrajšek K, Kovač J, Šket R, Bizjan B, Tesovnik T, et al. The role of epigenetic modifications in late complications in type 1 diabetes. Genes. 2022;13(4):705. doi: https://doi.org/10.3390/genes13040705
30. Sokolova LK, Pushkarev VM, Kovzun EI, Push­karev VV, Tronko ND. [Metabolic-associated diseass and the role of epigenetics and epigenetic age in their preven­tion]. Ukrainian J Cardiol. 2017;6:104-15. Ukrainian. doi: http://doi.org/nbuv.gov.ua/UJRN/Ukzh_2017_6_13
31. Shtanko VA, Tikhonova SA, Khyzhnyak OV, Ma­rish MYu, Tesliuk GB. [The role of genetic and epigenetic factors in the formation of hypertensive phenotype and associated metabolic disorders in patients with arterial hypertension]. Integrative Anthropology. 2015;1:38-41. Ukrainian.
32. Kumric M, Ticinovic Kurir T, Borovac JA, Bo­zic J. Role of novel biomarkers in diabetic cardio­myo­pathy. World J Diabetes. 2021;12(6):685-705. doi: https://doi.org/10.4239/wjd.v12.i6.685
33. Prandi F, Lecis D, Illuminato F, Milite M, Celot­to R, Lerakis S, et al. Epigenetic modifications and non-coding RNA indiabetes-mellitus-induced coronary artery disease: pathophysiological link and new therapeutic frontiers. IntJ Mol  2022;23:4589. doi: https://doi.org/10.3390/ijms23094589  
34. Geng T, Zhu K, Lu Q, Wan Z, Chen X, Liu L, et al. Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study. PLoS Med. 2023 Jan 10;20(1):e1004135. doi: https://doi.org/10.1371/journal.pmed.1004135
35. Rönn T, Volkov P, Davegårdh C, Dayeh T, Hall E, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PloS Genet. 2013;9(6):e1003572. doi: https://doi.org/10.1371/journal.pgen.1003572
36. Garcia LA, Zapata-Bustos R, Day SE, Campos B, Hamzaoui Y, Wu L, et al. Can exercise training alter human skeletal muscle DNA methylation? Metabolites. 2022;12(3):222. doi: https://doi.org/10.3390/metabo12030222
37. Światowy WJ, Drzewiecka H, Kliber M, Sąsia­dek M, Karpiński P, Pławski A, et al. Physical Activity and DNA Methylation in Humans. Int J Mol Sci. 2021 Nov 30;22(23):12989. doi: https://doi.org/10.3390/ijms222312989
38. Sun C, Förster F, Gutsmann B, Moulla Y, Stroh C, Dietrich A, et al. Metabolic effects of the waist-to-hip ratio associated locus GRB14/COBLL1 are related to GRB14 ex­pression in adipose tissue. Int J Mol Sci. 2022;23(15):8558. doi: https://doi.org/10.3390/ijms23158558
39. Nicoletti CF, Roschel H, Merege-Filho C, Lima AP, Gil S, Pinhel MA, et al. Exercise training and DNA me­thy­la­tion profile in post-bariatric women: Results from an ex­plo­ratory study. Front Sports Act Living. 2023 Feb 8;5:1092050. doi: https://doi.org/10.3389/fspor.2023.1092050
40. Hunter DJ, James LS, Hussey B, Ferguson RA, Lindley MR, Mastana SS. Impacts of Eccentric Resistance Exercise on DNA Methylation of Candidate Genes for Inflammatory Cytokines in Skeletal Muscle and Leu­kocytes of Healthy Males. Genes (Basel). 2023 Feb 13;14(2):478. doi: https://doi.org/10.3390/genes14020478
41. Garcia LA, Zapata-Bustos R, Day SE, Campos B, Hamzaoui Y, Wu L, et al. Can exercise training alter hu­man skeletal muscle DNA methylation? Metabolites. 2022;12(3):222. doi: https://doi.org/10.3390/metabo12030222
42. Raghubeer S, Matsha T. Methylenetetrahydro­fo­late (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients. 2021;13(12):4562. doi: https://doi.org/10.3390/nu13124562
43. Zhao M, Yuan M, Yuan L, Huang LL, Liao JH, Yu XL, et al. Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice. PLoS One. 2018;13(8):e0202910. doi: https://doi.org/10.1371/journal.pone.0202910
44. Elias MF, Brown CJ. New Evidence for Homo­cysteine Lowering for Management of Treatment-Resis­tant Hypertension. Am J Hypertens. 2022 Apr 2;35(4):303-5. doi: https://doi.org/10.1093/ajh/hpab194
45. Smyth L, Kilner J, Nair V, Liu H, Brennan E, Kerr K, et al. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: An exploratorystudy. Clin. Epigenetics 2021;13(1):99. doi: https://doi.org/10.1186/s13148-021-01081-x
46. Singh R, Chandel S, Dey D, Ghosh A, Roy S, Ra­vichandiran V, et al. Epigenetic modification and thera­peutic targets of diabetes mellitus. Biosci Rep. 2020 Sep 30;40(9):BSR20202160. doi: https://doi.org/10.1042/BSR20202160
47. Shuprovych A, Trofymenko O. Shuprovych A, Trofymenko O. [Significance of folate cycle gene poly­morphisms and their epigenetic modifications in the pathogenesis of type 2 diabetes and its complications]. Endokrynolohiia. 2022 Sep 30;27(3):243-50. Ukrainian. doi: https://doi.org/10.31793/1680-1466.2022.27-3.243
48. Kolesnikova OV, Zaprovalna OE, Potapenko AV. [Metabolic-associated diseases and the role of epigenetics, eoigenetic age in their prevention]. Therapeutic Journal. 2020;3:52-60. Ukrainian. doi: https://doi.org/10.30978/UTJ2020-3-52
49. Zinych OV, Shuprovich AA, Prybyla OV, Kush­na­reva NM, Kovalchuk AV, Korpachev VV, et al. [Pecu­liarities of anabolic-catabolic balance in type 2 diabetic patients with different metabolic phenotypes]. 2023;80(1):22-9. Ukrainian. doi: https://doi.org/10.21856/j-PEP.2023.1.03

Look through:

Zinych O.V. SI “V.P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science”, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
 https://orcid.org/0000-0002-0516-0148

Shuprovych A.A. SI “V.P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science”, Kyiv, Ukraine
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-7437-0309

Trofymenko O.M. SI “V.P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science”, Kyiv, Ukraine
https://orcid.org/0000-0002-0512-7997

Komisarenko K.P. SI “V.P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science”, Kyiv, Ukraine
https://orcid.org/0000-0002-6318-755X

Zinych O.V., Shuprovych A.A., Trofymenko O.M., Komisarenko K.P. The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mellitus (a literature review). Medicni perspektivi. 2023;28(3):28-35.
DOI: https://doi.org/10.26641/2307-0404.2023.3.288928

The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mellitus (a literature review)

Severe chronic urticaria (SCU) is a common disease that burdens the lives of millions of people, reduces their quality of life, and imposes a significant economic burden not only on the health care system, but also directly on the patient. To date, a single approach regarding the optimal dosing of omalizumab in this cohort of patients has not been determined. The purpose of the work: based on the assessment of the quality of life of patients with SCU and dynamic clinical and laboratory observation, to study the effectiveness and prove the feasibility of using the minimum dose of 150 mg for omalizumab according to the scheme every 21 days intramuscularly three times, which will allow to optimize the treatment tactics of these patients and reduce the economic burden of the cost of their treatment. In a prospective single-center study lasting 33 weeks, 104 patients with a diagnosis of SCU were included. All patients underwent a general clinical examination, quality of life indicators using the SKINDEX-29 questionnaire were studied; blood tryptase level once before the start of treatment using ImmunoCAP was determined, the level of total IgE in blood serum using an immunochemical method with electrochemiluminescence detection before and after the end of treatment was determined. The patients were divided into two groups: Group 1 (54 people) had a relapse of urticaria within 3 to 6 months after completing a course of second-generation histamine H1-receptor blockers and received a course of omalizumab at a dose of 150 mg intramuscularly every three weeks three times. Group 2 (50 people) had a relapse of urticaria no earlier than 6 months after the previous course of second-generation histamine H1-receptor blockers and received desloratadine, 5 mg during the first four weeks and 20 mg during the next four weeks. Indicators of urticaria activity (UAS7) and quality of life (SKINDEX-29) in patients were determined before the start of treatment and at each of the visits (on the 10th, 31st and 52nd days of therapy when treated with omalizumab and five and nine weeks after initiation of desloratadine therapy), and UAS7 was assessed six months after the end of treatment. Methods of descriptive and analytical statistics were used to process the obtained data. According to our data, patients with SCU are mostly people of working age, more than half of whom have a history of the disease for five years or more, in 70% of cases of a valid study, they are characterized by an increased content of total IgE and have a low level of indicators according to the questionnaire SKINDEX-29 at the level of physical symptoms, emotional sphere and functioning. We found that in patients of observation Groups 1 and 2, after the treatment, the level of total IgE in blood serum decreased statistically significantly. In patients of Group 1, the appointment of omalizumab in the minimum dose made it possible to ensure the control of urticaria symptoms already after the first injection in 15% of cases, and after the third injection there was a stable remission with the absence of urticaria symptoms during six months of follow-up in 92.3% of patients, against the existing 24% of subjects of Group 2, who after therapy according to UAS7 had very severe and severe symptoms. After the completion of treatment in patients of Group 2, nine weeks after the initiation of desloratadine therapy according to the SKINDEX-29 questionnaire, 44% of cases and 46% of very severe negative effects of urticaria on the emotional sphere and functioning remained, respectively; and in 46% of cases there was a low quality of life according to the generalized assessment of the impact of the disease at the level of "severe". At the same time, among the patients of Group 1, after completion of omalizumab therapy on the 52nd day of observation, no case of severe or very severe negative impact of urticaria on the quality of life was registered in any of the domains. Thus, the effectiveness and justified expediency of prescribing omalizumab treatment of 150 mg with an interval of 21 days three times in patients with SCU, who have a recurrence of chronic dermatosis within 3 to 6 months after the second-generation histamine H1-receptor blocker therapy has been confirmed.

Key words: urticaria, chronic forms of dermatosis, quality of life, rash, itching, immunoglobulin E, monoclonal antibodies, antihistamines, serum tryptase

1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy.2022;77(3):734-66. doi: https://doi.org/10.1111/all.15090
2. Denysenko OI. [Modern approaches to the treat­ment of chronic spontaneous urticaria in adult patients]. Ukrainskyi zhurnal dermatolohii, venerolohii, kosmeto­lohii. 2020;2:34-40. Ukrainian. doi: https://doi.org/10.30978/UJDVK2020-2-34
3. Kolkhir P, Giménez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers.2022;8(1):1-22. doi: https://doi.org/10.1038/s41572-022-00389-z
4. Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spon­taneous urticaria: Results of the PURIST Study. Allergy. 2019;74:2427-36. doi: https://doi.org/10.1111/all.13949
5. Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society. BrJ  2021;184(2):226-36. doi: https://doi.org/10.1111/bjd.19561
6. Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Ruëff F, et al. H1-antihistamine-refractory chro­nic spontaneous urticaria: it's worse than we thought – first results of the multicenter real-life AWARE study. Clin Exp Allergy.2017;47(5):684-92. doi: https://doi.org/10.1111/cea.12900
7. Tharp MD, Bernstein JA, Kavati A, Ortiz B, MacDonald K, Denhaerynck K, et al. Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence. JAMA Der­matol.2019;155(1):29-38. doi: https://doi.org/10.1001/jamadermatol.2018.3447
8. Curto-Barredo L, Spertino J, Figueras-Nart I, Ex­pósito-Serrano V, Guilabert A, Melé-Ninot G, et al. Oma­lizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria. Br J Dermatol. 2018;179(1):210-2. doi: https://doi.org/10.1111/bjd.16379
9. Metz M, Vadasz Z, Kocatürk E, Giménez-Ar­nau AM. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. Clin Rev Allergy 2020;59(1):38-45. doi: https://doi.org/10.1007/s12016-020-08794-6
10. Maurer M, Weller K, Bindslev-Jensen C, et al. Un­met clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317-30. doi: https://doi.org/10.1111/j.1398-9995.2010.02496.x
11. Lacour JP, Khemis A, Giordano-Labadie F, et al. The burden of chronic spontaneous urticaria: unsatis­factory treatment and healthcare resource utilization in France (the ASSURE-CSU study). Eur J Dermatol. 2018;28(6):795-802. doi: https://doi.org/10.1684/ejd.2018.3446
12. Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria Activity Score-Validity, Reliability, and Respon­siveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-90.e1. doi: https://doi.org/10.1016/j.jaip.2017.10.001
13. Botto N, Raffi J, Trivedi M, Ramirez F, Allen IE, Chren MM. Validating a Quality-of-Life Instrument for Allergic Contact Dermatitis. Dermatitis. 2019;30(5):300-5. doi: https://doi.org/10.1097/DER.0000000000000515
14. Immunoglobulin E (IgE), Individual Quant [Inter­net]. [cited 2023 Apr 02]. Available from: https://www.healthcare.uiowa.edu/path_handbook/rhandbook/test1094.html
15. Pagano M, Gauvreau K, Mattie H. Principles of Biostatistics. CRC Press; 2022. 735 p.
16. Agache I, Rocha C, Pereira A, et al. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines. Allergy. 2021;76:59-70. doi: https://doi.org/10.1111/all.14547

Look through:

Dytiatkovska Ye.M. Dnipro State Medical University; Public Non-profit Enterprise “Clinical Hospital of Emergency Medical Care of the Dnipro City Council", Allergology Center, Dnipro, Ukraine, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0001-9007-8634

Nedohybchenko N.O. Dnipro State Medical University, Dnipro, Ukraine
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0001-9644-0614

Dytiatkovska Ye.M., Nedohybchenko N.O. Optimization of the treatment of patients with severe chronic urticaria. Medicni perspektivi. 2023;28(3):36-45. DOI: https://doi.org/10.26641/2307-0404.2023.3.288930

Optimization of the treatment of patients with severe chronic urticaria

According to recent WHO estimates, chronic HBV infection is one of the leading causes of death and disability in patients with infectious diseases. From 780 thousand to 1 million deaths are annually recorded in the world as a result of cirrhosis of the liver and hepatocellular carcinoma. Pathogenetic features of the course and outcomes of chronic hepatitis B are determined by the immunological, genetic factors of the host, as well as the molecular biological structure of the virus. The aim of the work was to study the interaction of polymorphic loci of the cytokine genes SMAD 7 (rs4939827), TNFα (rs1800620), IL-10 (rs1800896), IL-4 (rs2243250) and the degree of structural changes in the liver based on the non-invasive Fibrotest technique in patients with chronic hepatitis B as part of a search for possible predictors of predisposition to the rapid progression of liver fibrosis. The study included 82 patients with chronic hepatitis B. Assessment of morphological changes (stage of fibrosis) was carried out by the method of non-invasive diagnosis of FibroScan, which is an alternative to puncture biopsy of the liver. It has been suggested that homozygous alleles СС IL-4 (rs2243250), GG TNFα (rs1800620), СС SMAD family member 7 (rs4939827) have a protective effect on the course of chronic hepatitis B, as these variants of allelic polymorphism of cytokine genes were found mainly in patients with CHB with a degree of fibrosis F0-F1. The heterozygous genotypes СТ IL-4 (rs2243250) and GA TNFα (rs1800620), the mutant homozygous ТТ SMAD family member 7 (rs4939827) have a profibrotic effect on the course of chronic hepatitis B, as they are found mainly in patients with chronic hepatitis B with degree of fibrosis F3. The established relationship between the liver fibrosis stage according to the METAVIR scale and the polymorphism of the cytokine genes SMAD 7 (rs4939827), TNFα (rs1800620) and IL-4 (rs2243250) made it possible to create a prognostic scale for assessing the individual risk of rapid progression of liver fibrosis. The proposed scale, due to a comprehensive assessment of the polymorphism of cytokine gene alleles and the stage of liver fibrosis using the METAVIR scale, makes it possible to carry out an individual assessment of the risk of progression of chronic hepatitis and, possibly, draw up a personalized treatment plan for the patient. Coding of the studied polymorphisms and subsequent counting can be automated, which does not require significant financial investments. The possibilities of the prognostic scale are proven on the example of a group of patients who received the antifibrotic agent bicyclol in comparison with the control group.

Key words: chronic hepatitis B, liver fibrosis, prognosis, allelic polymorphism of cytokine genes SMAD 7 (rs4939827), TNFα (rs1800620), IL-10 (rs1800896), IL-4 (rs2243250), antifibrotic therapy, bicyclol

1. [Public Health Center. Viral hepatitis 2020. Re­port]. [Internet]. Kyiv; 2021 [cited 2022 Dec 12]. 24 р. Ukrainian. Available from: https://phc.org.ua/sites/default/files/users/user90/A4_zvit_gepatit1021_online_zamina.pdf
2. Pashkov IV, Fedorova SF. [Immediate results of treatment with nucleotide/nucleoside analogues in patients with chronic hepatitis В]. Mizhnarodnyi medychnyi zhurnal. 2019;2(25):76-80. Ukrainian.
3. Lytovka SL, Batsiura HV, Berezenko VS, Bido­vanets OIu, Holubovska OA, Dyba MB, et al. [Viral hepa­titis B evidence-based clinical guidelines]. [Internet]. 2020. [cited 2022 Dec 12]. 159 р. Ukrainian. Available from: https://www.dec.gov.ua/wp-content/uploads/2021/01/2021_48_49_kn_vgv.pdf
4. European association for study of the liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatology. 2017;67:370-98. doi: https://doi.org/10.1016/j.jhep.2017.03.021
5. Herasun BA, Herasun OB. [Mutations of hepatitis B virus]. Hepatolohiia. 2019;2:45-52.
6. Afify SM, Hassan G, Osman A, et al. Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma. Bioengineering (Basel). 2019;6(3):E73. doi: https://doi.org/10.3390/bioengineering6030073
7. Calès P, Boursier J, Oberti F, et al. A 176 single blood test adjusted for different liver fibrosis targets im­proves fibrosis staging and especially cirrhosis diagnosis. Hepatol 2018;2(4):455-66. doi: https://doi.org/10.1002/hep4.1161
8. Moroz LV, Bondaruk IYu. [Diagnostic value of non-invasive markers of liver fibrosis in patients with chronic viral hepatitis C]. Hepatolohiia. 2019;2(44):28-34. Ukrainian.
9. Karsdal MA, et al. Collagen biology and non‐invasive biomarkers of liver fibrosis. Liver Int. 2020;40:736-50. doi: https://doi.org/10.1111/liv.14390
10. Usychenko EN, Usychenko EM. [Model of pre­diction of the progress of liver fibrosis on the basis of biochemical and genetic criteria in patients with chronic hepatitis С]. Georgian medical news. 2020;11(308):63-7. Russian.
11. Capelle C, Spit M, Dijke P. Current perspectives on inhibitory SMAD7 in health and disease. Critical Reviews in Biochemistry and Molecular Biology. 2020;55(6):691-715. doi: https://doi.org/10.1080/10409238.2020.1828260
12. [Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care for viral hepatitis B in adults. Order of the Ministry of Health of Ukraine 2016 Jun 21 No. 613]. Kyiv; 2016. 46 p. Ukrainian.
13. Lioznov DA, Geivandova NI, Morozov VG, et al. [Evaluation of the effectiveness of the original hepatoprotective drug Bicyclol in patients with chronic viral hepatitis C]. Ukrainskyi medychnyi chasopys. 2014;6(104):14-7. Russian.
14. [New opportunities in the treatment of chronic hepatitis. Bicyclol – 15 years of effective therapy!] [Internet]. [cited 2022 Dec 12]. Ukrainian. Available from: http://bicyclol.com/wp-content/uploads/reprint_Bicyclol.indd_.pdf
15. Hurianov VH, Liakh YuYe, Parii VD, Korot­kyi OV, Chalyi OV, Chalyi KO, et al. [Handbook of biostatistics. Analysis of medical research results in the EZR package (R–statistics)]. Kyiv: Vistka; 2018. 208 р. Ukrainian.
16. Moroz LV, Yatsyk IV, Ocheredko OM, Liv­shyts LA, Pampukha VM, inventors. [The method of predicting the rate of progression of liver fibrosis in patients with chronic hepatitis C]. Patent Ukrainy No. u201503954. 2015 Dec 10. Ukrainian.

Look through:

Usychenko К.М. Odesa National Medical University, Odessa, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-7314-7914

Usychenko К.М. The using of genetic markers as a possibility of predicting the rate of progress of liver fibrosis in patients with chronic hepatitis B. Medicni perspektivi. 2023;28(3):45-54. DOI: https://doi.org/10.26641/2307-0404.2023.3.288931

The using of genetic markers as a possibility of predicting the rate of progress of liver fibrosis in patients with chronic hepatitis B

The paper was aimed at deter­mination of the quantitative activity of iNOS and Arg1, as well as M1 and M2 phenotype macrophages in women with endometrioid disease to establish their role in the pathogenesis of endometriosis. A prospective study was performed in gynecological units of the medical facilities of Poltava city. 140 women of reproductive age who made up the main group (110 women with endometrioid disease) and the control group (30 women without endometrioid disease) voluntarily participated in the study. All women underwent planned surgical treatment for existing gynecological pathology. Before surgical treatment, women were examined in accordance with the current Orders of the Ministry of Health of Ukraine. The spectrophotometric method was used to determine the enzymatic markers of macrophages (in the endometrium and peritoneal fluid) polarized into M1(iNOS) and M2 (Arg1) phenotypes. The type of macrophages was determined individually in each patient according to the ratios: in iNOS>Arg1, the M1 macrophage type prevailed; in Arg1>iNOS, the M2 macrophage type prevailed. When examining endometrial samplings in women from the main group, the iNOS indicator was by 1.4 times higher compared to women from the control group. The obtained results at the stage of entry into the abdominal cavity showed that mostly women from the main group suffered from the pelvic adhesion, especially stage 3 and stage 4. Among the obtained results, the increased quantitative activity in the peritoneal fluid of both iNOS and Arg1 in women of the main group was significant compared to the control group. When comparing the stages of endometrioid disease to the rates of quantitative activity of macrophage enzyme markers (in peritoneal fluid), it was found that the increase in the stage of the disease (from stage 3 to stage 4) caused an increase in the quantitative activity of Arg1 by 1.9 times and a decrease in the quantitative activity of iNOS by 2.9 times. Therefore, the planning of surgical intervention for women with endometrioid disease should consider a significant percentage of the pelvic adhesive disease, especially at the severe stages. Initiation of the chronic aseptic inflammatory process in endometrioid disease is caused by an increased quantitative activity of iNOS in the endometrium. In the pathogenesis of endometrioid disease, the presence of M2 phenotype macrophages in the peritoneal fluid is important, while the switching of macrophage phenotypes from a pro-inflammatory subpopulation to an anti-inflammatory one is crucial.

Key words: endometriosis, inducible NO-synthase, arginase 1, M1 phenotype macrophages, M2 phenotype macrophages

1. Zondervan KT, Becker CM, Missmer SA. Endo­metriosis. N Engl J Med. 2020 Mar 26;382(13):1244-56. doi: https://doi.org/10.1056/NEJMra1810764
2. de Freitas Fonseca M, Aragao LC, Sessa FV, Dut­ra de Resende JA Jr, Crispi CP. Interrelationships among endometriosis-related pain symptoms and their effects on health-related quality of life: a sectional ob­servational study. Obstet Gynecol Sci. 2018Sep;61(5):605-14. doi: https://doi.org/10.5468/ogs.2018.61.5.605 
3. Hwang H, Chung YJ, Lee SR, Park HT, Song JY, Kim H, et al. Clinical evaluation and management of endo­metriosis: guideline for Korean patients from Korean Society of Endometriosis. Obstet Gynecol Sci. 2018 Sep;61(5):553-64. doi: https://doi.org/10.5468/ogs.2018.61.5.553
4. Abd El–Kader AI, Gonied AS, Lotfy Moha­med M, Lotfy Mohamed S. Impact of endometriosis–rela­ted adhesions on quality of life among infertile women. Int J Fertil Steril. 2019 Apr;13(1):72-6. doi: https://doi.org/10.22074/ijfs.2019.5572
5. Mehdizadeh Kashi A, Moradi Y, Chaichian S, Najmi Z, Mansori K, Salehin F, et al. Application of the World Health Organization Quality of life instrument, short form (WHOQOL–BREF) to patients with endo­metriosis. Obstet Gynecol Sci. 2018 Sep;61(5):598-604. doi: https://doi.org/10.5468/ogs.2018.61.5.598
6. Likhachov VK, Shymanska YV, Savelieva YS, Va­shchenko VL, Dobrovolska LМ. Changes of psycho-emotional state in the infertile pregnant females due to the anamnesis and IVF. Wiad Lek. 2019;72(4):562-7. doi: https://doi.org/10.36740/WLek201904111
7. Vallvé–Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endo­metriosis. Human Reproduction Update. 2019; 25(5):565-92. doi: https://doi.org/10.1093/humupd/dmz018
8. Korchynska OO, Mashtepa AM, Voloshyna UV, Petrenko TG. [Endometriosis as one of contemporary problems in gynecology and obstetrics (analytical survey of scientific literature)]. Ukraina. Zdorovia natsii. 2015;2:104-15. Ukrainian.
9. Ramírez-Pavez TN, Martínez-Esparza M, Ruiz-Alcaraz AJ, Marín-Sánchez P, Machado-Linde F, García-Peñarrubia P. The Role of Peritoneal Macrophages in Endometriosis. Int J Mol Sci. 2021 Oct 6;22(19):10792. doi: https://doi.org/10.3390/ijms221910792
10. Orlova YuA, Hromova AM, Akimov OYe, Keto­va OM. [The role of the macrophage polarization type in the pathogenesis of endometrioid disease]. Zaporozhskyi medytsynskyi zhurnal. 2021;23(5):644-50. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.5.233689
11. de Campos GY, Oliveira RA, Oliveira-Brito PK, Roque-Barreira MC, da Silva TA. Pro-inflammatory res­ponse ensured by LPS and Pam3CSK4 in RAW 264.7 cells did not improve a fungistatic effect on Cryptococcus gattii infection. Peer 2020 Nov 25;8:e10295. doi: https://doi.org/10.7717/peerj.10295
12. Kumar S, Gupta E, Gupta N, Kaushik S, Srivas­tava VK, Kumar S, et al. Functional role of iNOS-Rac2 interaction in neutrophil extracellular traps (NETs) induced cytotoxicity in sepsis. Clin Chim Acta. 2021 Feb;513:43-9. doi: https://doi.org/10.1016/j.cca.2020.12.004
13. Tanaka H, Kumasawa K, Kakigano A, Mimura K, Endo M, Tomimatsu T, et al. Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis. Biochem Biophys Res Commun. 2018 May 5;499(2):150-5. doi: https://doi.org/10.1016/j.bbrc.2018.03.086
14. [On the approval and implementation of medical and technological documents on the standardization of medical care for genital endometriosis. Order of the Ministry of Health of Ukraine dated 2016 Apr 06 No. 319] [Internet]. 2016 [cited 2023 Apr 21]. Ukrainian. Available from:https://www.dec.gov.ua/mtd/genitalnyj-endometrioz/
15. Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022 Feb 26;2022(2):hoac009. doi: https://doi.org/10.1093/hropen/hoac009
16. Yadav G, Rao M, Gothwal M, Singh P, Kathu­ria P, Sharma PP. Detection of nerve fibers in the eutopic endometrium of women with endometriosis, uterine fib­roids and adenomyosis. Obstet Gynecol Sci. 2021 Sep;64(5):454-61. doi: https://doi.org/10.5468/ogs.21114
17. Skrypnyk I, Maslova G, Lymanets T, Gusa­chen­ko I. L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia. Exp Oncol. 2017 Dec;39(4):308-11. doi: https://doi.org/10.31768/2312-8852.2017.39(4):308-311
18. Yelins’ka AM, Akimov OYe, Kostenko VO. Role of AP-1 transcriptional factor in development of oxidative and nitrosative stress in periodontal tissues during systemic inflammatory response. The Ukrainian Biochemical Journal.2019;91(1):80-5. doi: https://doi.org/10.15407/ubj91.01.080
19. Akimov OYe, Kostenko VO. Role of NF-κB trans­criptional factor activation during chronic fluoride intoxication in development of oxidative-nitrosative stress in rat’s gastric mucosa. Journal of Trace Elements in Medicine and Biology. 2020;61:126535. doi: https://doi.org/10.1016/j.jtemb.2020.126535
20. Akimov OYe, Kostenko VO. Functioning of nitric oxide cycle in gastric mucosa of rats under excessive combined intake of sodium nitrate and fluoride. The Ukrainian Biochemical Journal. 2016;88(6):70-5. doi: https://doi.org/10.15407/ubj88.06.070
21. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018. 579 p. Russian.
22. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, 201 mul­lerian anomalies and intrauterine adhesions. Fertil Steril. 1988 Jun;49(6):944-55. doi: https://doi.org/10.1016/S0015-0282(16)59942-7
23. Burns KA, Thomas SY, Hamilton KJ, Young SL, Cook DN, Korach KS. Early Endometriosis in Females Is Directed by Immune-Mediated Estrogen Receptor α and IL-6 Cross-Talk. Endocrinology. 2018 Jan 1;159(1):103-18. doi: https://doi.org/10.1210/en.2017-00562
24. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017 Jun;96(6):659-67. doi: https://doi.org/10.1111/aogs.13082
25. Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Curr Mol Med. 2004 Nov;4(7):763-75. doi: https://doi.org/10.2174/1566524043359908
26. Kvaskoff M, Mahamat-Saleh Y, Farland LV, Shi­gesi N, Terry KL, Harris HR, et al. Endometriosis and can­cer: a systematic review and meta-analysis. Hum Reprod Update. 2021 Feb 19;27(2):393-420. doi: https://doi.org/10.1093/humupd/dmaa045
27. Kielbik M, Szulc-Kielbik I, Klink M. The Poten­tial Role of iNOS in Ovarian Cancer Progression and Chemoresistance. Int J Mol Sci. 2019 Apr 9;20(7):1751. doi: https://doi.org/10.3390/ijms20071751

Look through:

Orlova Yu.A. Poltava State Medical University, Poltava, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0001-8839-1840

Hromova A.M. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0002-7396-7023

Ketova O.M. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0002-9538-0784

Liakhovska T.Yu. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0002-5001-406X

Martynenko V.B. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0001-7465-0215

Krutikova E.I. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0002-9403-3000

Orlova Yu.A., Hromova A.M., Ketova O.M., Liakhovska T.Yu., Martynenko V.B., Krutikova E.I. Aseptic inflammation as the essential link in the pathogenesis of endometrioid disease. Medicni perspektivi. 2023;28(3):55-61. DOI: https://doi.org/10.26641/2307-0404.2023.3.288961

Aseptic inflammation as the essential link in the pathogenesis of endometrioid disease

The aim of the work is to study the changes in indices of non-specific resistance and cytokine regulation, relevant for the early diagnosis of secondary peritonitis. During the period 2016-2022, in the Surgery Department of the Communal Non-Profit Enterprise “Regional Clinical Hospital, Ivano-Frankivsk Regional Council” there were treated 192 patients with postoperative peritonitis. Of them, in 69 (35.9%) patients the changes in indices of non-specific resistance and cytokine regulation were studied. These studies were performed in the laboratory of the Department of Biological and Medical Chemistry of the Ivano-Frankivsk National Medical University. The content of CD3⁺-lymphocytes in the blood of patients with secondary peritonitis on admission to the hospital was 35.49±3.39%, which is 1.8-fold less than in the comparison group (p<0.002), with their subsequent drop up to 31.00±2.88% (p<0.002) during the third day of the disease. When determining CD4⁺-lymphocytes during the first day of observation, their indices were 21.49±3.11%, by 56% less than in the comparison group (p<0.002). During the third day of the disease, we observed a slight increase in this index – up to 23.90±3.26% (p<0.01). The study of the level of CD8⁺-lymphocytes showed that, on admission to the hospital, their level in blood serum was 13.92±1.05%, which is 1.6-fold lower than in patients of the comparison group (p<0.002). Their decrease was observed further, and during the third day this index was 8.08±2.28% (p<0.002). The content of CD11a⁺-cells on hospitalization was 11.32±0.54%, which is more than 6-fold less than in the comparison group (p<0.002). The content of CD162⁺-cells in the blood on hospitalization was 21.49±3.11%, which is 3.1-fold less than in the comparison group (p<0.002). The content of CD16⁺-cells in the blood on hospitalization was 10.83±0.87% (p<0.002). A significant increase in the content of IL in the blood serum at the initial stage of secondary peritonitis with subsequent pathological changes are contributing factors in the disorder of the body’s immune response. The content of IL-6 on admission was 759.72±28.06%, which is almost 3.4-fold higher than the indices in the comparison group (p<0.002). After surgery, this index gradually decreased and during the seventh day was 438.63±19.84% (p<0.002). The results obtained on such indices of non-specific resistance and cytokine regulation as CD3+, CD4+, CD8+, CD11a, CD162, CD95, CD16, HLA-DR+, IL-2, IL-4, IL-6 showed their significant differences between the subgroups studied (p<0.002), indicating their high sensitivity for diagnosing and predicting the development of secondary peritonitis.

Key words: secondary peritonitis, non-specific resistance, cytokine regulation

1. Dumitrascu CO, Gherghe M, Costache M, Cre­tu B, Cirstoiu C. The Role of Serum and Peritoneal Biomarkers in Predicting Sepsis and Septic Multiorgan Failure in Patients With Secondary Peritonitis. Cureus. 2023;15(7):e41724. doi: https://doi.org/10.7759/cureus.41724
2. Grondman I, Pirvu A, Riza A, Ioana M, Netea MG. Biomarkers of inflammation and the etiology of sepsis. Biochem Soc Trans. 2020;48(1):1-14. doi: https://doi.org/10.1042/BST20190029
3. Dong C. Cytokine Regulation and Function in T   Cells. Annu Rev Immunol. 2021;39:51-76. doi: https://doi.org/10.1146/annurev-immunol-061020-053702
4. Tolonen M, Kuuliala K, Kuuliala A, et al. The Association Between Intra-abdominal View and Systemic Cytokine Response in Complicated Intra-abdominal In­fections. JSurg  2019;244:436-43. doi: https://doi.org/10.1016/j.jss.2019.06.081
5. Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mecha­nisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56. doi: https://doi.org/10.1186/s40779-022-00422-y
6. Clements TW, Tolonen M, Ball CG, Kirkpat­rick AW. Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies. Scand J Surg. 2021;110(2):139-49. doi: https://doi.org/10.1177/1457496920984078
7. Montravers P, Assadi M, Gouel-Cheron A. Priori­ties in peritonitis. Curr Opin Crit Care. 2021;27(2):201-7. doi: https://doi.org/10.1097/MCC.0000000000000805
8. Sartelli M, Abu-Zidan FM, Labricciosa FM, Klu­ger Y, Coccolini F, Ansaloni L, et al. Physiological para­meters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study. World J Emerg Surg. 2019;14:34. doi: https://doi.org/10.1186/s13017-019-0253-2
9. Martin-Loeches I, Timsit JF, Leone M, de Waele J, Sartelli M, Kerrigan S, et al. Clinical controversies in abdominal sepsis. Insights for critical care settings. Crit Care.2019;53:53-8. doi: https://doi.org/10.1016/j.jcrc.2019.05.023
10. Koshelev RV, Vatazin AV, Zulkarnayev AB, Faen­ko AP. The state of the immune system in abdominal sepsis. Ter 2019;91(2):82-6. doi: https://doi.org/10.26442/00403660.2019.02.000064
11. Hecker A, Reichert M, Reuß CJ, Schmoch T, Rie­del JG, Schneck E, et al. Intra-abdominal sepsis: new definitions and current clinical standards. Langenbecks Arch Surg. 2019;404(3):257-71. doi: https://doi.org/10.1007/s00423-019-01752-7
12. Hanslin K, Sjölin J, Skorup P, Wilske F, Fri­thiof R, Larsson A, et al. The impact of the systemic inflammatory response on hepatic bacterial elimination in experimental abdominal sepsis. Intensive Care Med Exp. 2019;7(1):52. doi: https://doi.org/10.1186/s40635-019-0266-x
13. Godínez-Vidal AR, Verónica RH, Montero-Gar­cía PJ, Martínez-Martínez AR, Zavala-Castillo JC, Graci­da-Mancilla NI. Evaluation of the serum procalcitonin level as an indicator of severity and mortality in abdominal sepsis due to secondary peritonitis. Cir Cir. 2019;87(3):255-9. doi: https://doi.org/10.24875/CIRU.18000301
14. Bensken WP, Ho VP, Pieracci FM. Basic In­troduction to Statistics in Medicine, Part 2: Comparing Data. Surg Infect (Larchmt). 2021;22(6):597-603. doi: https://doi.org/10.1089/sur.2020.430
15. Coccolini F, Sartelli M, Sawyer R, et al. Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines. World J Emerg Surg. 2023;18(1):41. doi: https://doi.org/10.1186/s13017-023-00509-4
16. Ho VP, Kaafarani H, Rattan R, Namias N, Evans H, Zakrison TL. Sepsis 2019: what surgeons need to know. SurgInfect (Larchmt). 2020;21(3):195-204. doi: https://doi.org/10.1089/sur.2019.126
17. Kao AM, Cetrulo LN, Baimas-George MR, Pra­sad T, Heniford BT, Davis BR, et al. Outcomes of open abdo­men versus primary closure following emergent lapa­rotomy for suspected secondary peritonitis: a propensity-matched analysis. J Trauma Acute Care Surg. 2019;87(3):623-9. doi: https://doi.org/10.1097/TA.0000000000002345

Look through:

Droniak M.M. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0001-7976-0384

Shevchuk I.M. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine
https://orcid.org/0000-0001-6684-946X

Snizhko S.S. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine
https://orcid.org/0000-0001-5418-7825

Sadovyi I.Ya. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine
https://orcid.org/0000-0003-1476-7555

Fedorkiv N.B. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine
https://orcid.org/0000-0002-0987-0286

Kuzenko R.T. Ivano-Frankivsk National Medical University,  Ivano-Frankivsk, Ukraine
https://orcid.org/0000-0003-1031-8787

The values of indices of non-specific resistance and cytokine regulation for early diagnosis of secondary peritonitis. Droniak M.M., Shevchuk I.M., Snizhko S.S., Sadovyi I.Ya., Fedorkiv N.B., Kuzenko R.T. Medicni perspektivi. 2023;28(3):61-67. DOI: https://doi.org/10.26641/2307-0404.2023.3.288963 

The values of indices of non-specific resistance and cytokine regulation for early diagnosis of secondary peritonitis

The scientific study aimed to explore the practical implementation of artificial intelligence (AI) technologies in radiology and traumatology for fracture detection, as well as evaluate their overall effectiveness in modern medicine. In recent years, AI has gained significant traction in the healthcare industry, enabling the analysis of patients' clinical data and facilitating disease diagnosis, monitoring, risk assessment, and surgical intervention possibilities. The relevance of the scientific work is in the gradual expansion of practical applications of artificial intelligence technologies in medicine, particularly in radiology for diagnosing fractures. The study aimed to investigate the practical effectiveness of AI technology in fracture detection on example of Hospital of Traumatology and Orthopaedics in Riga, Latvia. The methodological approach combined system analysis of AI system implementation in modern medical institutions for creating X-ray images with a clinical study of fracture diagnosis experience at the Hospital of Orthopedics and Traumatology in Riga, Latvia. Fractures were detected by radiologists, attending physicians, and the AI program, with comparisons made between them. Results were analyzed to assess the program's efficacy. The results of the study demonstrated the high effectiveness of AI technologies in fracture detection. The application of these systems in clinical practice led to a significant reduction in diagnostic errors (by 2-3 times) and an increase in diagnostic accuracy (from 78.1% to 85.2%). Moreover, AI systems proved to be capable of detecting fractures that were not initially identified during routine examinations by paramedics and medical practitioners. This emphasized the practicality of expanding the use of these systems in clinical practice. The practical significance of the obtained results is in their potential use in the development of software systems based on AI, aimed at enhancing fracture diagnosis in medical institutions. These findings provided valuable insights for further advancements in AI-based technologies for fracture detection.

Key words: traumatology, radiology, clinical studies, fluoroscopy, orthopaedics diagnostics

1. Hrubar YuO, Hrubar MYu. Tactics choice of treat­ment of shoulder calcific tendinitis taking into account the phase of the disease. Bulletin of Medical and Biological Research.2021;9(3):17-23. https://doi.org/10.11603/bmbr.2706-6290.2021.3.12230
2. Sandris Rūsiņš A. DRB was the first in Latvia to use artificial intelligence in diagnostics [Internet]. Nasha. 2022[cited 2023 Jun 7]. Available from: https://nasha.la.lv/drb-pervaya-v-latvii-stala-ispolzovat-iskusstvennyj-intellekt-pri-diagnostike
3. Duron L, Ducarouge A, Gillibert A, Lainé J, Al­louche C, Cherel N, et  al. Assessment of an AI aid in detection of adult appendicular skeletal fractures by emer­gency physicians and radiologists: A multicenter cross-sectional diagnostic study. Radiology. 2021;300(1):120-9. doi: https://doi.org/10.1148/radiol.2021203886
4. Boginskis V. Effectiveness of artificial intel­ligen­ce in fracture diagnosis. Riga: University of Latvia; 2022.
5. Yokota H, Goto M, Bamba C, Kiba M, Yama­da K. Reading efficiency can be improved by minor mo­dification of assigned duties: a pilot study on a small team of general radiologists. Jpn J Radiol. 2017;35(5):262-8. doi: https://doi.org/10.1007/s11604-017-0629-8
6. Hayashi D, Kompell AJ, Ventre J, Ducarouge A, Nguyen T, Regnard N-E, et al. Automated detection of acute appendicular skeletal fractures in pediatric patients using deep learning. Skeletal Radiol. 2022;51(11):2129-39. doi: https://doi.org/10.1007/s00256-022-04070-0
7. Guermazi A, Tannoury C, Kompel AJ, Mura­ka­mi AM, Ducarouge A, Gillibert A, et al. Improving radio­graphic fracture recognition performance and efficiency using artificial intelligence. Radiology. 2021;302(3):1-10. doi: https://doi.org/10.1148/radiol.210937
8. Aung YYM, Wong DCS, Ting DSW. The promise of artificial intelligence: a review of the opportunities and challenges of artificial intelligence in healthcare. Br Med Bull.2021;139(1):4-15. doi: https://doi.org/10.1093/bmb/ldab016
9. Medical Diagnostic Information System [Internet]. 2022 [cited 2023 Jul 7]. Available from: https://datamed.lv/
10. Backer HC, Wu CH, Strauch RJ. Systematic re­view of diagnosis of clinically suspected scaphoid fractures.J Wrist  2020;9(1):81-9. doi: https://doi.org/10.1055/s-0039-1693147
11. Sakaguchi T, Tanaka M, Sake N, Latka K, Fuji­wara Y, Arataki S, et al. The Most Significant Factor Affecting Gait and Postural Balance in Patients’ Acti­vities of Daily Living Following Corrective Surgery for Defor­mity of the Adult Spine. Medicina (Lithuania). 2022;58(8):1118.
    doi: https://doi.org/10.3390/medicina58081118
12. Canoni-Meynet L, Verdot P, Danner A, Calame P, Aubry S. Added value of an artificial intelligence solution for fracture detection in the radiologist’s daily trauma emer­gencies workflow. Diagn Interv Imaging. 2022;103(12):594-600. doi: https://doi.org/10.1016/j.diii.2022.06.004
13. Al-Sani F, Prasad S, Panwar J, Stimec J, Khos­roawshahi A, Mizzi T, et al. Adverse events from emer­gency physician pediatric extremity radiograph interpre­tations: A prospective cohort study. Acad Emerg Med. 2020;27(2):128-38. doi: https://doi.org/10.1111/acem.13884
14. Alberich-Bayarri A, Marti-Bonmati L, Angeles Pérez M, Sanz-Requena R, Lerma-Garrido JJ, García-Martí G, et al. Assessment of 2D and 3D fractal dimension measurements of trabecular bone from high-spatial reso­lution magnetic resonance images at 3 T. Med Phys. 2010;7(9):4930-7. doi: https://doi.org/10.1118/1.3481509
15. Kuo RYL, HarrisonC, Curran TA, Jones B, Freethy A, Cussons D, et al. Artificial intelligence in frac­ture detection: A systematic review and meta-analysis. Radiology. 2022;304(1):50-62. doi: https://doi.org/10.1148/radiol.211785
16. Aliaga I, Vera V, Vera M, Garcia E, Pedrera M, Pajares G. Automatic computation of mandibular indices in dental panoramic radiographs for early osteoporosis detection.Artif Intell  2020;103:101816. doi: https://doi.org/10.1016/j.artmed.2020.101816
17. Reichert G, Bellamine A, Fontaine M, Nai­peanu B, Altar A, Mejean E, et al. How can a deep learning algorithm improve fracture detection on x-rays in the emergencyroom? J  2021;7(7):1-10. doi: https://doi.org/10.3390/jimaging7070105
18. Rosenberg GS, Cina A, Schiró GR, Giorgi PD, Gueorguiev B, Alini M, et Artificial intelligence ac­curately detects 39 traumatic thoracolumbar fractures on sagittal radiographs. Medicina. 2022;58(8):1-12. doi: https://doi.org/10.3390/medicina58080998
19. Tarantino U, Giai Via A, Macrì E, Eramo A, Marino V, Marsella LT. Professional liability in ortho­paedics and traumatology in Italy. Clin Orthop Relat 2013;471(10):3349-57. doi: https://doi.org/10.1007/s11999-013-3165-6
20. Rebours C, Glatre R, Plaisance P, Dohan A, Tru­chot J, Chauvin A. Diagnostic errors of nasal fractures in the emergency department: A monocentric retrospective study.World J Emerg  2022;13(2):120-3. doi: https://doi.org/10.5847/wjem.j.1920-8642.2022.014
21. Khan IH, Jamil W, Lynn SM, Khan OH, Mark­land K, Giddins G. Analysis of NHSLA claims in ortho­pedic surgery. Orthopedics. 2012;35(5):726-31. doi: https://doi.org/10.3928/01477447-20120426-28

Look through:

Boginskis V. Hospital of Traumatology and Orthopaedics, Riga, Latvia,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0009-0001-1320-8471

Zadoroznijs S. Hospital of Traumatology and Orthopaedics, Riga, Latvia,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0000-5207-3576 

Cernavska I. Hospital of Traumatology and Orthopaedics, Riga, Latvia,
e-mail:This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0006-7429-543X

Beikmane D. Riga Stradins University, Riga, Latvia,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0003-0322-4093

Sauka J. Hospital of Traumatology and Orthopaedics, Riga, Latvia,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0003-2422-2994

Boginskis V., Zadoroznijs S., Cernavska I., Beikmane D., Sauka J. Artificial intelligence effectivity in fracture detection. Medicni perspektivi. 2023;28(3):68-78. DOI: https://doi.org/10.26641/2307-0404.2023.3.288965

Artificial intelligence effectivity in fracture detection

The aim of our study was to evaluate the differences in intra­operative and postoperative outcomes of cholecystectomy using the Senhance robotic platform and laparoscopic cholecystectomy. A retrospective analysis of medical cases history of patients who underwent cholecystectomy from December 2021 to February 2022 was conducted. The treatment outcomes of patients with chronic calculous cholecystitis who underwent robotic cholecystectomy (RC) were compared with those who underwent laparoscopic cholecystectomy (LC). Robotic cholecystectomy was performed using the Senhance robotic platform. The RC and LC groups were matched for age, sex, body mass index and compared for the duration of the operation and hospital stay. For normally distributed data, the mean and standard deviation, determined using the Shapiro-Wilk test (p-value>0.05), were applied. Median and interquartile range (IQR) were also used. Difference between cohorts - 95% confidence interval (95% Confidence Interval) were estimated for normally distributed data. Data analysis was performed using standard summary statistics on the Jamovi 2.2.5 platform. Data were processed using application program packages. All surgical procedures were performed by two surgeons from Odesa National Medical University. Robotic cholecystectomy was performed on 18 pa­tients and laparoscopic cholecystectomy was performed on 20 patients. There were no statistically significant differences between the groups in terms of length of hospital stay, blood loss or complications. There were no bile duct injuries, intra­operative complications, or conversions in either group. The only statistically significant difference was the total time under anesthesia (p>0.05), which was longer in the robotic cholecystectomy group. Cholecystectomy using the Senhance robotic platform was found to be safe, with an average operative time of 35.2±5.0 minutes, while the duration of laparoscopic cholecystectomy was 32.2±3.3 minutes. The study results showed that robotic cholecystectomy using the Senhance system is safe and effective. The use of robotic systems can improve precision and control during surgery, reduce blood loss and complications.

Key words: snhance surgical system, cholecystectomy, minimally invasive surgery, robotic surgery

1. Hutchins AR, Manson RJ, Lerebours R, et al. Objective assessment of the early stages of the learning curve for the senhance surgical robotic system. J Surg Educ.2019;76:201-14. doi: https://doi.org/10.1016/j.jsurg.2018.06.026
2. Keller DS, Jenkins CN. Safety with innovation in colon and rectal robotic surgery. Clin Colon Rectal Surg. 2021 Sep;34(5):273-9.
   doi: https://doi.org/10.1055/s-0041-1726352
3. Wee IJ, Kuo LJ, Ngu JC. A systematic review of the true benefit of robotic surgery: Ergonomics. Int J Med Robot. 2020 Aug;16(4):e2113. doi: https://doi.org/10.1002/rcs.2113
4. Satava RM, Stefanidis D, Levy JS, et al. Proving the effectiveness of the Fundamentals of Robotic Surgery (FRS) skills curriculum. Annals of Surgery. 2020;272(2):384-92. doi: https://doi.org/10.1097/SLA.0000000000003220
5. McKechnie T, Khamar J, Daniel R, Lee Y, Park L, Doumouras AG, et al. The Senhance Surgical System in Colorectal Surgery: A Systematic Review. J Robot Surg. 2023 Apr;17(2):325-34. doi: https://doi.org/10.1007/s11701-022-01455-0
6. Aggarwal R, Winter Beatty J, Kinross J, von Roon A, Darzi A, Purkayastha S. Initial Experience With a New Robotic Surgical System for Cholecystectomy. Surg Innov.2020 Apr;27(2):136-42. doi: https://doi.org/10.1177/1553350619890736
7. Samalavicius NE, Kaminskas T, Zidonis Z, Janu­sonis V, Deduchovas O, Eismontas V, et al. Robotic cho­lecystectomy using Senhance robotic platform versus laparoscopic conventional cholecystectomy: a propensity score analysis. Acta Chir Belg. 2022 Jun;122(3):160-3. doi: https://doi.org/10.1080/00015458.2021.1881332
8. Stephan D, Sälzer H, Willeke F. First Experiences with the New Senhance® Telerobotic System in Visceral Surgery. Visc 2018 Feb;34(1):31-6. doi: https://doi.org/10.1159/000486111
9. Spinelli A, David G, Gidaro S, et al. First expe­rience in colorectal surgery with a new robotic platform with haptic feedback. Colorectal Dis. 2018;20:228-35. doi: https://doi.org/10.1111/codi.13882
10. Willuth E, Hardon SF, Lang F, et al. Robotic-as­sisted cholecystectomy is superior to laparoscopic chole­cystectomy in the initial training for surgical novices in an ex vivo porcine model: a randomized crossover study. Surg Endosc.2022 Feb;36(2):1064-79. doi: https://doi.org/10.1007/s00464-021-08373-6
11. Milone M, Vertaldi S, Bracale U, D'Ambra M, Cassese G, Manigrasso M, et al. Robotic cholecystectomy for acute cholecystitis: Three case reports. GD.Medicine (Baltimore). 2019 Jul;98(30):e16010. doi: https://doi.org/10.1097/MD.0000000000016010
12. Melling N, Barr J, Schmitz R, Polonski A, Miro J, Ghadban T, et al. Robotic cholecystectomy: first expe­rience with the new Senhance robotic system. J Robot Surg.2019 Jun;13(3):495-500. doi: https://doi.org/10.1007/s11701-018-0877-3
13. Peacock JL, Peacock PL. Oxford Hadbook of Me­dical Statistics. 2nd ed. Oxford University Press, UK; 2020. 640 p. doi: https://doi.org/10.1093/med/9780198743583.001.0001

Look through:

Kashtalian M.A. Odesa national medical university, Odesa, Ukraine
https://orcid.org/0000-0002-2945-2161

Kvasnevskyi Ie.A. Odesa national medical university, Odesa, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-0753-7666

Kvasnevskyi O.A. Odesa national medical university, Odesa, Ukraine
https://orcid.org/0000-0001-6630-0143

Kashtalian M.A., Kvasnevskyi Ie.A. Kvasnevskyi O.A. The first experience of using the "Senhance" robotic surgical system during cholecystectomy. Medicni perspektivi. 2023;28(3):79-85. DOI: https://doi.org/10.26641/2307-0404.2023.3.289167 

The first experience of using the "Senhance" robotic surgical system during cholecystectomy

The phenomenon of inferiority as a key concept of Adler's theory of psychology can contribute to the appearance of social anxiety. Since both anxiety and feeling of inferiority have an impact on mental and somatic health, the aim of the study was to investigate the association of the phenomenon of inferiority with the feeling of anxiety. During October-November 2021 in the course of the study, a questionnaire survey of 612 students of higher education institutions of Lviv was conducted. Two questionnaires were used for the survey: the Comparative Feeling of Inferiority Index and Beck's Anxiety Inventory. The analysis of the findings was performed using the methods of descriptive (median, 25% and 75% quartiles, percentages with 95% confidence intervals) and analytical statistics (Kruskal-Wallis test, Dunn's post-hoc paired test, Pearson's test). The research established that the feeling of anxiety is characteristic of 54.95% [45.67-64.07] of the respondents with the Index of Superiority, 48.84% [34.17-63.61] of the respondents with the Index of Inferiority and 43.91% [39.60-48.28] of respondents with the absence of the phenomenon of altered self-esteem (Norma). Median scores on Beck's Anxiety Inventory were significantly higher in individuals with the index of superiority – 8.5 [5; 16.3] points. A comparison of the presence of anxiety by gender showed that anxiety symptoms are significantly more common in women than in men: 57.85% [51.82-63.77] vs 37.04% [32.07-42.15] respectively, p<0.001. Anxiety is most often characteristic of women with the index of superiority – 76.67% [60.16-89.79]) of women in this group. The value of the findings is determined by the fact that in Ukraine this is the first scientific study regarding the research of the association of the phenomenon of inferiority and anxiety in adult population with using proven and valid questionnaires that are actively used by scientists around the world.

Key words: phenomenon of inferiority, feeling of anxiety, index of inferiority, index of superiority, absence of the phenomenon of altered self-esteem

1. Adler A. Compulsion neurosis. International Jour­nal of Individual Psychology. 1936;2:3-22.
2. Strano DA, Dixon PN. The Comparative Feeling of Inferiority Index. Individual Psychology: The Journal of Adlerian Theory, Research & Practice. 1990;46(1):29-42.
3. Akdoğan R, Çimşir E. Linking inferiority feelings to subjective happiness: Self-concealment and loneliness as serial mediators. Personality and Individual Differences. 2019;149:14-20. doi: https://doi.org/10.1016/j.paid.2019.05.028
4. Li J, Jia S, Wang L, Zhang M, Chen S. Relation­ships among inferiority feelings, fear of negative evaluation, and social anxiety in Chinese junior high school students. Front Psychol. 2023;13:1015477. doi: https://doi.org/10.3389/fpsyg.2022.1015477
5. Liu Y, Xu C, Kuai X, Deng H, Wang K, Luo Q. Analysis of the causes of inferiority feelings based on so­cial media data with Word2Vec. Sci Rep. 2022;12(1):5218. doi: https://doi.org/10.1038/s41598-022-09075-2
6. Wang S, Shi X, Zhu Y, Wang Z. Factor structure of the Chinese version of the Screen for Adult Anxiety Related Disorders (SCARRED). Asian J Psychiatr. 2022;73:103159. doi: https://doi.org/10.1016/j.ajp.2022.103159
7. Akdogan R, Aydın M, Eken H. Understanding the contribution of abnormal inferiority feelings on insecure attachment through gender and culture: A study of university students seeking psychological support. The Journal of Individual Psychology. 2018;74(1):96-116. doi: https://doi.org/10.1353/jip.2018.0006
8. Filts O, Fitkalo O, Lyzak O, Berezyuk O, Mysha­kivska  O, Samsonova L, et al. Toward a cohesive clinical in­terpretation of mental disorders in SARS-CoV-2 pan­demic: An expert opinion Proceedings of the Shev­chenko Scientific Society. Medical Sciences. 2021;64(1):155-60. doi: https://doi.org/10.25040/ntsh2021.01.15
9. Robinson OJ, Pike AC, Cornwell B, Grillon C. The translational neural circuitry of anxiety. J Neurol Neurosurg 2019;90(12):1353-60. doi: https://doi.org/10.1136/jnnp-2019-321400
10. Andreescu C, Lee S. Anxiety Disorders in the Elderly. Adv Exp Med Biol. 2020;1191:561-76. doi: https://doi.org/10.1007/978-981-32-9705-0_28
11. Penninx BW, Pine DS, Holmes EA, Reif A. An­xiety disorders. Lancet. 2021;397(10277):914-27. doi: https://doi.org/10.1016/S0140-6736(21)00359-7
12. Pang Z, Tu D, Cai Y. Psychometric Properties of the SAS, BAI, and S-AI in Chinese University Students. Front 2019;10:93. doi: https://doi.org/10.3389/fpsyg.2019.00093
13. Beck AT, Steer RA. Beck Anxiety Inventory ma­nual. San Antonio; TX: Psychological Corporation, 1993.
14. Garcia JM, Gallagher MW, O'Bryant SE, Medi­na LD. Differential item functioning of the Beck Anxiety Inventory in a rural, multi-ethnic cohort. J Affect Disord. 2021;293:36-42. doi: https://doi.org/10.1016/j.jad.2021.06.005
15. Akdoğan R, Çimşir E. Collectivistic ambivalence: A potential source of social anxiety for individuals with higher inferiority feelings, International Journal of Inter­cultural Relations. 2022;89:195-207. doi: https://doi.org/10.1016/j.ijintrel.2022.07.003
16. Berezyuk O, Filts O, Hrabchak V, Sirko R. Ques­tionnaire of comparative feeling of inferiority index: trans­lation, validation and experience of use in Ukrai­ne. Reports of Vinnytsia National Medical University. 2022;26(4):633-6. doi: https://doi.org/10.31393/reports-vnmedical-2022-26(4)-20
17. Belka B, Muzyka I, Gutor T, Zayachkivska O. Comparable Characteristics Of Biologically Driven Eating Behavior In Different Ethnic Groups Of Medical Students. Proc Shevchenko Sci Soc Med Sci. 2020;59(1):137-43. doi: https://doi.org/10.25040/ntsh2020.01.15
18. Schober P, Vetter TR. Analysis of Variance in Medical Research. Anesth Analg. 2020;131(2):508-9. doi: https://doi.org/10.1213/ANE.0000000000004839
19. Sedykh KV, Filts OO, Bantser VI, et al. [Basics of psychotherapy: a study guide]. Alma-mater. Akademiia. 2017. 192 p. Ukrainian.
20. Gilbert P, McEwan K, Bellew R, Mills A, Gale C. The dark side of competition: How competitive behaviour and striving to avoid inferiority are linked to depression, anxiety, stress and self-harm. Psychol Psychother. 2009;82(Pt2):123-36. doi: https://doi.org/10.1348/147608308X379806
21. Kumaraswamy N. Academic Stress, Anxiety and Depression among College Students- A Brief Review. International Review of Social Sciences and Humanities. 2013;5(1):135-43.
22. Si Yu, Chunyang Zhang, Yuyang Zhou, Yiwei Shi, Wei Xu. Longitudinal relationship between inferiority and maladjustment among college students: The mediation of dispositional mindfulness and moderation of left-behind experience. Children and Youth Services Review. 2020;116:105249. doi: https://doi.org/10.1016/j.childyouth.2020.105249

Look through:

Berezyuk O.R. Danylo Halytsky Lviv National Medical University, Lviv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0003-4554-4928

Filts O.O. Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
https://orcid.org/0000-0002-5350-8305

Berezyuk O.R., Filts O.O. Association of the feeling of anxiety and the phenomenon of inferiority. Medicni perspektivi. 2023;28(3):86-93. DOI: https://doi.org/10.26641/2307-0404.2023.3.289202 

Association of the feeling of anxiety and the phenomenon of inferiority

The article presents the results of the study of “The Integrative Model of Resiliency” in higher education seekers in war conditions. 174 higher education seekers were examined, among them: 144 students of the 4th-6th year of the medical faculty and the faculty of medicine and pharmacy of the Dnipro State Medical University, majoring in 222 “Medicine” (main group) and 30 students of the 4th-5th year of the Ukrainian State University of Science and Technology (comparison group). The aim of the study was to determine the modalities of resiliency in higher education seekers in the war condition. A psychodiagnostic method with the integrative model of resiliency “BASIC Ph” was used in the research. The distribution of modalities, their degree of expression (scoring), gender features of the distribution of modalities and their correlations were studied. In the vast majority of higher education seekers, one modality of resiliency dominated (94% in the main group, 100% in the comparison group), which was cognitive modality (64% in the main group, 67% in the comparison group) as the most mature, adaptive and constructive way of overcoming the crisis, especially during the war. In 6% of the investigated ones in the main group, the dominance of two modalities was found, among which the cognitive strategy was once again the leading one (89%). Some gender features of the use of stress coping strategies were revealed. Thus, a statistically significant difference was observed between the indicators of the modalities “Belief”, “Emotions” and “Social support” among males and females of the main group and “Emotions” and “Imagination” in the comparison group (p<0.05). Analyzing the gender characteristics of the correlations of resiliency modalities, a more multifaceted model was found in medical students of male gender. The obtained data contribute to a deeper understanding of own personal strengths and the involvement of less developed ones by higher education seekers, aimed at strengthening and enriching their resources to overcome resiliency of war crisis. Thus, the results of the study should be taken into account when developing psychoeducational and psychocorrective measures and conducting psychological support for of higher education seekers in the conditions of war and post-war time.

Key words: resiliency, resources, seekers higher education, coping strategies, modalities, Basic Ph, war

1. van Voren R, Andreescu C. Ukrainian Mental Health – A Report From the War. Am J Geriatr Psychiatry. 2022 Aug;30(8):940-3. doi: https://doi.org/10.1016/j.jagp.2022.04.004
2. Riad A, Drobov A, Krobot M, Antalová N, Alka­saby MA, Peřina A, et al. Mental Health Burden of the Russian-Ukrainian War 2022 (RUW-22): Anxiety and Depression Levels among Young Adults in Central Euro­pe. Int J Environ Res Public Health. 2022 Jul 9;19(14):8418. doi: https://doi.org/10.3390/ijerph19148418
3. Maruta N, Panko T, Fedchenko V, Semikina O. Internally displaced persons and their mental health status. European Psychiatry. Cambridge University Press. 2021;64(S1):S406. doi: https://doi.org/10.1192/j.eurpsy.2021.1088
4. Danese A, Martsenkovskyi D. Editorial: Measu­ring and Buffering the Mental Health Impact of the War in Ukraine in Young People. J Am Acad Child Adolesc Psychiatry. 2023 Mar;62(3):294-6. doi: https://doi.org/10.1016/j.jaac.2022.11.001
5. Yuryeva LM, Sharun AI. Аdjustment disorder among students, who has suffered psychoemotional stress: systematic review of diagnostics, treatment and preventive care. Medicni 2021;4:47-51. doi: ttps://doi.org/10.26641/2307-0404.2021.4.248082
6. Sampson K, Priestley M, Dodd AL, Broglia E, Wykes T, Robotham D, et al. Key questions: research priorities for student mental health. BJPsych Open. 2022 May 10;8(3):e90.
   doi: https://doi.org/10.1192/bjo.2022.61
7. Sattar K, Yusoff MSB, Arifin WN, Yasin MAM, Nor MZM. Effective coping strategies utilised by medical students for mental health disorders during undergraduate medical education-a scoping review. BMC Med Educ. 2022 Feb 23;22(1):121. doi: https://doi.org/10.1186/s12909-022-03185-1 Erratum in: BMC Med Educ. 2022 Mar 10;22(1):164. doi: https://doi.org/10.1186/s12909-022-03223-y
8. Sharun AI, Yuryeva LM. Clinical-Psycho­patholo­gical and Psychometric Features of Maladaptive Disorders which are a Characteristic of Students who Have Expe­rien­ced Psycho-Emotional Stress. Medicni perspektivi. 2022;2:88-95. doi: https://doi.org/10.26641/2307-0404.2022.2.260257
9. Pascoe MC, Hetric SE, Parker AG. The impact of stress on students in secondary school and higher educa­tion. IntJ Adoles  2020;25(1):104-12. doi: https://doi.org/10.1080/02673843.2019.1596823
10. Ang WHD, Shorey S, Hoo MXY, Chew HSJ, Lau Y. The role of resilience in higher education: A meta-ethnographic analysis of students' experiences. J Prof Nurs. 2021 Nov-Dec;37(6):1092-109. doi: https://doi.org/10.1016/j.profnurs.2021.08.010
11. The Universal Declaration on Bioethics and Human Rights. International Social Science Journal [Internet]. 2005 Dec [cited 2022 Oct 29];57(186):745-53. doi: https://doi.org/10.1111/j.1468-2451.2005.00592
12. World Medical Association Declaration of Helsinki. JAMA [Internet]. 2013 Nov 27 [cited 2022 Oct 29];310(20):2191. doi: https://doi.org/10.1001/jama.2013.281053
13. Ajdukovic D, Kimhi S, Lahad M. Resiliency: En­hancing Coping with Crisis and Terrorism: IOS Press BV. 2015. 236 p.
14. Cataldo R, Arancibia M, Stojanova J, Papu­zinski C. General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs. Medwave. 2019 Sep 25;19(8):e7698. doi: https://doi.org/10.5867/medwave.2019.08.7698
15. Lahad M. From victim to victor: The development of the BASIC PH model of coping and resiliency. Traumatology.2017;23(1):27-34. doi: https://doi.org/10.1037/trm0000105

Look through:

Ogorenko V.V. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0003-0549-4292

Nikolenko A.Ye. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0001-5523-8858

Shusterman T.Y. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0001-5422-1624

Kokashynskyi V.O. Dnipro State Medical University, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-6191-3757

Ogorenko V.V., Nikolenko A.Ye., Shusterman T.Y., Kokashynskyi V.O. The integrative model of resiliency in higher education seekers in war conditions. Medicni perspektivi. 2023;28(3):94-109. DOI: https://doi.org/10.26641/2307-0404.2023.3.289204 

The integrative model of resiliency in higher education seekers in war conditions

Victims with closed blunt trauma of the hyoid-laryngeal complex often become the object of forensic examination. The purpose of the work was the forensic determination of the severity of injuries of the hyoid-laryngeal complex based on the materials of a specialized otolaryngological clinic in order to establish ways to improve the effectiveness of forensic diagnostics. 62 medical inpatient and outpatient cards of patients with injuries of the hyoid-laryngeal complex, who were treated in the Kharkiv clinical otolaryngological hospital No. 30 during 2011-2021, were processed. The mechanism of occurrence of injuries of the hyoid-laryngeal complex was as follows: in 51 (82.3% of cases there were blows to the neck with blunt hard objects (blows with fists and other objects), in 11 (17.7%) cases – squeezing of the neck with hands or blunt hard objects. The severity of injuries of the hyoid-laryngeal complex was determined from a forensic-medical point of view based on the observations of patients in a specialized hospital. Injuries of the hyoid-laryngeal complex in 3 (4.8%) patients with the occurrence of life-threatening phenomena, namely acute respiratory failure, were assessed as serious ones. Injuries in 8 (12.9%) patients were assessed as injuries of medium severity, mainly in cases of laryngeal cartilage fractures due to the lack of danger to life. Injuries in 38 (61.3%) patients were assessed as slight physical injuries that caused a short-term health disorder, mainly in cases of damage to the soft tissues of the larynx (hematoma, hemorrhage, swelling). Injuries in 13 (20.9%) patients in cases of acute post-traumatic laryngitis without pronounced morphological changes were assessed as slight ones. It was determined that additional diagnostic criteria for determining the severity of injuries of the hyoid-laryngeal complex, which have to be considered are: the dynamics and terms of restoration of post-traumatic morphological-clinical, and functional changes, the occurrence of life-threatening phenomena. The conducted scientific work made it possible to determine the ways of further improvement of diagnostics in the forensic-medical determination of the severity of the investigated injuries.

Key words: forensic-medical examination, trauma of the hyoid-laryngeal complex, diagnostic criteria, degree of severity of physical injuries

1. Tamilmani K. Practical Guide for Forensic Medi­cine and Toxicology. 2nd. Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2021. 260 p.
2. Chand S. Essentials of Forensic Medicine and Toxi­cology. 2nd. Elsevier Health Sciences, India; 2023. 650 p.
3. Famokunwa B, Kemp S, Selby J, Madani G, San­dhu G, Hull JH. Life‐threatening laryngeal injury in Elite Rugby Union: Prevention and management laryngeal trauma in rugby. Clin Case Rep. 2021;9:494-8. doi: https://doi.org/10.1002/ccr3.3565
4. Viejo-Moreno R, García-Fuentes C, Mudarra-Reche C, Terceros-Almanza LJ, Chico-Fernández M. La­ryngeal injury in closed cervical traumatism Med Intensiva. 2019;43:503-7. doi: https://doi.org/10.1016/j.medin.2018.01.003
5. Dubey PK, Singh K, Bharti AK. Point-of-Care Ultrasonography for Evaluation of Blunt Tracheal Injury. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(8):2545-6. doi: https://doi.org/10.1053/j.jvca.2021.01.015
6. Shi J, Uyeda JW, Duran-Mendicuti A, Potter CA, Nunez DB. Multidetector CT of Laryngeal Injuries: Prin­ciples of Injury Recognition. Radiographics. 2019;39(3):879-92. doi: https://doi.org/10.1148/rg.2019180076
7. Dhattarwal SK, Jakhar JK, Yadav N. Practical as­pects of Forensic Medicine For MBBS and MD Students Paperback. Bhilai: OrangeBooks Publication; 2021. 240 p.
8. [On the development and improvement of the forensic medical service of Ukraine. Rules of forensic medical determination of the severity of bodily injuries. Order of the Ministry of Health of Ukraine No. 6 of 1995 Jan 17]. Kyiv; 1995. 220 p. Ukrainian.
9. Biswas S, Saran M. Blunt trauma to the neck presenting as dysphonia and dysphagia in a healthy young woman; a rare case of traumatic laryngocele. Bull Emerg Trauma.2020;8(2):129-31. doi: https://doi.org/10.30476/BEAT.2020.46455
10. Max Houck Forensic Pathology (Advanced Foren­sic Science Series). 1st Edition. USA; 2016. 436 p.
11. Payne-James J, Jones RM. Simpson's Forensic Medicine. 14th Edition. USA, Boca Raton: CRC Press; 2019. 353 p.
12. Stewart ME, Erath BD. Investigating Blunt Force Trauma to the Larynx: the role of inferior-superior vocal fold displacement on phonation. Journal of Biomechanics. 2020;18:1-28. doi: https://doi.org/10.1016/j.jbiomech.2021.110377
13. Aksakal C, Karaca I. Isolated vocal cord he­matoma developing after blunt neck trauma. Turkish Journal of Emergency Medicine. 2019;19:30-2. doi: https://doi.org/10.1016/j.tjem.2018.08.004
14. Moser JB, Stefanidis K, Vlahos I. Imaging eva­luation of tracheobronchial injuries. Radiographics. 2020;40:515-28. doi: https://doi.org/10.1148/rg.2020190171
15. [Medical care protocols "Otolaryngology". Nor­mative production-practical edition]. Kyiv: MNIATs medychnoi statystyky; MVTs «Medinform»; 2009. 104 p. Ukrainian.

Look through:

Gubin M.V. Kharkiv National Medical University, Kharkiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-2383-3211

Olkhovskyi V.O. Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0000-0003-2843-2692

Garyuk G.I. Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0000-0003-0344-8997

Gubin V.M. Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0009-0009-8795-5152 

Gubin M.V., Olkhovskyi V.O., Garyuk G.I., Gubin V.M. Forensic-medical determination of the severity of closed injuries of the hyoid-laryngeal complex according to the data of a specialized clinic. Medicni perspektivi. 2023;28(3):110-116. DOI: https://doi.org/10.26641/2307-0404.2023.3.289205 

Forensic-medical determination of the severity of closed injuries of the hyoid-laryngeal complex according to the data of a specialized clinic

Intermittent claudication is a common symptom of peripheral arterial disease, affecting up to 50% of patients over the age of 50, which is characterized by pain, discomfort, and cramping in the leg muscles during physical activity. Intermittent claudication is a common symptom of lower extremity arterial disease (LEAD), which significantly impacts patients’ quality of life and drives healthcare costs. Current treatments for intermittent claudication are often inadequate, leading to a need for more effective treatments. Developing new treatments is critical to improve outcomes for patients and address the public health implications of LEAD. This study’s aim was to present the impact of comprehensive physiotherapy, conducted independently, with the supervision of a physiotherapist, for 14 weeks, on a patient with intermittent claudication caused by peripheral arterial disease. The therapy included bicycle training in a form of physical therapy at home, combined with deep oscillation therapy. Deep oscillation therapy involved the use of an electrostatic field with a frequency of 5 to 250 Hz. The field was applied following the lymphatic drainage methodology. In the discussed case, a statistically significant and favourable increase in the measured variables was observed, such as the increase of bone-brachial index from 0.65 to 0.8, the increase of tissue perfusion, measured by laser Doppler flowmetry, from 12.3% to 61%, depending on the measurement site, and the increase in pain-free walking distance by 451%. TcPO₂ measurement in the affected leg increased from 31 to 48 mmHg. The use of physical therapy at home combined with deep oscillation showed improvements in pain-free walking distance, Ankle Brachial Index, and other measures in patients with peripheral arterial disease. Deep oscillation therapy demonstrated potential analgesic effects but also raised concerns about possible nerve damage. The study indicated that physical therapy at home might serve as an alternative to supervised exercise therapy, but it had limitations like a small sample size and lack of direct comparisons.

Key words: physical medicine, microcirculation, intermittent claudication, physical training, vascular disease

1. Jawień A, Filipiak KJ, Bręborowicz A, Mrozi­kiewicz-Rakowska B, Szymanski FM, Terlecki P, et al. Recommendations for the management of lower extremity artery disease (LEAD) based on ESVS/ /ESC 2017 guidelines. Position document of PTChN, PTNT, PTLR and SFSN PTK experts. Acta Angiologica. 2019;25:219-69. doi: https://doi.org/10.5603/AA.2019.0015
2. Nowakowski P, Buszman P, Janas A, Kiesz S, Buszman P. Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter. Advances in Interventional Cardiology. 2019;15(4):472-6. doi: https://doi.org/10.5114/aic.2019.90222
3. Bielecka-Dabrowa A, Lewek J, Sakowicz A, Pa­duszyńska A, Dąbrowa M, Orszulak-Michalak D, et al. Effects of Implementing Personalized Health Education in Ambulatory Care on Cardiovascular Risk Factors, Com­pliance and Satisfaction with Treatment. Journal of Personalized Medicine. 2022;12(10):1583. doi: https://doi.org/10.3390/jpm12101583
4. Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology Euro­bservational Research Programme EUROASPIRE V survey in 16 European countries. European Journal of Preventive Cardiology. 2021;28(4):370-9. doi: https://doi.org/10.1177/2047487320908698
5. Kapusta J, Irzmański R. The Impact of Controlled Physical Training with Hydrotherapy on Changes in Swel­ling and Claudication Distance in Patients with Athe­rosclerotic Ischemia of the Lower Limbs. International Journal of Environmental Research and Public Health. 2022;19(23):15715. doi: https://doi.org/10.3390/ijerph192315715
6. Pogorzelska J, Zaglaniczny D, Zmyślna A, Kiebzak W. Observation of deep oscillation usage and its effectiveness on burn scars – a case report. Medical Studies. 2017;33(1):46-50. doi: https://doi.org/10.5114/ms.2017.66956
7. Opuchlik A, Biskup M, Włoch A, Lipińska-Stań­czak M, Lipińska A. Methods of physiotherapeutic mana­gement used in the treatment of secondary lymphoedema in the Holycross Cancer Centre in Kielce. Medical Studies. 2014;30(2):123-30. doi: https://doi.org/10.5114/ms.2014.43606
8. Belmonte R, Tejero M, Ferrer M, Muniesa JM, Duarte E, Cunillera O, et al. Efficacy of low-frequency low-intensity electrotherapy in the treatment of breast cancer-related lymphoedema: a cross-over randomized trial. Clinical Rehabilitation. 2012;26(7):607-18. doi: https://doi.org/10.1177/0269215511427414
9. Hammad TA, Smolderen KG, Spertus JA, Jones PG, Shishehbor MH. Associations of exercise an­kle–bra­chial index, pain-free walking distance and maxi­mum wal­king distance with the Peripheral Artery Ques­tion­naire: Finding from the PORTRAIT PAD Registry. Vascular Medicine (United Kingdom). 2019;24(1):32-40. doi: https://doi.org/10.1177/1358863X18785026
10. Banerjee D, Kamuren J, Baird GL, Klinger JR, Ventetuolo CE. The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hyper­tension. Pulmonary Circulation. 2017;7(2):384-90. doi: https://doi.org/10.1177/2045893217695568
11. Vaidya A, Kleinegris M-C, Severens JL, Ten Cate H, Joore MA. Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication. Jour­nal of Comparative Effectiveness Research. 2018;7(6):535-48. doi: https://doi.org/10.2217/cer-2017-0029
12. Morris CJ, Zawieja DC, Moore JE. A multiscale sliding filament model of lymphatic muscle pumping. Biomechanics and Modelling in Mechanobiology. 2021;20(6):2179-202. doi: https://doi.org/10.1007/s10237-021-01501-0
13. Hur S, Kim J, Ratnam L, Itkin M. Lymphatic Inter­vention, the Frontline of Modern Lymphatic Medicine: Part I. History, Anatomy, Physiology, and Diagnostic Imaging of the Lymphatic System. Korean Journal of Radiology. 2023;24(2):95-108. doi: https://doi.org/10.3348/kjr.2022.0688
14. Ma KF, Kleiss SF, Schuurmann RCL, Nijboer TS, El Moumni M, Bokkers RPH, et al. Laser Doppler Flow­metry Combined with Spectroscopy to Determine Pe­ripheral Tissue Perfusion and Oxygen Saturation: A Pilot Study in Healthy Volunteers and Patients with Peripheral Arterial Disease. J Pers Med. 2022 May 24;12(6):853. doi: https://doi.org/10.3390/jpm12060853
15. Shiba S, Shiba A, Hatada A. Differences in Physi­cal Activity between Patients with Peripheral Artery Disease and Healthy Subjects. Journal of Ageing Research. 2020;2020:5093528. doi: https://doi.org/10.1155/2020/5093528
16. McDermott MM, Dayanidhi S, Kosmac K, Saini S, Slysz J, Leeuwenburgh C, et al. Walking Exercise Therapy Effects on Lower Extremity Skeletal Muscle in Peripheral Artery Disease. Circ Res. 2021 Jun 11;128(12):1851-67. doi: https://doi.org/10.1161/CIRCRESAHA.121.318242
17. Аntoaneta B, Magdalena GZ. Deep oscillation – a modern additional physical modality for analgesia in pa­tients with back pain. Praemedicus. 2013;29:85-90.
18. Szymczak M, Oszkinis G, Majchrzycki M. The Im­pact of Walking Exercises and Resistance Training upon the Walking Distance in Patients with Chronic Lower Limb  Ischaemia. BioMed Res Int. 2016;2016:7515238. doi: https://doi.org/10.1155/2016/7515238
19. McDermott MM, Spring B, Tian L, Treat-Jacob­son D, Ferrucci L, Lloyd-Jones D, et al. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients with Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 Apr 6;325(13):1266-76. doi: https://doi.org/10.1001/jama.2021.2536.1276
20. Waddell A, Seed S, Broom DR, McGregor G, Bir­kett ST, Harwood AE. Safety of home-based exercise for people with intermittent claudication: A systematic review. Vascular Medicine. 2022;27(2):186-92. doi: https://doi.org/10.1177/1358863X211060388
21. Leslie R, May S, Scordis C, Isgar V, Poulton P, Garnham A. Outcomes following supervised exercise and home-based exercise for patients with intermittent claudication. Journal of Vascular Nursing: Official Publication of the Society for Peripheral Vascular Nursing. 2022;40(4):157-61. doi: https://doi.org/10.1016/j.jvn.2022.09.006
22. Jansen SCP, Hoeks SE, Nyklíček I, Scheltin­ga MRM, Teijink JAW, Rouwet EV. Supervised Exercise The­rapy is Effective for Patients with Intermittent Claudication Regardless of Psychological Constructs. European Journal of Vascular and Endovascular Surgery. 2022;63(3):438-45. doi: https://doi.org/10.1016/j.ejvs.2021.10.027
23. Pymer S, Ibeggazene S, Palmer J, Tew GA, Ing­le L, Smith GE, et al. An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication. Journal of Vascular Surgery. 2021;74(6):2076-85. doi: https://doi.org/10.1016/j.jvs.2021.03.063
24. Afridi A, Rathore FA. What are the effects of dif­ferent modes of exercise training for intermittent claudi­cation? – A Cochrane Review summary with commentary. Journal of Rehabilitation Medicine. 2021;53(4):2778. doi: https://doi.org/10.2340/16501977-2820
25. Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink JA. Supervised exercise therapy versus physical therapy at home versus walking advice for intermittent claudication. The Cochrane Database of Systematic Reviews. 2018;4(4):CD005263. doi: https://doi.org/10.1002/14651858.CD005263.pub4
26. Sakibaev KS, Nikityuk DB, Alekseyeva NT, Klo­chkova SV, Tashmatova NM. Characteristics of muscle mass in women of different constitutions. Research Journal of Pharmacy and Technology. 2019;12(12):6193-7. doi: https://doi.org/10.5958/0974-360X.2019.01075.8
27. Doszhanova GN, Abduldayeva AA. Hygienic as­ses­sment of nutrition status of the population of the geronto­lo­gical group. Gigiena i Sanitariya. 2017;96(11):1084-7. doi: https://doi.org/10.18821/0016-9900-2017-96-11-1084-1087
28. Mamontov IN. Results of treatment for mirizzi syndrome. Klinichna Khirurhiia. 2016;9:25-7. doi: https://pubmed.ncbi.nlm.nih.gov/30265472/
29. Shakiyeva R, Abduldayeva A, Akhmetova K, Tu­leshova G, Dosmambetova K, Maltabarova N, et al. The structure of a daily food ration of the inhabitants over 40 years old in the Republic of Kazakhstan. Iranian Journal of Public Health. 2018;47(8):1215-7.
30. Hajiyeva NN. Clinical presentations of pain synd­rome depending on the grade of CNS lesions at newborns. Azerbaijan Medical Journal. 2008;3:50-2.
31. Sakibaev K, Kozuev K, Atabaev I, Alimbekova A, Argynbaeva A. Somatotypological Indicators of Physical Development in Residents of Kyrgyzstan. Iranian Journal  of War and Public Health. 2022;14(3):279-85. doi: https://doi.org/10.29252/ijwph.14.3.279
32. Schapovalova O, Gorlova A, de Munter J, Sheve­leva E, Eropkin M, Gorbunov N, et al. Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice. Frontiers in Medicine. 2022;9:952977. doi: https://doi.org/10.3389/fmed.2022.952977
33. Altayeva AA, Issenova SS, Machtejeviene E, Bo­dykov GZ, Bishekova BN. Results of using the robson classification in Kazakhstan. Open Access Macedonian Journal of Medical Sciences. 2021;9:663-9. doi: https://doi.org/10.3889/oamjms.2021.6398
34. Tápanes SH, Fernández MJS, Iturralde Y, Fer­nández AS. The effect of deep oscillation therapy in fibro­cystic breast disease. A randomized controlled clinical trial. International Archives of Medicine. 2018;11(14):1-10. doi: https://doi.org/10.3823/2555
35. Sakibaev KS, Nikityuk DB, Atabaev IN, Sat­tarov AE, Nuruev MK. Somatotypological features of the physique of ethnic Kyrgyz women of different ages. Asia Life Sciences. 2020;Supp 22(2):185-200.
36. Von Stengel S, Teschler M, Weissenfels A, Wil­lert S, Kemmler W. Effect of deep oscillation as a recovery method after fatiguing soccer training: A randomized cross-over study. Journal of Exercise Science and Fitness. 2018;16(3):112-7. doi: https://doi.org/10.1016/j.jesf.2018.10.004
37. Jahr S, Schoppe B, Reisshauer A. Effect of treat­ment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. Journal of Rehabilitation Medicine. 2008;40(8):645-50. doi: https://doi.org/10.2340/16501977-0225
38. Boisnic S, Branchet MC. Anti-inflammatory and draining effect of the Deep Oscillation device tested clinically and on a model of human skin maintained in survival condition. European Journal of Dermatology. 2013;23(1):59-63. doi: https://doi.org/10.1684/ejd.2012.1904
39. Ayazbekov A, Nurkhasimova R, Khudaiber­geno­va SS, Zhunussov D, Zulpukharov A. Puberty Start of Girls Residing in Urban and Rural Areas of the Turkestan Region. Advances in Gerontology. 2022;12(1):47-55. doi: https://doi.org/10.1134/S2079057022010040
40. Mamed-zade GT. Congenital development disor­der: the system of data collection. Georgian medical news. 2009;166:21-5. PMID: 19202212

Look through:

Trybulski R. Upper Silesian Academy, Department of Physiotherapy, Katowice, Poland,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-4276-4813

Biolik G. Medical University of Silesia, Department of General Surgery, Vascular Surgery, Angiology and Phlebology, Katowice, Poland
https://orcid.org/0000-0001-8223-9370

Kuczmik W. Medical University of Silesia, Department of General Surgery, Vascular Surgery, Angiology and Phlebology, Katowice, Poland
https://orcid.org/0000-0002-0927-0977

Ivasyk N. Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies of Lviv, Lviv, Ukraine
https://orcid.org/0000-0002-0053-2854

Tyravska O. Ivan Bobersky Lviv State University of Physical Culture, Lviv, Ukraine
https://orcid.org/0000-0002-4555-7756

Trybulski R., Biolik G., Kuczmik W., Ivasyk N., Tyravska O. Application of deep oscillation therapy in the treatment of peripheral arterial diseases. Medicni perspektivi. 2023;28(3):116-127. DOI: https://doi.org/10.26641/2307-0404.2023.3.289207 

Application of deep oscillation therapy in the treatment of peripheral arterial diseases

The issue of improving dental care protocols for children with multiple (decompensated) and complicated caries of permanent teeth, their full rehabilitation is particularly relevant, especially in periods of social cataclysms (the COVID-19 pandemic, martial law, etc.). The purpose of this study was an assessment of the dental caries experience, analysis of modern approaches to diagnosis, treatment, prevention and rehabilitation of complicated caries of permanent teeth among children in Kyiv. The material of the study was data from medical histories of 236 children aged 7-18 years. During the analysis of the obtained data, the dental caries experience, % of cases of toothache complaints and part of the need for replacement or correction of restorations after the treatment of complicated caries were calculated. The prevalence of caries of permanent teeth among 7-18-year-old children (n=236) in the period 2020-2023 was 42-95%, the dental caries experience – 1.73-6.4, the frequency of diagnosis of complicated caries – 4.8-37,1%, the prevalence of toothache – 31%, the part of the need for replacement of restorations after treatment of complicated caries – 62%. The obtained indicators confirm the absence of a downward trend compared to similar data for more than 15 years of observation. Diagnosis, treatment and full rehabilitation of complicated caries of permanent teeth in children is complex, multi-stage and requires the practical experience and patience of a dentist and the usage of the most modern materials and technologies. To date, there are no clear scientifically based protocols for the restoration of permanent teeth, in particular with incomplete root formation, after endodontic treatment. The usage of modern technologies of orthopedic dentistry and materials science (3D scanner, 3D printer, T-scan, polymers) will allow to significantly improve the quality of comprehensive treatment and rehabilitation of children with complications of caries of permanent teeth.

Key words: permanent teeth, caries, children, hard tooth tissues, tooth restoration, endodontic treatment, digital dentistry

1. Rechmann P, Chaffee B, Rechmann B, et al. Ca­ries Management by Risk Assessment: Results from a Practice-Based Research Network Study. J Calif Dent Assoc. 2019 Jan;47(1):15-24. doi: https://doi.org/10.1080/19424396.2019.12220742
2. Horokhivskyi VV, Dienha OV. [Dental status of children with dental caries under the influence of deve­loped preventive measures including mineralol]. Innovatsii v stomatolohii. 2022;1:39-42. Ukrainian. doi: https://doi.org/10.35220/2523-420X/2022.1.6
3. Mandziuk TB, Goncharenko VA, Kaskova LF. Comparative characteristics of dental caries indices in children at the first period of changeable occlusion. The scientific heritage. 2018;23(Р 2):31-4.
4. Hodovanets OI, Kotelban AV. [Caries incidence rates of permanent teeth in children aged 12 and 15]. Visnyk stomatolohii. 2020;2(111),36:80-4. Ukrainian. doi: https://doi.org/10.35220/2078-8916-2020-36-2-80-84
5. Danyltsiv LO, Rozhko MM. [Dental status of 15-year-old schoolchildren in the Ivano-Frankivsk region]. Klinichna Stomatolohiia. 2022;4:39-43. Ukrainian. doi: https://doi.org/10.11603/2311-9624.2021.4.12660
6. Savychuk NO. [Innovative approaches to the pre­vention of dental caries in children and pregnant women]. Sovremennaia stomatolohyia. 2013;5:50-4. Ukrainian.
7. Kaskova LF, Mandziuk ТB, Ulasevych LP, et al. Correlation relations of caries and socio-hygienic factors. Problemy ekolohii ta medytsyny. 2019;23(3-4):9-12. doi: https://doi.org/10.31718/mep.2019.23.3-4.03
8. Hryhorenko HM, Khomenko LO, Soro­chen­ko HV. [In vitro study of the enamel surface layer of permanent teeth in the period of secondary mineralization]. Ukrainskyi stomatolohichnyi almanakh. 2015;1:11-5. Ukrainian.
9. Al‑Halabi M, Salami A, Alnuaimi E, et al. As­sessment of paediatric dental guidelines and caries mana­gement alternatives in the post COVID‑19 period. A cri­tical review and clinical recommendations. European Archives of Paediatric Dentistry. 2020;21:543-56. doi: https://doi.org/10.1007/s40368-020-00547-5
10. Khomenko LO, Ostapko OI, Trachuk YuM, [The main indicators of dental morbidity in 12-15-year-old children in Kyiv]. Aktualni problemy medytsyny ta byolohyy. 2005;1(33):200-6. Ukrainian.
11. Sorochenko HV, Ishutko IF, Karachevska KO. [Condition of hard tissues of permanent teeth in children of Kyiv]. Visnyk problem biolohii i medytsyny. 2016;1,2(127):267-9. Ukrainian.
12. Hruzieva TS, Lekhan VM, Ohniev VA, Haliien­ko LI, Kriachkova LV, Palamar BI, et al. [Biostatistics]. Vinnytsia: New Book; 2020. 384 p. Ukrainian.
13. Pavlenko OV, Lystopad OP. [In vitro study of the enamel surface layer of permanent teeth in the period of secondary mineralization]. Sovremennaia stomatolohyia. 2014;2:100-3. Ukrainian.
14. Borysenko AV, Nespriadko VP, Klitynskyi YV, et al. [Computer simulation of stresses in mandibular incisors with different restoration designs]. Sovremennaia stoma­tolohyia. 2013;2:90-2. Ukrainian.
15. Chua DR, Tan BL, Nazzal H, et al. Outcomes of preformed metal crowns placed with the conventional and Hall techniques: A systematic review and meta‐analysis. International Journal of Paediatric Dentistry. 2022;33,2:141-57. doi: https://doi.org//10.1111/ipd.13029  
16. Ayedun OS, Oredugba FA, Sote EO. Comparison of the treatment outcomes of the conventional stainless steel crown restorations and the hall technique in the treatment of car-ious primary molars. Niger J Clin Pract. 2021;24(4):584-94. doi: https://doi.org//10.4103/njcp.njcp_460_20
17. Vamshi NS, Agarwal A, Sachanandani HM, et al. Revolution in Pediatric Dentistry: A Review. Journal of Advanced Medical and Dental Sciences Research. 2021;9,11:47-51. doi: https://doi.org//10.21276/jamdsr

Look through:

Proshchenko N.S. O.O. Bogomolets National Medical University, Kyiv, Ukraine
https://orcid.org/0000-0001-7317-6590 

Sorochenko H.V. O.O. Bogomolets National Medical University, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-0559-6080

Ostapko O.I. O.O. Bogomolets National Medical University, Kyiv, Ukraine
https://orcid.org/0000-0001-6777-5116

Plyska O.M. O.O. Bogomolets National Medical University, Kyiv, Ukraine
https://orcid.org/0000-0002-3843-5582

Trokhimets Yu.V. O.O. Bogomolets National Medical University, Kyiv, Ukraine
https://orcid.org/0009-0004-2936-9263 

Proshchenko N.S., Sorochenko H.V., Ostapko O.I., Plyska O.M., Trokhimets Yu.V.  Complicated caries of permanent teeth in children: status of the problem and modern solution ways. Medicni perspektivi. 2023;28(3):128-136. DOI: https://doi.org/10.26641/2307-0404.2023.3.289211 

Complicated caries of permanent teeth in children: status of the problem and modern solution ways

In general, 5-7% of global deaths are related to occupational diseases and industrial injuries. The social expenses related to occupational diseases reach 2-14% of the gross national product (GNP) in different countries. The aim of the investigation is to analyze the indicators and dynamics of occupational morbidity, related incapacity for work and disability in Ukraine in comparison with other countries of the world. The analysis of reporting materials of the State Labor Service of Ukraine, reports of the World Health Organization, and the International Labor Organization was carried out. According to the State Statistics Committee of Ukraine, the number of people working in the main sectors of the economy in conditions that do not meet sanitary and hygienic standards and requirements is 836,600 people, or 28.4% of the registered number of full-time employees. The results obtained in the study indicate the discrepancy of statistical data on occupational morbidity and its consequences with the real situation: the level of occupational morbidity in Ukraine is 17 times lower than the European average, despite the fact that the working conditions in most of them do not meet hygienic standards. The most common occupational diseases in Ukraine are diseases caused by dust exposure: pneumoconiosis, chronic bronchitis, COPD, which make up 39% of the occupational morbidity structure. The global indicator of Disability Adjusted Life Year (DALYs) from the occupational exposure factors in the world (5.1%) is 3 times higher than the similar one in Ukraine (1.53%). The rate of Years lived with disability (YLDs) caused by occupatipnal factors in Ukraine is 0.38 per 100,000 population, and is significantly lower than the similar rate in most European countries and the USA as well. Obvious distortion of statistical indicators on occupational morbidity and related consequences leads to inconsistency in determining priority areas of health care activity. Due to the process of reintegration of Ukraine into the European Union, the requirements for sanitary and hygienic working conditions, medical and sanitary services for workers, the system of recognition, registration and prevention of occupational diseases should definitely be adapted to international requirements and recommendations as well.

Key words: occupational diseases, incapacity, handicap

1. Nahorna AM. [Occupational morbidity in Ukraine during the COVID-19 pandemic: an epidemiological analysis]. Ukrainskyi zhurnal z problem medytsyny pratsi. 2022;18(1):12-21. Ukrainian. doi: https://doi.org/10.33573/ujoh
2. GehannoJ-F, Letalon S, Gislard A, Rollin L. Inequities in occupational diseases recognition in France. Rev Epidemiol Sante Publique. 2019;67(4):247-52. doi: https://doi.org/10.1016/j.respe.2019.04.054
3. Basanets AV. [The state of occupational morbidity in Ukraine: realities and trends]. Promyslova bezpeka. 2014;12(75):50-2. Ukrainian. doi:
4. Nahorna AM. [Medico-social and demographic characteristics of the formation of occupational morbidity in Ukraine in the pre-war period and during martial law]. Ukrainskyi zhurnal z problem medytsyny pratsi. 2022;18(3):171-80. Ukrainian. doi: https://doi.org/10.33573/ujoh2022.03
5. [Labor of Ukraine. Statistical collection]. Kyiv; TOV “Avhust Treid”, 2020. Ukrainian. Available from: http://www.ukrstat.gov.ua/druk/publicat/kat_u/2020/zb/08/zb_Pracia2019.pdf
6. Nahorna AM, Sokolova MP, Vitte PM. [The state of occupational morbidity during the period of legislative changes in Ukraine]. Ukrainskyi zhurnal z problem medytsyny pratsi. 2016;1:3-17. Ukrainian.
7. Basanets AV, Bulavko MM. [Labor conditions and peculiarities of the clinical course of deforming arthrosis in workers of mining industry]. Medicni perspektivi.2018;23(3):6-11.  doi: https://doi.org/10.26641/2307-0404.2018.3(part1).142326
8. Palacios NavaVE, Moreno Sánchez AR, Paz Román MDP, García JJ, Nava Hernández Situation of occupational and environmental health in Mexico. Ann Glob Health. 2018;84(3):348-59. doi: https://doi.org/10.29024/aogh.2317
9. Saha Occupational health in India. Ann Glob Health.2018;84(3):330-3. doi: https://doi.org/10.29024/aogh.2302
10. Murray CJ. GBD 2015 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet.2016;388:1659-724. doi: https://doi.org/10.1016/S0140-6736(16)31679-8
11. Rushton The Global Burden of Occupational Disease Curr Environ Health Rep. 2017;4(3):340-8. doi: https://doi.org/10.1007/s40572-017-0151-2
12. Boirysova IS. [Disability status due to occu­pational diseases: Ukraine 2015-2018]. Medicni pers­pektivi.2021;26,(1):232-8.  doi: https://doi.org/10.26641/2307-0404.2021.1.228021
13. GBD Compare [Internet]. IHME, University of Washington; 2019 [cited 2023 Apr 14]. Available from: https://vizhub.healthdata.org/gbd-compare/
14. Van der Molen HF, de Vries S, Sluiter JK. Oc­cupational diseases among workers in lower and higher socioeconomic positions. Int J Environ Res Public Health. 2018;15(12):2849. doi: https://doi.org/10.3390/ijerph15122849
15. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and oc­cupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923-94. doi: https://doi.org/10.1016/S0140-6736(18)32225-6
16. Arustamiam OM, Tkachyshin VS, Kondratiuk VYe, Korzh AV. [Modern problems of oc­cupational pathology in Ukraine]. Dovkillia ta zdorovia. 2017;4(84):62-7. doi: https://doi.org/10.32402/dovkil2017.04.062
17. Basanets AV. Work-related diseases: problems and solutions. Svet rada. 2017;14(4):524-9.
18. Basanets AV, Andrysyshyna IM, Lashko OM. [Essential elements role in pathogenesis of occupational chronic lumbosacral radiculopathy in coal miners]. Medicni perspektivi. 2020;25(2):71-7. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2020.2.206365
19. Obermeyer LK, John SM, Skudlik C. Occupa­tional skin diseases. MMW Fortschr Med. 2021;163(18):56-63. doi: https://doi.org/10.1007/s15006-021-0292-y
20. HerlochV, Elsner The (new) occupational disease no. 5101: "Severe or recurrent skin diseases. J Dtsch Dermatol Ges. 2021;19(5):720-41. doi: https://doi.org/10.1111/ddg.14537
21. Thomas L. Diepgen Occupational skin diseases. J Dtsch Dermatol Ges. 2012;10:297-315. doi: https://10.1111/j.1610-0387.2012.07890
22. Total WHO/ILO Joint Estimates of the Work–related Birden of Disease and Injury, 2000-2016: Global Monitoring Report [Internet]. [cited 2023 Apr 14].  Available from: https://www.who.int/publications-detail-redirect/9789240034945
23. Takala J. Eliminating occupational cancer. Indust Hlth. 2015;53:307-9. doi: https://doi.org/10.2486/indhealth.53-307
24. Perlman DM, Maier LA. Occupational lung disease. Med Clin North Am. 2019;103(3):535-48. doi: https://doi.org/10.1016/j.mcna.2018.12.012
25. Chen KH, Su SB, Chen KT. An overview of occupational noise-induced hearing loss among workers: epidemiology, pathogenesis, and preventive measures. EnvironHealth Prev  2020;25(1):65. doi: https://doi.org/10.1186/s12199-020-00906-0
26. Ntlhakana L, Nelson G, Khoza-Shangase KS. Es­timating miners at risk for occupational noise-induced hearing loss: a review of data from a South African platinum mine. Afr J Commun Disord. 2020;67(2):e1-e8. doi: https://doi.org/10.4102/sajcd.v67i2.677
27. Diagnostic and exposure criteria for occupational diseases - Guidance notes for diagnosis and prevention of the diseases in the ILO List of Occupational Diseases (revised 2010) [Internet]. [cited 2023 Apr 14]. Available from: https://www.ilo.org/global/topics/safety-and-health-at-work/resources-library/
28. Disability-adjusted life years (DALYs) (who.int) [Internet]. [cited 2023 Apr 14]. Available from: http://www.who.int/data/gho/indicator-metadata-registry/imr-details/158
29. Raulf M. Occupational respiratory allergy: risk factors, diagnosis, and management. Handb Exp Pharmacol.2022;268:213-25. doi: https://doi.org/10.1007/164_2021_472
30. Ochmann U, Mueller-Lisse UG. Occupational diseases of the airways and the lungs. Nowak Internist (Berl). 2021;62(9):906-20. doi: https://10.1007/s00108-021-01109-7
31. Si S, Lewkowski K, Fritschi L, Heyworth J, Liew D, Li I. Productivity burden of occupational noise-induced hearing loss in Australia: a life table modelling study. Int J Environ Res Public Health. 2020;17(13):4667. doi: https://10.3390/ijerph17134667
32. Roio LC, Mizutani RF, Pinto RC, Terra-Filho M, Santos UP. Work-related asthma. J Bras Pneumol. 2021;47(4):e20200577.
    doi: https://10.36416/1806-3756/e20200577
33. Kundiiev YuI, Varyvonchyk DV, Remennyk OI. [Occupational cancer: state and prospects of study in Ukraine]. Onkolohiia. 2010;12(3):224-8. Ukrainian.
34. Varyvonchyk DV, Ejibiya OM, Kopach KD. Modern approaches for improving prevention, screening and early diagnosis of head and neck tumors of occupational genesis. Ukrainian journal of occupational health.2020;16(3):187-201. doi: https://10.33573/ujoh2020.03.187
35. ViegiG, Maio S, Fasola S, Baldacci Global burden of chronic respiratory diseases. J Aerosol Med Pulm Drug Deliv. 2020;33(4):171-7. doi: https://10.1089/jamp.2019.1576
36. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. LancetRespir  2020;8(6):585-96. doi: https://10.1016/S2213-2600(20)30105-3
37. SafiriS, Carson-Chahhoud K, Noori M, Nejad­ghaderi SA, Sullman MJM, Heris Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679. doi: https://10.1136/bmj-2021-069679
38. Murgia N, Gambelunghe A. Occupational COPD – The most under-recognized lung disease? Respirology. 2022;27(6):399-410. doi: https://10.1111/resp.14272
39. Nowak-Pasternak J, Lipińska-Ojrzanowska A, Świą­tkowska B. Epidemiology of silicosis reported to the central register of occupational diseases over last 20 years in Poland. Int J Occup Med Environ Health. 2022;35(5):561-70. doi: https://10.13075/ijomeh.1896.01950
40. Fazen LE, Linde B, Redlich CA. Occupational lung diseases in the 21st century: the changing landscape and future challenges. Curr Opin Pulm Med. 2020;26(2):142-8. doi: https://10.1097/MCP.0000000000000658
41. Hoy RF, Chambers DC. Silica-related diseases in the modern world. Eur J Allergy Clin Immunol. 2020;75(11):2805-17.doi: https://doi.org/10.1111/all.14202
42. Qi XM, Luo Y, Song MY, Liu Y, Shu T, Liu Y, et al. Pneumoconiosis: current status and future prospects. Chin Med J (Engl). 2021;134(8):898-907. doi: https://10.1097/CM9.0000000000001461
43. Shimin ChenS, Liu M, Xie Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019. BMC Pulm Med. 2022;22(1):240. doi: https://10.1186/s12890-022-02040-9
44. Shydlovska TV, Shydlovska TA, Shevtsova TV, Kozak YuM. [Diagnosis and prevention of early auditory disorders due to exposure to industrial noise in machine-building industry workers]. Zhurnal vushnykh, nosovykh i horlovykh khvorob. 2012;6:19-23.
45. WangD, Liang R, Yang M, Ma J, Li W, Mu M, et al. Incidence and disease burden of coal workers' pneu­moconiosis worldwide, 1990-2019: evidence from the Global Burden of Disease Study 2019. Eur Respir J. 2021;58(5):2101669. doi: https://10.1183/13993003.01669-2021
46. Pal A, Dasgupta A, Sanjoy K, Sadhukhan SK, Ban­dyopadhyay L, Paul B, et al. How common are aches and pains among garment factory workers? A work‑related musculoskeletal disorder assessment study in three factories of south 24 Parganas district, West Bengal. Journal of Family Medicine and Primary Care. 2021;10(2):91. doi: https://10.4103/jfmpc.jfmpc_55_20
47. Baur X. Asbestos-related disorders in Germany: background, politics, incidence, diagnostics and compensation. Int J Environ Res Public Health. 2018;15(1):143. doi: https://10.3390/ijerph15010143

Look through:

Prodanchuk M.H. State Enterprise “L.I. Medved Research Center of Preventive Toxicology, Food and Chemical Safety of the Ministry of Healthcare of Ukraine”, Kyiv, Ukraine
https://orcid.org/0000-0002-9229-9761

Basanets A.V. State Enterprise “L.I. Medved Research Center of Preventive Toxicology, Food and Chemical Safety of the Ministry of Healthcare of Ukraine”, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0001-8236-4251

Kravchuk O.P. State Enterprise “L.I. Medved Research Center of Preventive Toxicology, Food and Chemical Safety of the Ministry of Healthcare of Ukraine”, Kyiv, Ukraine
https://orcid.org/0000-0003-3608-5555

Hashynova K.Y. Dnipro State Medical University, Dnipro, 49044, Ukraine 
https://orcid.org/0000-0003-2955-9687

Hvozdetskyy V.A. Prof. Kolomiichenko Institute of Otolaryngology of the National Academy of medical Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0000-0002-4663-141X

Prodanchuk M.H., Basanets A.V., Kravchuk O.P., Hashynova K.Y., Hvozdetskyy V.A. Analysis of the dynamics of occupational morbidity and its consequences in Ukraine in comparison with other countries of the world. Medicni perspektivi. 2023;28(3):137-152. DOI: https://doi.org/10.26641/2307-0404.2023.3.289217 

Analysis of the dynamics of occupational morbidity and its consequences in Ukraine in comparison with other countries of the world

In the context of the constant increase in the burden of chronic non-communicable diseases, the World Health Organization's (WHO) activities are aimed at developing policies and strategies in the field of non-communicable disease (NCD) prevention, which have been continuously evolving. The work is dedicated to examining the sequential policy of the WHO outlined in documents regarding the link between nutrition and the development of non-communicable diseases. The objective of this study is to identify the main stages of WHO's policy on healthy nutrition as a key prerequisite for preventing the development of non-communicable diseases and outline the corresponding measures in Ukraine. Materials and methods: informational, bibliographic, normative-legal. The study utilized systematic-structural, formal-logical, bibliographic, and non-forma­lized (traditional) analysis methods. An analysis of WHO's policy on healthy nutrition as a factor in preventing the development of chronic non-communicable diseases has been conducted. The key stages of policy development and decision-making at the global level over the past three decades have been identified. It has been determined that the evolution of the role of nutrition within WHO's policy has progressed from urging governments to develop national food policies and create national action plans in the 1990s to global strategies and actions that have taken place in the 21st century. The basic WHO documents regarding the link between nutrition and the development of chronic diseases have been examined, as well as the expansion of understanding the content and necessity of healthy nutrition. The implementation of WHO's policy in Ukraine has been highlighted: the "National Action Plan on Non-communicable Diseases to Achieve the Sustainable Development Goals by 2030" (2018) has been developed and implemented, serving as a roadmap for the development of a series of guiding documents. The most important of these documents pertain to the organization and standards of healthy nutrition for children. However, the formation of a national regulatory and legal framework regarding healthy nutrition has not yet been completed. It has been determined that Ukraine needs to improve its policy on limiting the use of saturated fats, industrially produced trans fatty acids, and marketing unhealthy food and non-alcoholic beverages targeted at children. There is a need for extensive informational and educational activities to promote WHO's recommendations on healthy nutrition.

Key words: healthy nutrition, prevention of chronic diseases, WHO policy, legislative and regulatory acts of Ukraine, healthy eating habits

1. Food and health in Europe: WHO regional pub­lications european series [Internet]. Copenhagen: WHO Regional Office for Europe; WHO Regional Publications European Series 96. 2004 [cited 2023 Jul 15]; 385 p. Available from: https://apps.who.int/iris/bitstream/handle/10665/272255/9789289013635-eng.pdf?sequence=3
2. Murray CJ, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet [Internet]. 2020 Oct [cited 2023 Jul 15];396(10258):1223-49. doi: https://doi.org/10.1016/s0140-6736(20)30752-2
3. Diet, nutrition, and the prevention of chronic diseases. World Health Organization technical report series, 797 [Internet]. Geneva: World Health Organization; 1990 [cited 2023 Jul 15]; 203 p. Available from: https://apps.who.int/iris/handle/10665/39426
4. Martini D, Tucci M, Bradfield J, Di Giorgio A, Marino M, Del Bo' C, et al. Principles of Sustainable Healthy Diets in Worldwide Dietary Guidelines: Efforts So Far and Future Perspectives. Nutrients [Internet]. 2021 May 27 [cited 2023 Jul 9];13(6):1827. doi: https://doi.org/10.3390/nu13061827
5. Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet [Internet]. 2019 May [cited 2023 Jul 15];393(10184):1958-72. doi: https://doi.org/10.1016/s0140-6736(19)30041-8
6. International Conference on Nutrition : final report of the Conference, Rome, December 1992 [Internet]. Geneva: World Health Organization; 1992 [cited 2023 Jul 15]; 65 p. Available from: https://apps.who.int/iris/handle/10665/61254
7. Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation [Internet]. Geneva: World Health Organization; 2003 [cited 2023 Jul 15]; WHO Technical Report Series, No. 916. Available from: http://whglibdoc.who.int/trs/WHO_TRS_916.pdf
8. Comparative Analysis of Nutrition Policies in WHO European Member States [Internet]. World Health Organization. Regional Office for Europe; 1998 Oct [cited 2023 Jul 15]; 72 p. EUR/ICP/LVNG 01 02 01. Available from: https://apps.who.int/iris/handle/10665/108120
9. Gassner L, Zechmeister-Koss I, Reinsperger I. National Strategies for Preventing and Managing Non-communicable Diseases in Selected Countries. Frontiers in Public Health [Internet]. 2022 Feb 10 [cited 2023 Jul 9];10. doi: https://doi.org/10.3389/fpubh.2022.838051
10. Djojosoeparto SK, Kamphuis CB, Vande­vijve­re S, Murrin C, Stanley I, Romaniuk P, et al. Strength of EU-level food environment policies and priority recom­mendations to create healthy food environments. European Journal of Public Health [Internet]. 2022Mar 9 [cited 2023 Jul 12]. doi: https://doi.org/10.1093/eurpub/ckac010
11. Rao P, Rodriguez RL, Shoemaker SP. Addressing the sugar, salt, and fat issue the science of food way. npj Science of Food [Internet]. 2018Jul 16 [cited 2023 Jun 28];2(1). doi: https://doi.org/10.1038/s41538-018-0020-x
12. Milajerdi A, Djafarian K, Shab-Bidar S. Dose–response association of dietary sodium intake with all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective studies. Public Health Nutrition [Internet]. 2018 Oct 22 [cited 2023Jun 28];22(2):295-306. doi: https://doi.org/10.1017/s1368980018002112
13. Jessri M, Hennessey D, Bader Eddeen A, Ben­nett C, Zhang Z, Yang Q, et al. Sodium, Added Sugar and Saturated Fat Intake in Relation to Mortality and Cardiovascular Disease Events in Adults: Canadian National Nutrition Survey Linked with Vital Statistics and Health Administrative Databases. British Journal of Nutrition [Internet]. 2022 Apr 8 [cited 2023 Jun 28]:1-33. doi: https://doi.org/10.1017/s000711452200099x
14. Khendel NV. [Organizational and legal aspects of the World Health Organization as a coordinating universal organization]. Aktualni problemy polityky [Internet]. 2020Jan 23 [cited 2023 Jul 12];(64):145-58. Ukrainian. doi: https://doi.org/10.32837/app.v0i64.193
15. Holdenberh TV. [The main directions of interna­tional legal cooperation of the Ukraine with the World Health Organization]. Naukovyi visnyk Mizhnarodnoho humanitarnoho universytetu. Ser.: Yurysprudentsiia [Inter­net]. 2018[cited 2023 Jul12];36(2):179-82. Ukrainian. Available from: https://vestnik-pravo.mgu.od.ua/archive/juspradenc36/part_2/44.pdf
16. World Health Organization (WHO) [Internet]. [cited 2023 Jul14]. Available from: https://www.who.int/
17. European Union [Internet]. [cited 2023 Jul14]. Available from: https://european-union.europa.eu/
18. S. Food and Drug Administration [Internet]. [cited 2023 Jul14]. Available from: https://www.fda.gov/
19. [Ministry of Health of Ukraine]. [Internet]. [cited 2023 Jul14]. Ukrainian. Available from: https://moz.gov.ua
20. National Library of Ukraine named after VI.Ver­nadskyi [Internet]. [cited 2023 Jul 14]. Ukrainian. Available from: http://nbuv.gov.ua/
21. Sountrywide integrated noncommunicable disease intervention (CINDI) phogramme [Internet]. Copenhagen: WHO Regional Office for Europe; 1996 [cited 2023 Jul14]. 200 p. Available from: http://whqlibdok.who.int/hq/1994/EUR_ICP_CINDI_94.02_PB04.pdf
22. CINDI dietary guide [Internet]. Copenhagen: WHO Regional Office for Europe; 2000 [cited 2023 Jul14]. 32 p. Available from: https://apps.who.int/iris/handle/10665/108342
23. Nishida C, Uauy R, Kumanyika S, Shetty P. The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutrition [Internet]. 2004Feb [cited 2023 Jun 28];7(1a):245-50. doi: https://doi.org/10.1079/phn2003592
24. Li C, Cobb LK, Vesper HW, Asma S. Global Sur­veillance of trans-Fatty Acids. Preventing Chronic Disease [Internet]. 2019 Oct 31 [cited 2023 Jun 28];16. doi:https://doi.org/10.5888/pcd16.190121
25. World Health Organization (WHO) [Internet]. Noncommunicable diseases; 2022 Sep 16 [cited 2023 Jun 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
26. 23. Global strategy on diet, physical activity and health [Internet]. [place, publisher, date unknown]. WHA55.23 [cited 2023 Jun 27]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA57/A57_R17-en.pdf
27. The First Action Plan for Food and Nutrition Policy. WHO European Region 2000-2005 [Internet]. Co­penhagen: WHO Regional Office for Europe; 2001 [cited 2023 Jun27]. 41 p. EUR/01/5026013. Available from: https://apps.who.int/iris/handle/10665/108379
28. WHO European Action Plan for Food and Nutrition Policy 2007–2012 [Internet]. Copenhagen: WHO Regional Office for Europe; 2008 [cited 2023 Jun 27]. 28 p. 4245-44004-62047. WHO/EURO:2008. Available from: https://apps.who.int/iris/handle/10665/349767?search-result=true&amp;query=second+action+plan&amp;current-scope=10665/107133&amp;rpp=10&amp;sort_by=score&amp;order=desc
29. European food and nutrition action plan 2015-2020 [Internet]. Copenhagen: World Health Organization; 2014 [cited 2023 Jun27]. 24 p. EUR/RC64/14 EUR/RC64/Conf.Doc./8. Available from: https://apps.who.int/iris/bitstream/handle/10665/337971/64wd14e-FoodAndNutritionAP-140426.pdf?sequence=1&amp;isAllowed=y
30. Thirteenth general programme of work 2019–2023 [Internet]. Geneva: World Health Organization; 2018 [cited 2023Jun 27]. 53 p. WHO/PRP/18.1. Available from: https://www.who.int/publications/i/item/thirteenth-general-programme-of-work-2019-2023
31. Garde A, Zrilič J. International Investment Law and Non-Communicable Diseases Prevention. The Journal of World Investment & Trade [Internet]. 2020Oct 14 [cited 2023 Jul 12];21(5):649-73. doi: https://doi.org/10.1163/22119000-12340190
32. Global action plan for the prevention and control of noncommunicable diseases 2013-2020 [Internet]. Geneva: WHO Document Production Services; 2013 [cited 2023 Jul12]. 55 p. Available from: https://www.who.int/publications/i/item/9789241506236
33. Cena H, Calder PC. Defining a Healthy Diet: Evidence for the Role of Contemporary Dietary Patterns in Health and Disease. Nutrients [Internet]. 2020 Jan 27 [cited 2023 Jul12];12(2):334. doi: https://doi.org/10.3390/nu12020334
34. Framework for Action. In: Second International Conference on Nutrition; 2014 Nov19-21; Rome, Italy. Rome: Food and Agriculture Organization of the United Nations/World Health Organization; 2014. p. 1-8.
35. World Health Organization (WHO) [Internet]. Healthy diet; 2020 Apr 29 [cited 2023 Jun27]. Available from: https://www.who.int/news-room/fact-sheets/detail/healthy-diet
36. Guideline: Sugars intake for adults and children [Internet]. Geneva: World Health Organization; 2015.59 p. WHO/NMH/NHD/15.2. Available from: https://www.who.int/publications/i/item/9789241549028
37. Guideline: Sodium intake for adults and children [Internet]. Geneva: World Health Organization; 2012.56 p. WHO/NMH/NHD/13.2. Available from: https://apps.who.int/iris/bitstream/handle/10665/77985/9789241504836_eng.pdf
38. Messerli FH, Hofstetter L, Syrogiannouli L, Rex­haj E, Siontis GC, Seiler C, et al. Sodium intake, life expectancy, and all-cause mortality. European Heart Journal [Internet]. 2020Dec 22 [cited 2023 Jun 28]. Available from: https://doi.org/10.1093/eurheartj/ehaa947
39. Li C, Cobb LK, Vesper HW, Asma S. Global Surveillance of trans-Fatty Acids. Preventing Chronic Disease [Internet]. 2019 Oct 31 [cited 2023Jun 28];16. Available from: https://doi.org/10.5888/pcd16.190121
40. Guidelines: Saturated fatty acid and trans-fatty acid intake for adults and children [Internet]. Geneva: World Health Organization; 2018. 101 p. Available from: https://cdn.who.int/media/docs/default-source/nutritionlibrary/cfs-vgfsyn/draft-who-sfa-tfa-guidelines-public-consultation.pdf?sfvrsn=dc29c6af_5
41. Technical consultation on setting global sodium benchmarks for different food categories: report of a virtual meeting [Internet]. Geneva: World Health Organization; 2022.36 p. Available from: https://apps.who.int/iris/handle/10665/353331
42. Grosso G, Di Cesare M. Dietary factors and non-communicable disease risk in Europe: evidence for Euro­pean nutritional guidelines? European Journal of Public Health [Internet]. 2021Oct 1 [cited 2023 Jul 9];31(Suppl 3). doi: https://doi.org/10.1093/eurpub/ckab164.185
43. Ahmad R, Akter F, Haque M. Editorial: Diet and nutrition for non-communicable diseases in low and middle-income countries. Frontiers in Nutrition [Internet]. 2023Mar 28 [cited 2023 Jul 12];10. doi: https://doi.org/10.3389/fnut.2023.1179640
44. Mikkelsen B, Williams J, Rakovac I, Wickrama­singhe K, Hennis A, Shin HR, et al. Life course approach to prevention and control of non-communicable diseases. BMJ [Internet]. 2019 Jan 28 [cited 2023 Jul15]:l257. doi: https://doi.org/10.1136/bmj.l257
45. Fanzo J, Rudie C, Sigman I, Grinspoon S, Ben­ton TG, Brown ME, et al. Sustainable food systems and nutrition in the 21st century: A report from the 22nd annual harvard nutrition obesity symposium. The American Journal of Clinical Nutrition [Internet]. 2021Sep 15 [cited 2023 Jul 15]. doi: https://doi.org/10.1093/ajcn/nqab315
46. Buoncristiano M, Spinelli A, Williams J, Nar­done P, Rito AI, García‐Solano M, et al. Childhood over­weight and obesity in Europe: Changes from 2007 to 2017. Obesity Reviews [Internet]. 2021Aug 10 [cited 2023 Jul 15]. doi: https://doi.org/10.1111/obr.13226
47. Report of the commission on ending childhood obesity [Internet]. Geneva: World Health Organization; 2016 [cited 2023Jul 15]. 65 p. Available from: https://www.who.int/publications/i/item/9789241510066
48. WHO European Childhood Obesity Surveillance Initiative (‎COSI)‎ Report on the fourth round of data collection, 2015–2017 [Internet]. Copenhagen: World Health Organization. Regional Office for Europe; 2021 [cited 2023Jul 15]. 90 p. 2495-42251-58349. WHO/EURO:2021. Available from: https://apps.who.int/iris/handle/10665/341189
49. Chrissini MM, Panagiotakos DB. Public health inter­ventions tackling childhood obesity at European level: A literature review. Preventive Medicine Reports [Internet]. 2022Dec [cited 2023 Jun 28];30:102068. doi: https://doi.org/10.1016/j.pmedr.2022.102068
50. Romanelli R, Cecchi N, Carbone MG, Dinardo M, Gaudino G, Miraglia del Giudice E, et al. Pediatric obesity: prevention is better than care. Italian Journal of Pediatrics [Internet]. 2020Jul 24 [cited 2023 Jul 15];46(1). doi: https://doi.org/10.1186/s13052-020-00868-7
51. [Resolution adopted by the General Assembly on 1 April 2016. United Nations Decade of Action on Nutrition (2016-2025)]. [Internet]. Geneva: World Health Orga­nization; 2016 [cited 2023Jul 15]. 3 p. 70/259. Rus­sian. Available from: http://cawater-info.net/pdf/n1609308.pdf
52. Baker P, Hawkes C, Wingrove K, Demaio AR, Par­khurst J, et al. What drives political com­mitment for nutrition? A review and framework synthesis to inform the United Nations Decade of Action on Nutrition. BMJ Global Health [Internet]. 2018Feb [cited 2023 Jul 15];3(1):e000485. doi: https://doi.org/10.1136/bmjgh-2017-000485
53. Breda J, Castro LS, Whiting S, Williams J, Jewell J, Engesveen K, et al. Towards better nutrition in Europe: Evaluating progress and defining future directions. Food Policy [Internet]. 2020Oct [cited 2023 Jun 28];96:101887. doi: https://doi.org/10.1016/j.foodpol.2020.101887
54. Use of nutrient profile models for nutrition and health policies: meeting report on the use of nutrient profile models in the WHO European Region, September 2021 [Internet]. Copenhagen: World Health Organization. Regional Office for Europe; 2022 [cited 2023 Jun 28]. 78 p. 6201-45966-66383. WHO/EURO:2022. Available from: https://apps.who.int/iris/handle/10665/363379
55. Nutrition labelling: policy brief [Internet]. Geneva: World Health Organization; 2022 [cited 2023Jun 28]. Available from: https://apps.who.int/iris/handle/10665/355295
56. Reformulation of food and beverage products for healthier diets: policy brief [Internet]. Geneva: World Health Organization; 2022 [cited 2023Jun 28]. 21 p. Available from: https://apps.who.int/iris/handle/10665/355755
57. REPLACE trans fat: an action package to eliminate industrially produced trans-fatty acids [Internet]. World Health Organization; 2019 [cited 2023Jun 28]. 7 p. WHO/NMH/NHD/18.4. Available from: https://www.who.int/publications/i/item/9789240021105
58. Countdown to 2023: WHO report on global trans-fat elimination 2022 [Internet]. Geneva: World Health Organization; 2023 [cited 2023Jun 28]. 62 p. Available from:https://www.who.int/publications/i/item/9789240067233
59. WHO global report on sodium intake reduction [Internet]. Geneva: World Health Organization; 2023 [cited 2023Jun 28]. 99 p. Available from: https://www.who.int/publications/i/item/9789240069985
60. He FJ, Brown M, Tan M, MacGregor GA. Re­ducing population salt intake –An update on latest evidence and global action. The Journal of Clinical Hypertension [Internet]. 2019 Aug 26 [cited 2023Jul 12];21(10):1596-601. doi: https://doi.org/10.1111/jch.13664
61. Smyrnov IP, editor. [Principles of healthy nut­rition: a guide to improving the quality of work]. Kyiv: CINDI- Ukraina; 2001. 29 p. Ukrainian.
62. [On the approval of the Concept of improving the food supply and quality of nutrition of the population. Order Kabinet of the Ministers of Ukraine dated 2004May 26, No. 332-r: as of 2020 Sept 26]. [Internet]. [cited 2023 Jun 01]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/332-2004-р#Text
63. Serdiuk A, Gulich M, Polka N. [The prevention of non-infectious diseases related to lifestyle, nutrition and physical activity is an important direction of the national strategy of health protection of the population of Ukraine]. Zhurnal Akademii medychnykh nauk Ukrainy. 2010;16(2):299-307. Ukrainian.
64. Brych V, Bilak-Lukianchuk V, Slabkyi H, Hut­sol I, Potokii N, editors. [Healthy nutrition: a collection of materials for health care workers kharchuvannia] [Internet]. Uzhhorod: FOP SabovM; 2020. 64 p. Ukrainian. Available from: https://dspace.uzhnu.edu.ua/jspui/bitstream/lib/29992/1/інформ.Харч.%20збірник%20нові%20поля.pdf
65. [Pro On the approval of the Norms of physiological needs of the population of Ukraine in basic nutrients and energy. Order of the Ministry of Health of Ukraine dated 2017 Sept3, No. 1073]. [Internet]. [cited 2023 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1206-17#Text
66. [Pro On the approval of the National Action Plan for non-communicable diseases to achieve the global goals of sustainable development. Order Cabinet of the Ministers of Ukraine dated 2018 Jul26, 530]. [Internet]. [cited 2023 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/530-2018-р#Text
67. [On the approval of norms and the Procedure for the organization of meals in educational institutions and children's health and recreation institutions. Decree of the Cabinet of Ministers of the Ministers of Ukraine dated 2021 Mar 24 No. 305: as of 2021 Sept 1]. [Internet]. 2021 [cited 2023 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/305-2021-п#Text
68. [On the National Strategy for the Development of a Safe and Healthy Educational Environment in a New Ukrainian School. Decree of the President of Ukraine dated 2020May 25, 195/2020]. [Internet], 2020 [cited 2023 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/195/2020#Text
69. [On the approval of the Sanitary Regulations for general secondary education institutions. Order of the Ministry of Health of Ukraine dated 2020 Sept25 No. 2205: as of 2022 Sept 9]. [Internet], 2020 [cited 2023 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1111-20#Text
70. [Information bulletin Ukraine. Food habits of adults aged 18-69 years. Key findings from the STEPS study]. [Internet]. Geneva: World Health Organization; 2022. 4 p. Ukrainian. Available from: https://cdn.who.int/media/docs/librariesprovider2/ukraine/ukraine-factsheet-dietary-habits-of-adults-aged-18-69-years-highlights-from-steps-ukr.pdf?sfvrsn=23409983_7&amp;download=true
71. Serdyuk AM, Gulich MP, Petrenko OD, Lyubars­kaya LS, Koblyanskaya AV. The awareness and con­sciousness of young students about the threat of risk factors of development of non-infectious diseases – modern status of the problem. Medicni perspektivi [Internet]. 2019 Apr 2 [cited 2023 Jun28];24(1):4-14. doi: https://doi.org/10.26641/2307-0404.2019.1.162168
72. Gulich MP, Petrenko OD, Liubarska LS. Compe­tences acquired at school age and their role in formation of food behavior in young people. Environment & Health [Internet]. 2021Jun [cited 2023 Jun 28];99(2):22-7. doi: https://doi.org/10.32402/dovkil2021.02.022
73. [Monitoring the implementation of obligations to combat non-communicable diseases in Europe as of 2021]. [Internet]. Kopenhahen: Evropeiskoe rehyonalnoe biuro VOZ; 2021 [cited 2023Jun 28]. 64 p. Available from: https://apps.who.int/iris/bitstream/handle/10665/350461/WHO-EURO-2021-4479-44242-62495-rus.pdf?sequence=1&amp;isAllowed=y
74. Branca F, Lartey A, Oenema S, Aguayo V, Stordalen GA, Richardson R, et al. Transforming the food   system to fight non-communicable diseases. BMJ   [Internet]. 2019Jan 28 [cited 2023 Jun 28]:l296. doi: https://doi.org/10.1136/bmj.l296
75. Bongaarts J. FAO, IFAD, UNICEF, WFP and WHOThe State of Food Security and Nutrition in the World 2020. Transforming food systems for affordable healthy dietsFAO, 2020, 320 p. Population and Deve­lopment Review [Internet]. 2021Jun [cited 2023 Jul 15];47(2):558. doi: https://doi.org/10.1111/padr.12418
76. Baker P, Machado P, Santos T, Sievert K, Backholer K, Hadjikakou M, et Ultra‐processed foods and the nutrition transition: Global, regional and  national trends, food systems transforma­tions   and  political economy drivers. Obesity Re­views [Internet]. 2020 Aug 6 [cited 2023 Jul 15];21(12). doi: https://doi.org/10.1111/obr.13126
77. Yu E, Malik VS, Hu FB. Cardiovascular Disease Prevention by Diet Modification. Journal of the American College of Cardiology [Internet]. 2018 Aug [cited 2023Jul 15];72(8):914-26. doi: https://doi.org/10.1016/j.jacc.2018.02.085
78. UN-Nutrition Strategy 2022–2030. One UN for nutrition [Internet]. Rome, Italy: UN-Nutrition; 2022 [cited 2023 Jul 15]. 22 p. Available from: https://www.unnutrition.org/sites/default/files/2023-03/UN-Nutrition-Strategy-2022-2030_WEB_28Oct2022_EN.pdf

Look through:

Gulich M.P. SI “O.M. Marzіeiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine, е-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-1708-3012

Petrenko O.D. SI “O.M. Marzіeiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
https://orcid.org/0000-0001-5819-1901

Gulich M.P., Petrenko O.D. Healthy nutrition as a disease prevention factor: WHO Policy and National Experience (to mark the 75th anniversary of WHO in Ukraine). Medicni perspektivi. 2023;28(3):152-162. DOI: https://doi.org/10.26641/2307-0404.2023.3.289218 

Healthy nutrition as a disease prevention factor: WHO Policy and National Experience (to mark the 75th anniversary of WHO in Ukraine)

Today, chlorine dioxide has begun to be more widely implemented in water treatment technologies on river running water systems of Ukraine. Chlorine dioxide is used in traditional water treatment technology for both primary and secondary water treatment on the Dnipro running water system in Kyiv. Objective – to analyze the results of the content of dangerous chlorites in tap drinking water of certain districts of the city of Kyiv, and calculate and assess non-carcinogenic risk of this drinking water for human health. It was shown that in the drinking water from the running water networks of Svyatoshynskyi, Shevchenkivskyi, Obolonskyi and Podilskyi districts of the city, into which it enters after treatment with chlorine dioxide from the Dnipro running water system, the levels of chlorites were the lowest in winter and spring. In summer, the concentrations of chlorites in the water from the studied networks were the highest and averaged from 0.32 to 0.45 mg/dm³. In autumn, chlorites in the water from these systems were at the level of 0.22-0.28 mg/dm³. In spring (May) and especially in summer, the levels of chlorites in drinking water, according to average data, exceeded the national hygienic standard (0.2 mg/dm³) by 1.5-2 times, but they were never higher than the chlorite standard (0.7 mg/dm³) recommended by WHO. Our analysis of sanitary-chemical and microbiological indicators in drinking water showed that the water is characterized by high quality and safety during the entire period of observation. The risk assessment of the development of non-carcinogenic effects for the oral route of intake of chlorites with drinking water from the specified water networks based on average annual data showed the value of the danger coefficient (HQ) at the level of 0.24-0.38, that is, it was lower than 1.0. The danger coefficient for chlorite content in drinking water was also determined at the level of 0.2 mg/dm³ and 0.7 mg/dm³. According to this indicator, the lifetime use of drinking water with a chlorite content of 0.2 mg/dm³ and even 0.7 mg/dm³ does not pose a threat to human health, since the danger coefficient is within 1.0, which is a permissible (acceptable) risk by degree of danger. Thus, the use of chlorine dioxide in traditional water treatment technology ensures high quality and safety of drinking water in terms of microbiological and sanitary-chemical indicators. There is a periodic (mainly in summer) excess of chlorite content in drinking water in relation to the national standard (0.2 mg/dm³), but its level was never higher than the standard recommended by WHO (0.7 mg/dm³). It has been shown that the existing levels of chlorites in drinking water and its use with such a toxic load do not pose a threat to human health.

Key words: drinking water, chlorine dioxide, chlorites, drinking water quality, non-carcinogenic risk

1. Directive (EU) 2020/2184 of the European Par­liament and of the Council of 16 December 2020 on the quality of water intended for human consumption (recast) [Internet]. [cited 2023 Apr 02]. Available from: http://data.europa.eu/eli/dir/2020/2184/oj
2. [On the approval of the State sanitary norms and rules "Safety indicators and separate indicators of the quality of drinking water in conditions of martial law and emergency situations of a different nature». Order of the Ministry of Health of Ukraine dated 2022 Apr 22 No. 683] [Internet]. [cited 2023 Apr 02]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0564-22#Text
3. Prokopov VO, Lypovetska OB, Kulish TV, et al. [The use of chlorine dioxide in the drinking water pre­paration technology at the Dnipro water supply in Kyiv]. Dovkillia ta zdorovia. 2018;4(89):15-9. Ukrainian. doi: https://doi.org/10.32402/dovkil2018.04.015
4. Human Health Risk Assessment [Internet]. [cited 2023 Apr 02]. Available from: https://www.epa.gov/risk/human-health-risk-assessment
5. Toxicological review of chlorine dioxide and chlorite. In Support of summary information on the integrated risk information system. EPA; 2000. 49 p. Available from: https://iris.epa.gov/static/pdfs/0496tr.pdf
6. [On the approval of methodological instructions "Assessment of the carcinogenic risk to the health of the population from the consumption of chlorinated drinking water." Order of the Ministry of Health of Ukraine dated 2005 Oct 21 No. 545] [Internet]. [cited 2023 Apr 02]. Ukrainian. Available from: https://mozdocs.kiev.ua/view.php?id=4448 
7. Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. 2-e izd. Kyiv; 2018. 579 p. Russian.
8. SrivastavA, Patel N, Chaudhary Disinfection by-products in drinking water: occurrence, toxicity and abatement. Environmental Pollution. 2020;267:115474. doi: https://doi.org/10.1016/j.envpol.2020.115474
9. GanW, Huang S, Ge Y, et al. Chlorite formation during ClO 2 oxidation of model compounds having various functional groups and humic substances. Water Research. 2019;159:348-57. doi: https://doi.org/10.1016/j.watres.2019.05.020
10. Prokopov VO. [Drinking water of Ukraine: medical-ecological and sanitary-hygienic aspects]. Kyiv: Medytsyna; 2016. 400 р. Ukrainian.
11. PadhiRK, Subramanian S, Satpathy Forma­tion, distribution, and speciation of DBPs (THMs, HAAs, ClO2-,and ClO3-) during treatment of different source water with chlorine and chlorine dioxide. Chemosphere. 2019;218:540-50. doi: https://doi.org/10.1016/j.chemosphere.2018.11.100
12. Özdemir K. Chlorine and chlorine dioxide oxi­dation of natural organic matter in water treatment plants. Environment Protection Engineering. 2020;46(4):87-97. doi: https://doi.org/10.37190/epe200407
13. Feretti D, Acito M, Dettori M, et al.  Genotoxicity of source, treated and distributed water from four drinking water treatment plants supplied by surface water in Sardinia, Italy. Environmental Research. 2020;185:109385. doi: https://doi.org/10.1016/j.envres.2020.109385

Look through:

Prokopov V.О. SI “O.M. Marzieiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-1611-8930

Lypovetska О.B. SI “O.M. Marzieiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
https://orcid.org/0000-0001-7096-1243

Kulish T.V. SI “O.M. Marzieiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
https://orcid.org/0009-0009-9658-2570

Prokopov V.О., Lypovetska О.B., Kulish T.V. Hygienic assessment of dangerous chlorites in drinking water treated with chlorine dioxide and the risk of its consumption to the health of the population. Medicni perspektivi. 2023;28(3):162-169. DOI: https://doi.org/10.26641/2307-0404.2023.3.289220 

Hygienic assessment of dangerous chlorites in drinking water treated with chlorine dioxide and the risk of its consumption to the health of the population

Atmospheric air can be polluted as a result of the ingress of various chemicals into it, which have a harmful effect on human health, causing an exacerbation of cardiovascular, airborne diseases, diseases of the gastrointestinal tract and the endocrine system, and exceeding the norms of dust content in the air leads to an increase in incidence of allergies and bronchial asthma. The relevance of the subject under study lies in the investigation of the sources of air pollution, as they lead to an increase in the degree of morbidity and mortality among the population. This, in turn, requires a radical change in the way people live, as well as the adoption of specific measures to ensure the reduction of air pollution. In this regard, the objective of this study was to perform a comprehensive analysis of the ecological and hygienic conditions of atmospheric air and evaluate its impact on human health due to pollution. The study incorporated empirical research methods such as empirical description and comparison to analyze emissions of pollutants, assess population morbidity rates, and conduct correlation and regression analyses. Official data from the State Committee of Uzbekistan on Statistics and scientific papers were utilized, alongside statistical analysis techniques and logical reasoning to investigate atmospheric air pollution and its impact on public health. The study analysed the indicators of emissions of pollutants into the atmosphere in the Republic of Uzbekistan as a whole and by regions. Furthermore, the paper provides a detailed analysis of the general morbidity of the population of the Republic of Uzbekistan and indicators of the incidence of cardiovascular diseases, based on which a correlation and regression analysis was performed. In addition, the morbidity rates of the population with diseases of the respiratory system and eye diseases throughout the Sirdaryo Region were analysed.  The study revealed that Uzbekistan experiences high levels of environmental pollution, with a direct correlation found between atmospheric pollutants and the incidence of cardiovascular diseases, respiratory organ issues, and eye conditions. To protect the atmosphere, reducing pollutant emissions and implementing sustainable development principles, such as industrial modernization and the use of alternative energy sources, are necessary. The results highlight the importance of identifying pollutant types, their properties, and release conditions for effective pollution assessment. The practical significance of this study is to optimize the data of environmental monitoring of urban air pollution in the Republic of Uzbekistan, where in general there is a high level of pollutants in the atmosphere, which affects the health of the population.

Key words: urbanization, pathological condition, atmosphere, total mortality, industry

1. Liu H, Huang B, Zhan Q, Gao S, Li R, Fan Z. The influence of urban form on surface urban heat island  and its planning implications: Evidence from 1288 urban clusters in China. Sustain Cities Soc. 2021;71:102987. doi: https://doi.org/10.1016/j.scs.2021.102987
2. Roxon J, Ulm FJ, Pellenq RM. Urban heat island impact on state residential energy cost and CO2 emissions in the United States. Urban Climate. 2020;31:100546. doi: https://doi.org/10.1016/j.uclim.2019.100546
3. Li X, Stringer LC, Dallimer M. The spatial and temporal characteristics of urban heat island intensity: Im­plications for East Africa’s urban development. Cli­mate. 2021;9(4):51. doi: https://doi.org/10.3390/cli9040051
4. Barwise Y, Kumar P. Designing vegetation bar­riers for urban air pollution abatement: A practical review for appropriate plant species selection. NPJ Clim Atmos Sci. 2020;3:12. doi: https://doi.org/10.1038/s41612-020-0115-3
5. Yakhshieva ZZ, Ahmadjonova YT, Ahmadjo­no­va UT. Impact of vehicle emissions on the environment and human health. Science and Education Scientific Journal. 2021;2(6):119-23.
6. Adam MG, Tran PT, Balasubramanian R. Air qua­zlity changes in cities during the COVID-19 lockdown: A critical review. Atmos Res. 2021;264:105823. doi: https://doi.org/10.1016/j.atmosres.2021.105823
7. Iravani H, Rao V. The effects of new urbanism on public health. J Urban Des. 2020;25(2):218-35. doi: https://doi.org/10.1080/13574809.2018.1554997
8. Degirmenci K, Desouza KC, Fieuw W, Wat­son RT, Yigitcanlar T. Understanding policy and techno­logy res­ponses in mitigating urban heat islands: A literature review and directions for future research. Sustain Cities Soc. 2021;70:102873. doi: https://doi.org/10.1016/j.scs.2021.102873
9. Jacobs L, Emmerechts J, Hoylaerts MF, Mat­hieu C, Hoet PH, Nemery B, et al. Traffic air pollution and oxidized LDL. PLoS One. 2011;6(1):e16200. doi: https://doi.org/10.1371/journal.pone.0016200
10. Brook RD, Bard RL, Burnett RT, Shin HH, Vet­te A, Croghan C, et al. Differences in blood pressure and vascular responses associated with ambient fine particulate matter exposures measured at the personal versus com­munity level. Occup Environ Med. 2011;68(3):224-30. doi: https://doi.org/10.1136/oem.2009.053991
11. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Jerrett M, et al. Long-term exposure to air pol­lution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med. 2011;184(7):828-35. doi: https://doi.org/10.1164/rccm.201012-2082OC
12. Zhang P, Dong G, Sun B, Zhang L, Chen X, Ma NY, et al. Long-term exposure to ambient air pollution and mortality due to cardiorespiratory disease and cerebrovascular disease in Shenyang, China. PLoS One. 2011;6(6):e20827. doi: https://doi.org/10.1371/journal.pone.0020827
13. De Paula Santos U, Braga ALF, Giorgi DMA, Pe­reira LAA, Grupi CJ, Lin CA, et al. Effects of air pollution on blood pressure and heart rate variability: A panel study of 78 vehicular traffic controllers in the city of Sao Paulo, Brazil. EurHeart  2005;26(2):193-200. doi: https://doi.org/10.1093/eurheartj/ehi035
14. World Health Organization. 2021 [Internet]. [cited 2023 Apr 20]. Available from: https://www.who.int/
15. United Nations Environment Programme [Inter­net]. 2022 [cited 2023 Apr 20]. Available from: https://www.unep.org/interactive/air-pollutionnote/?gclid=CjwKCAiAheacBhB8EiwAItVO28FdQ8FyDFWCxALLulpPB6gu9M2F8y2qqqi7vqeiNPRTTAmcml4UqhoCWpEQAvD_BwE
16. State Committee of the Republic of Uzbekistan on Statistics [Internet]. 2021 [cited 2023 Apr 20]. Available from: https://ru.knoema.com/atlas/sources/STAT-UZThe
17. Dong R, Li S, Zhang Y, Tan X, Fu X. Analysis of urban environmental problems based on big data from the urban municipal supervision and management information system. Ecol 2018;94:52-69. doi: https://doi.org/10.1016/j.ecolind.2016.09.020
18. Ulpiani G. On the linkage between urban heat island and urban pollution island: Three-decade literature review towards a conceptual framework. Sci Total Environ.2021;751:141727. doi: https://doi.org/10.1016/j.scitotenv.2020.141727
19. Czernych R, Badyda AJ, Kozera G, Zagożdżon P. Assessment of Low-Level Air Pollution and Cardio­vascular Incidence in Gdansk, Poland: Time-Series Cross-Sectional Analysis. J Clin Med. 2023;12(6):2206. doi: https://doi.org/10.3390/jcm12062206
20. Wang F, Chen T, Chang Q, Kao YW, Li J, Chen M, et al. Respiratory diseases are positively asso­ciated with PM2.5 concentrations in different areas of Taiwan. PloS 2021;16(4):e0249694. doi: https://doi.org/10.1371/journal.pone.0249694
21. Yujing G, Qian Z, Kin L, Yingqin Z, Shubin W, Zhang W. The impact of urban transportation infra­structure on air quality. Sustainability. 2020;12:5626. doi: https://doi.org/10.3390/su12145626
22. Rapa M, Gobbi L, Ruggieri R. Environmental and economic sustainability of electric vehicles: Life cycle assessment and life cycle costing evaluation of electricity sources. Energies.2020;13:6292. doi: https://doi.org/10.3390/en13236292
23. Gehring U, Wijga AH, Koppelman GH, Vonk JM, Smit HA, Brunekreef B. Air pollution and the develop­ment of asthma from birth until young adulthood. Eur Respir 2020;56(1):2000147. doi: https://doi.org/10.1183/13993003.00147-2020
24. Holst GJ, Pedersen CB, Thygesen M, Brandt J, Geels C, Bonlokke JH, et al. Air pollution and family related determinants of asthma onset and persistent whee­zing in children: Nationwide case-control study. BMJ. 2020;370:m2791. doi: https://doi.org/10.1136/bmj.m2791
25. Lizogub VG, Kramarova VN, Polonska LN, Ka­minska TM, Melnychuk IO, Tyrayska YV. Dietary correction of hyperinsulinemia and hemostasis parameters in overweight arterial hypertension patients. World of Medicine and Biology. 2020;73(3):65-69. doi: https://doi.org/10.26724/2079-8334-2020-3-73-65-69
26. Wrobel A, Zapala L, Kluz T, Rogowski A, Mi­siek M, Juszczak K, et al. The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats. International Journal of Molecular Sciences. 2021;22(11):5853. doi: https://doi.org/10.3390/ijms22115853
27. Tyravska Y, Savchenko O, Lizogub V, Raksha N, Savchuk O. Blood Plasma Serotonin and von Willebrand Fac­tor as Biomarkers of Unstable Angina Progression Toward Myocardial Infarction. Galician Medical Journal. 2021;28(1):202112. doi: https://doi.org/10.21802/gmj.2021.1.2

Look through:

Komilova N. National University of Uzbekistan named after Mirzo Ulugbek, Tashkent, Republic of Uzbekistan, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0003-2618-6010 

Egamkulov Kh. Gulistan State University, Gulistan, Republic of Uzbekistan,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0004-7030-0233

Hamroyev M. Urgench State University, Urgench, Republic of Uzbekistan,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0005-8044-4334

Khalilova Kh. Regional Center for Retraining and Advanced Training of Public Education Workers of the Tashkent Region, Nurafshon, Republic of Uzbekistan,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0006-7639-5426

Zaynutdinova D. Samarkand State University, Samarkand, Republic of Uzbekistan,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0009-0002-8987-1947

Komilova N., Egamkulov Kh., Hamroyev M., Khalilova Kh., Zaynutdinova D. The impact of urban air pollution on human health. Medicni perspektivi. 2023;28(3):170-179. DOI: https://doi.org/10.26641/2307-0404.2023.3.289221 

The impact of urban air pollution on human health

The article discusses the issue of extending the legal protection of intellectual property rights for medicines. The research aims to provide a comprehensive overview of the problems related to the implementation of Supplementary Protection Certificates (SPCs) in national legislation and possible solutions. The study also seeks to draw conclusions and make proposals for improving the regulatory framework for the SPCs of medicines. The work utilizes general scientific and specialized methods of scientific cognition, including dialectical, formal-logical, systemic-structural, comparative legal, as well as modeling, analysis, and synthesis methods, which collectively contributed to the organization, planning, and conduct of the research. The study is based on scientific publications from databases and search systems (PubMed, JAMA, Scopus, Springer, BMC, Oxford Academic), international and national regulatory acts, statistical studies by international organizations (Precedence Research), patents for inventions related to medicines, recommendations by national government bodies, as well as prescriptions and guidelines from international and national experts. Considering the analysis of statistical data on the development and implementation of medicines, it has been determined that original biological medicines are a major factor in the rising prices of treating conditions such as diabetes, oncological diseases, and others. Examples of patents for medicines owned by global pharmaceutical companies (Gilead, Bayer Intellectual Property Gmbh, etc.) that have ensured their commercial success and competitive advantages are examined. It has been established that patent protection provides the right holder with the opportunity to maintain a monopoly in the market, thereby compensating for the time spent on the development and research of original medicinal products. Legislative approaches to regulating relationships concerning the supplementary protection of inventions related to medicines in the form of SPCs in Ukraine and the EU are identified. The exclusivity periods for regulatory data protection for medicines in the EU are outlined. Based on the conducted research, it is concluded that the application of the SPC mechanism is a tool to achieve a balance between the protection of intellectual property rights and access to original medicines. Timely entry of generics and biosimilars to the market contributes to reducing market prices but negatively impacts the profitability of manufacturers of original medicines. Attention is drawn to problematic aspects of the legislative implementation of the SPC mechanism in Ukraine, which leads to incorrect interpretation and implementation of relevant provisions and necessitates updating. In light of the aforementioned, there is an urgent need in Ukraine to implement, update, and improve the legislative mechanism for regulating SPCs.

Key words: medicines, intellectual property, supplementary protection certificate, legal protection, patent

1. Wouters OJ, McKee M, Luyten J. Estimated Re­search and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 2020 Mar 3;323(9):844-53. doi: https://doi.org/10.1001/jama.2020.1166
2. [On protection of rights to inventions and utility models. Law of Ukraine dated 1993 Dec 15, No. 3687-XII: as of 2023 Apr 15]. [Internet]. 2023 [cited 2023 May 14]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/3687-12#Text
3. Androshchuk H. [New opportunities for European generic companies]. [Internet]. Yurydychna Hazeta online. 2019;27(681) [cited 2023 May 14]. Ukrainian. Available from: https://yur-gazeta.com/publications/practice/zahist-intelektualnoyi-vlasnosti-avtorske-pravo/novi-mozhlivosti-evropeyskih-generichnih-kompaniy.html
4. Rabotiahova LI, Androshchuk HO. [Extending the term of validity of a patent for an invention: the inter­national legal aspect of regulation]. Pytannia intelektualnoi vlasnosti: zbirnyk naukovykh prats. 2018;15:89-108. Ukrainian.
5. Kodynets A, Doroshenko O, Volynets I, Do­rozh­ko G, Petrenko V, Belitsky V. [Protection from unfair competition on the pharmaceutical market in the conditions of the COVID-19 pandemic]. Medicni Perspektivi. 2022;27(4):231-8. doi: https://doi.org/10.26641/2307-0404.2022.4.271235
6. Hu Y, Eynikel D, Boulet P, Krikorian G. Supple­mentary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib. Journal of pharmaceutical policy and practice. 2020;13:1. doi: https://doi.org/10.1186/s40545-019-0198-6
7. Vidal-Quadras M. Analysis of EU Regulation 2019/933 on the SPC Manufacturing Waiver Excep­tion. IIC - International Review of Intellectual Property and Competition Law. 2019;50(8):971-1005. doi: https://doi.org/10.1007/s40319-019-00860-7
8. Seuba X. The export and stockpiling waivers: new exceptions for supplementary protection certifi­cates. Journal of Intellectual Property Law & Practice. 2019;14(11):876-86. doi: https://doi.org/10.1093/jiplp/jpz108
9. Lamping M, Henrique D, Batista P, Correa JI, Hilty RM, Kim D, et al. Revisiting the Framework for Compulsory Licensing of Patents in the European Union – Reflections on the European Commission’s Initiative. GRUR 2023;72(5):471-82. doi: https://doi.org/10.1093/grurint/ikad029
10. Kunst M, Kaufmann U. Authorized Generics and Biosimilars as Part of Drug Life Cycle Management. GRUR 2020;69(11):1105-12. doi: https://doi.org/10.1093/grurint/ikaa116
11. Whitehead B, Jackson S, Kempner R. Managing generic competition and patent strategies in the pharma­ceutical industry. Journal of Intellectual Property Law & Practice. 2008;3(4):226-35. doi: https://doi.org/10.1093/jiplp/jpn013
12. Biologics Market Size to Worth Around US$ 719.84 Bn by 2030.  GlobeNewswire News Room [In­ternet]. 2022 Apr 20 [cited 2023 May 14]. Available from: https://www.globenewswire.com/en/news-release/2022/04/20/2425668/0/en/Biologics-Market-Size-to-Worth-Around-US-719-84-Bn-by-2030.html
13. Sciberras J, Zammit R, Bonanno PV. The Euro­pean framework for intellectual property rights for biological medicines. Generics and Biosimilars Initiative Journal. 2021;10(4):172-83. doi: https://doi.org/10.5639/gabij.2021.1004.022
14. Niggins-Dunn N. The top 15 blockbuster patent expirations coming this decade. Fierce Pharma [Internet]. 2021 Jul 12 [cited 2023 May 14]. Available from: https://www.fiercepharma.com/special-report/top-15-blockbuster-patent-expirations-coming-decade
15. Several blockbuster patents to expire in 2023. BioStock [Internet]. 2022 Dec 16 [cited 2023 May 14]. Available from: https://www.biostock.se/en/2022/12/several-blockbuster-patents-to-expire-in-2023/
16. Pope C. What is the cost of Sovaldi? Why is it so expensive? [Internet]. 2023 Apr 13 [cited 2023 May 14]. Available from: https://www.drugs.com/medical-answers/cost-sovaldi-expensive-3538358/#:~:text=Sovaldi%20is%20expensive.&amp;text=This%20means%20a%2012-week,with%20other%20treatments,%20never%20alone
17. First-Ever US. Patent Challenges Dispute Gi­lead’s Monopoly on Hepatitis C Drugs that Blocks Mil­lions from Treatment. I-MAK [Internet]. 2017 Oct 25 [cited 2023 May 14]. Available from:https://www.i-mak.org/2017/10/25/first-ever-us-patent-challenges-gilead-hepatitis-c/
18. [Composition (options) and method (options) of treatment of viral hepatitis C. Рat. Ukraine No. a201405757. 2017 Apr 25]; 2017. Ukrainian.
19. Benke K, inventor; Bayer Intellectual Property GmbH, assignee. B Solid, orally administrable pharma­ceutical composition. Рatent US No. 9.415,053 B2. 2016 Aug 16. [Internet]. [cited 2023 May 14]. Available from: https://patentimages.storage.googleapis.com/84/62/13/63f0bf483d00bb/US9415053.pdf 
20. Misselwitz F, Kubitza D, Son-Mi Park, Weh­ling K, inventors; Bayer Intellectual Property GmbH, assignee. Prevention and treatment of thromboembolic disorders. Рatent  US No. 9,539,218 B2. 2017 Jan 10. [Internet]. [cited 2023 May 14]. Available from: URL: https://patentimages.storage.googleapis.com/d8/a7/13/45e4c6d6fffa52/US9539218.pdf
21. [Substituted oxazolidinones and their use to prevent blood coagulation. Pat. Ukraine No. 2002076161. 2005 Jul 15]. Ukrainian.
22. Alkousaa R, Macfie N. Bayer wins EU patent extension for best-selling Xarelto drug. Reuters [Internet]. 2021 Oct 29 [cited 2023 May 14]. Available from: https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-wins-eu-patent-extension-best-selling-xarelto-drug-2021-10-29/
23. Thompson MJ, Bader MA, Gassmann O. Patent Management: Protecting Intellectual Property and Innovation. Springer International Publishing 1. Auflage. Cham: Springer; 2021. 264 р.
24. Generic Drugs Market Size, Trends, Growth, Report 2022 to 2030. Precedence Research - Market Research Reports & Consulting Firm [Internet]. [cited 2023 May 14]. Availablefrom:https://www.precedenceresearch.com/generic-drugs-market 
25. Kapitsa Yu. [Certificate of additional protection of EU medicinal products and extension of the validity period of the patent for an invention in Ukraine]. Theory and practice of intellectual property. 2016;5:69-57. Ukrainian.
26. Regulation (EC) No. 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version). EUR-Lex [Internet]. [ci­ted 2023 May 14]. Available from: https://eur-lex.eu­ropa.eu/legal-content/EN/TXT/?uri=­CELEX%3A32009R0469
27. Regulation (EU) 2019/933 of the European Parliament and of the Council of 20 May 2019 amending Regulation (EC) No. 469/2009 concerning the supple­mentary protection certificate for medicinal products. EUR-Lex [Internet]. [cited 2023 May 14]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32019R0933
28. Whittaker S, Johnson R, Walker A. Pharma­ceutical Patent Term Extension: An Overview. Pharma & Biotech Consulting | R&D & Business Support [Internet]. [cited 2023 May 14]. Available from: https://www.alacrita.com/whitepapers/pharmaceutical-patent-term-extension-an-overview#:~:text=The%20maximum%20term%20extension%20is,expiration%20(with%20term%20extension
29. Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No. 726/2004. EUR-Lex [Internet]. [cited 2023 May 14]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32006R1901
30. Frequently Asked Questions: Patents. WIPO - World Intellectual Property Organization [Internet]. [cited 2023 May 14]. Available from: https://www.wipo.int/patents/en/faq_patents.html
31. Regulation (EC) 726/2004 of the European Par­liament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and ve­terinary use and establishing a European Medicines Agency. EUR-Lex [Internet]. [cited 2023 May 14]. Available from: https://eur-lex.europa.eu/legal-content/­EN/TXT/?uri=CELEX%3A32004R0726
32. Regulation (EU) 2019/5 of the European Par­liament and of the Council of 11 December 2018 amending Regulation (EC) No. 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No. 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use. EUR-Lex [Internet]. [cited 2023 May 14]. Available from: https://eur-lex.europa.eu/eli/reg/2019/5/oj
33. Doyle-Rossi M, Dirkzwager R, Beley L. EU Phar­ma Legislation Review Series: Unitary Supplementary Protection Certificates and Recast. Inside EU Life Sciences [Internet]. 2023 May 05 [cited 2023 May 14]. Available from: https://www.insideeulifesciences.com/2023/05/05/eu-pharma-legislation-review-series-unitary-supplementary-protection-certificates-and-recast/
34. Unitary Patent to Enter Into Operation on 1 June 2023: Successful Completion of the Necessary Ratification Procedures. IP Helpdesk [Internet]. 2023 Feb 20 [cited 2023 May 14]. Available from: https://intellectual-pro­perty-helpdesk.ec.europa.eu/news-events/news/unitary-patent-enter-operation-1-june-2023-successful-completion-necessary-ratification-procedures-2023-02-20_en
35. [Association Agreement between Ukraine, on the one hand, and the European Union, the European Atomic Energy Community and their member states, on the other hand. Agreement Ukraine dated 2014 Jun 27: as of 2022 Oct 25. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/984_011#Text
36. Kashyntseva O. [Search for a legal compromise in the implementation of certificates of additional protection of inventions]. Theory and practice of intellectual property. 2019;3:28-31. Ukrainian.
37. Supplementary protection of inventions for the object of medicinal product. UNBA [Internet]. 2023 [cited 2023 May 14]. Available from: https://drive.google.com/file/d/16aIlMxcRm7LdAQAAJRcLGm5GiPTv90-C/view?fbclid=IwAR1E4dSyKs9xMshyzhWhV8y_hmMJs6hHYF1YuRgjRFObFY3_0ZiAznXjesI
38. Prokhoda Yu. [Problems of SPC. Supplementary protection of inventions for the object of medicinal product. Round Table]. Kyiv; 2023. 12 p. Ukrainian. Available from: https://drive.google.com/drive/folders/1DVux7EoLNhK-mEnVF4H4-2EbVI-PJOhl?fbclid=IwAR2zh7iUBhICA9s_PsEjil-ATR2u-a4_RjAu_99Zywt74Atqiwp3e9UT_Qw
39. Kislyi T. [The beginning of the application of the SPC regime: controversial issues. Supplementary protection of inventions for the object of medicinal product. Round Table]. Kyiv; 2023. 12 p. Ukrainian. Available from: https://drive.google.com/drive/folders/1DVux7EoLNhK-mEnVF4H4-2EbVI-PJOhl?fbclid=IwAR2zh7iUBhICA9s_PsEjil-ATR2u-a4_RjAu_99Zywt74Atqiwp3e9UT_Qw
40. [On approval of the Rules for drawing up, submitting and conducting examination of an application for an invention and an application for a utility model. Notice of publication of the draft order of the Ministry of Economy of Ukraine. Ministry of Economy of Ukraine]. [Internet]. 2022 Feb 18 [cited 2023 May 14]. Available from: https://me.gov.ua/Do­cuments/Detail?lang=uk-UA&isSpecial=True&id=­11b0bc41-5349-49a6-8453-9eb51d594ca2&title=Povi­domlenniaProOpriliudnenniaProktuNakazuMinisterstvaEkonomikiUkrainiproZatverdzhenniaPravilSkladannia-PodanniaTaProvedenniaEkspertiziZaiavkiNaVinakhidIZaiavkiNaKorisnuModel

Look through:

Kodynets A.O. Taras Shevchenko National University of Kyiv, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-0954-1474 

Doroshenko O.F. Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, Kyiv, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0002-2542-2328 

Volynets I.P. Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0000-0002-2029-2165 

Dorozhko G.K. Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0000-0001-6506-3203

Petrenko V.O. Ukrainian State University of Science and Technologies, Institute of Industrial and Business Technologies, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0001-5017-1674 

Belitsky V.V. Dnipro State Medical University, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-2841-7372

Kodynets A.O., Doroshenko O.F., Volynets I.P., Dorozhko G.K., Petrenko V.O., Belitsky V.V.  Supplementary protection of intellectual property rights for medicines. Medicni perspektivi. 2023;28(3):180-189. DOI: https://doi.org/10.26641/2307-0404.2023.3.289223 

Supplementary protection of intellectual property rights for medicines

The orientation of the world medical community, and Ukraine in particular, towards the improvement of the quality of medical services includes the introduction of modern tools and methods for quality regulation in the healthcare system. The focus of research on the modernization of medical services, methods and forms of treatment and diagnosis, as well as focus on global experience in regulating the quality of services provided by relevant institutions, undoubtedly contributes to the transition of the Ukrainian healthcare system to a new level. One of the most powerful and modern ways to improve the medical health care system is to introduce the standardization of the format and content of medical data. Quality implementation of the standardization program is a leading factor in the improvement of the quality of medical services, such as: early detection of diseases and emergencies, setting new therapeutic goals, improving the quality of clinical trials, improving of assessment of the quality of medical services and work of the doctors and nursing staff, improving the efficiency of health care programs, improving the safety of use of medical devices, forecasting medical consequences, reducing administrative costs, integrating artificial intelligence into the healthcare system, etc.

Key words: data standardization, common data model (CDM), eHealth, Observational Medical Outcomes Partnership Common Data Model (OMOP CDM)

1. Informatics The Book of OHDSI [Internet]. Ohdsi.github.io. 2022 [cited 2022 Apr 14]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/
2. SchneiderF, Maurer C, Friedberg  Interna­tional Organization for Standardization (ISO) 15189. Ann Lab Med. 2017 Sep;37(5):365-70. doi: https://doi.org/10.3343/alm.2017.37.5.365
3. RodriguesJM, Kumar A, Bousquet C, Trom­bert  Standards and biomedical terminologies: the CEN TC 251 and ISO TC 215 categorial structures. A step towards increased interoperability. Stud Health Technol Inform. 2008;136:857-62. PMID: 18487839.
4. Caring about health and safety [Internet]. ISO. 2022 [cited 2022Apr 14]. Available from: https://www.iso.org/caring-about-health-and-safety.html
5. Home [Internet]. Who.int. 2022 [cited2022 Apr 14]. Available from: https://www.who.int/
6. International Classification of Diseases (ICD) [Internet]. Who.int. 2022 [cited cited 2022Apr 14]. Available from: https://www.who.int/standards/classifications/classification-of-diseases
7. SNOMED Home page [Internet]. SNOMED. 2022 [cited 2022Apr 14]. Available from:https://www.snomed.org/
8. LOINC version 2.72 is now available – LOINC % [Internet]. LOINC. 2022 [cited 2022Apr 14]. Available from: https://loinc.org/news/loinc-version-2-72-is-now-available/
9. International Introduction to HL7 Standards | HL7 International [Internet]. Hl7.org. 2022 [cited 2022 Apr 14]. Available from:https://www.hl7.org/implement/standards/
10. RxNorm [Internet]. Nlm.nih.gov. 2022 [cited 2022Apr 14]. Available from: https://www.nlm.nih.gov/research/umls/rxnorm/index.html
11. DICOM [Internet]. DICOM. 2022 [cited 2022Apr 14]. Available from: https://www.dicomstandard.org/
12. ISCO – International Standard Classification of Occupations [Internet]. Ilo.org. 2022 [cited 2022Apr 14]. Available from: https://www.ilo.org/public/english/bureau/stat/isco/isco08
13. What is Clinical Document Architecture (CDA)? – Definition from WhatIs.com [Internet]. SearchHealthIT. 2022 [cited 2022Apr 14]. Available from: https://searchhealthit.techtarget.com/definition/Clinical-Document-Architecture-CDA
14. Evans Electronic Health Records: Then, Now, and in the Future. Yearb Med Inform. 2016 May 20;(Suppl 1):S48-61. doi: https://doi.org/10.15265/IYS-2016-s006
15. Caring about health and safety [Internet]. ISO. 2022 [cited 2022Apr 13]. Available from: https://www.iso.org/caring-about-health-and-safety.html
16. ChenL, Liu T, Zhao  Inferring anatomical the­rapeutic chemical (ATC) class of drugs using shortest path and random walk with restart algorithms. Biochim Biophys  Acta Mol Basis Dis. 2018;1864(6 Pt B):2228-40. doi: https://doi.org/10.1016/j.bbadis.2017.12.019
17. Fast Healthcare Interoperability Resources^® (FHIR^®)|eCQI Resource Center [Internet]. Ecqi.healthit.gov. 2022 [cited 2022Apr 13]. Available from: https://ecqi.healthit.gov/fhir
18. SDTM|CDISC [Internet]. Cdisc.org. 2022 [cited 2022Apr 13]. Available from: https://www.cdisc.org/standards/foundational/sdtm
19. Amatayakul American National Standards In­stitute (ANSI) Healthcare Informatics Standards Planning Panel. Subcommittee on Scope of Medical Record Standards. Stud Health Technol Inform. 1993;6:66-9. PMID: 10163825.
20. ChuteCG, Cohn SP, Campbell KE, et al. The con­tent coverage of clinical classifications. For The Com­puter-Based Patient Record Institute's Work Group on Codes & Structures. J Am Med Inform Assoc. 1996 May-Jun;3(3):224-33. doi: https://doi.org/10.1136/jamia.1996.96310636 
21. S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics. National committee on vital and health statistics report, 2003-2004. Hyattsville, MD.: U.S. Dept. of Health and Human Services; 2005.
22. Millar The Need for a Global Language – SNOMED CT Introduction. Stud Health Technol Inform. 2016;225:683-5. PMID: 27332304.
23. ChangE, Mostafa  The use of SNOMED CT, 2013-2020: a literature review. J Am Med Inform Assoc. 2021 Aug 13;28(9):2017-26. doi: https://doi.org/10.1093/jamia/ocab084 
24. DrenkhahnC, Ingenerf  The LOINC Content Mo­del and Its Limitations of Usage in the Laboratory Domain. Stud Health Technol Inform. 2020 Jun 16;270:437-42. doi: https://doi.org/10.3233/SHTI200198
25. FiebeckJ, Gietzelt M, Ballout S, et al. Imple­menting LOINC: Current Status and Ongoing Work at the Hannover Medical School. Stud Health Technol Inform. 2019;258:247-8. PMID: 
26. BhargavaA, Kim T, Quine DB, Hauser  A 20-Year Evaluation of LOINC in the United States' Largest Integrated Health System. Arch Pathol Lab Med. 2020 Apr;144(4):478-84. doi: https://doi.org/10.5858/arpa.2019-0055-OA 
27. PetersLB, Bodenreider  Approaches to Sup­porting the Analysis of Historical Medication Datasets with RxNorm. AMIA Annu Symp Proc. 2015 Nov 5;2015:1034-41. PMID: 26958241.
28. DhavleAA, Ward-Charlerie S, Rupp MT, Kil­bourne J, Amin VP, Ruiz  Evaluating the implementation of RxNorm in ambulatory electronic prescriptions. J Am Med Inform Assoc. 2016 Apr;23(e1):e99-e107. doi: https://doi.org/10.1093/jamia/ocv131 
29. The DAMA Dictionary of Data Management | Guide books [Internet]. Guide books. 2022 [cited 2022Apr 14]. doi: https://doi.org/10.5555/1796076
30. GliklichRE, Leavy MB, Dreyer  Registries for Evaluating Patient Outcomes: A User's Guide [Inter­net]. PubMed. 2022 [cited 2022 Apr 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/24945055
31. AbdelhakM, Grostick S, Hanken MA, Jacobs  Health Information: Management of a Strategic Resource [Internet]. Find-more-books. 2022 [cited 2022 Apr 15]. Available from: https://every-book.com/t/en/b/health-information-management-strategic-resource-mervat-abdelhak-rhia-fahima-sara-grostick-rhia-fahima-mary-alice-hanken-chps-rhia-ellen-jacobs--9781416030027
32. OHDSI – Observational Health Data Sciences and Informatics [Internet]. Omop.org. 2022 [cited 2022Apr 15]. Available from: http://omop.org/
33. Sentinel Initiative [Internet]. Mini-sentinel.org; 2022 [cited 2022Apr 15]. Available from: http://www.mini-sentinel.org/
34. About – The National Patient-Centered Clinical Research Network [Internet]. The National Patient-Cen­tered Clinical Research Network; 2022 [cited 2022Feb 1]. Available from: https://pcornet.org/about/
35. RossTR, Ng D, Brown JS, et al. The HMO re­search network virtual data warehouse: a public data model to support collaboration. EGEMS. 2014;2(1):1049. doi: https://doi.org/10.13063/2327-9214.1049
36. Clinical Data Interchange Standards Consortium (CDISC) Experience | PPD Inc [Internet]. PPD Inc.; 2022 [cited 2022Apr 15]. Available from: https://www.ppd.com/our-solutions/clinical/phase-ii-iv-clinical-trial-management/data-management/clinical-data-interchange-standards-consortium-cdisc-experience
37. Harmonization of Various Common Data Models and Open Standards for Evidence Generation [Internet]. ASPE. 2022 [cited 2022Apr 14]. Available from: https://aspe.hhs.gov/harmonization-various-common-data-models-open-standards-evidence-generation
38. About the Food and Drug Administration (FDA) Sentinel Initiative | Sentinel Initiative [Internet]. Senti­nelinitiative.org. 2022 [cited 2022Apr 13]. Available from: https://www.sentinelinitiative.org/about
39. TenenbaumJD, Christian V, Cornish MA, et al. The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am J Transl Res. 2012;4(3):291-301. Epub 2012 Jul  PMID: 22937207.
40. GarzaM, et al. Evaluating common data models for use with a longitudinal community registry. Journal of biomedical informatics. 2016;64:333-41. doi: https://doi.org/10.1016/j.jbi.2016.10.016
41. com. [Internet]. 2022 [cited 2022Apr 14]. Available from: http://www.rhoworld.com/wp-content/up­loads/2020/02/Data_Standards__Clinical_Data_Interchange_Standards_Consortium_CDISC.pdf
42. Park CDISC Transformer: a metadata-based trans­formation tool for clinical trial and research data into CDISC standards. KSII Transactions on Internet and Information Systems. 2011;5(10). doi: https://doi.org/10.3837/tiis.2011.10.009
43. Network – The National Patient-Centered Clinical Research Network [Internet]. The National Patient-Cen­tered Clinical Research Network. 2022 [cited 2022Apr 13]. Available from: https://pcornet.org/network/
44. ForrestCB, McTigue KM, Hernandez AF, Co­hen LW, Cruz H, Haynes K, et al. PCORnet® 2020: cur­rent state, accomplishments, and future directions. J Clin Epidemiol. 2021 Jan;129:60-7. doi: https://doi.org/10.1016/j.jclinepi.2020.09.036
45. Informatics The Common Data Model. The Book of OHDSI. Chapter 4. [Internet]. Ohdsi.github.io. 2022 [cited 2022 Apr 13]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html
46. IencaM, Vayena  On the responsible use of digital data to tackle the COVID-19 pandemic. Nat Med. 2020;26(4):463-4.
    doi: https://doi.org/10.1038/s41591-020-0832-5
47. HripcsakG, Duke JD, Shah NH, et al. Obser­vational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574-8. PMID: 
48. Society for Clinical Data Management – SCDM 2021 Annual Conference [Internet]. TSNN. 2022 [cited 2022Apr 15]. Available from: https://www.tsnn.com/events/society-clinical-data-management-scdm-2021-annual-conference
49. Athena [Internet]. Athena.ohdsi.org. 2022 [cited 2022Apr 14]. Available from: https://athena.ohdsi.org/search-terms/terms
50. ShawT, McGregor D, Brunner M, Keep M, Jans­sen A, Barnet  What is eHealth (6)? Development of a Conceptual Model for eHealth: Qualitative Study with Key Informants. J Med Internet Res. 2017 Oct 24;19(10):e324. doi: https://doi.org/10.2196/jmir.8106
51. YenPY, McAlearney AS, Sieck CJ, Hefner JL, Huerta  Health Information Technology (HIT) Adap­tation:Refocusing on the Journey to Successful HIT Im­plementation. JMIR Med Inform. 2017;5(3):e28. doi: https://doi.org/110.2196/medinform.7476
52. [On the approval of the Concept of quality management of medical care in the field of health care in Ukraine for the period up to 2010. Order Ministry of Health of Ukraine No.166 of 2008 Mar ] [Internet]. 2008 [cited 2022 Sept 14]. Ukrainian. Available from: https://zakon.rada.gov.ua/go/v0166282-08
53. [How the National Health Service of Ukraine will work] [Internet]. 2022 [cited 2022Apr 13]. Ukrainian. Available from: https://moz.gov.ua/article/news/jak-pra­cjuvatime-nacionalna-sluzhba-zdorovja-ukraini
54. [About state financial guarantees of medical care for the population. Law of Ukraine No.2168-VIII. from 2017 Oct 19] [Internet]. 2017 [cited 2022 Oct 23]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/2168-19#Text
55. [Electronic healthcare system eHealth. Autho­ri­zation portal] [Internet]. 2022 [cited 2022April15]. Ukrainian. Available from: http://nhs-auth-web.hero­kuapp.com/sign-in/
56. ua [Internet]. 2022 [cited 2022Apr 13]. Ukrainian. Available from: https://ezdorovya.ua/
57. [On the public health system No. 2573-IX of 2022 Sept 06. Law of Ukraine] [Internet]. [cited 2022 Nov 29]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/2573-20#Text

Look through:

Kaduk D.Ye. V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
https://orcid.org/0000-0003-1516-4545

Aleksandrova T.M. Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0000-0002-9279-3559

Talapova P.S. Kharkiv National Medical University, Kharkiv, Ukraine,
е-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0003-4147-1485

Agieieva I.B. IT-company SciForce, Kharkiv, Ukraine
https://orcid.org/0000-0002-8787-9569

Ved M.M. IT-company SciForce, Kharkiv, Ukraine
https://orcid.org/0000-0003-2702-6852

Trofymenko M.O. IT-company SciForce, Kharkiv, Ukraine
https://orcid.org/0000-0002-9347-5982

Kolesnyk M.R. Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0000-0002-9682-149X

Nesmiian T.S. H.S. Skovoroda Kharkiv National Pedagogical University, Kharkiv, Ukraine
https://orcid.org/0000-0001-8140-2180

Kaduk D.Ye., Aleksandrova T.M., Talapova P.S., Agieieva I.B., Ved M.M., Trofymenko M.O., Kolesnyk M.R., Nesmiian T.S. Current state and prospects of implementation of data standardization in the health care system of Ukraine (literature review). Medicni perspektivi. 2023;28(3):190-198. DOI: https://doi.org/10.26641/2307-0404.2023.3.289226 

Current state and prospects of implementation of data standardization in the health care system of Ukraine (literature review)

Acute gastrointestinal bleeding was and remains one of the severe emergency surgical diseases both in Ukraine and in other countries. The study of epidemiology, namely of the prevalence of gastrointestinal bleedings is relevant and will allow to intensify the diagnostic stage and create clearer algorithms for the treatment of this pathology. The aim of the work was to study the dynamics of emergency medical care for patients with gastrointestinal bleedings in Ukraine and the Poltava region. A statistical retrospective study of indicators of emergency medical care for patients with gastrointestinal bleedings in Ukraine and the Poltava region was conducted using data from official sources of the Center for Medical Statistics of the Ministry of Health of Ukraine. The wave-like nature of the increase in hospitalization of patients with gastrointestinal bleedings was observed in Ukraine and the Poltava region. The growth rates obtained as a result of the alignment of the dynamic series gave a clear trend towards the acceleration of the decline of this indicator: from -1.25 to -1.36 in Ukraine; and in the Poltava region before increasing the rate: from 4.85 to 3.62. During the entire studied period, the average level of hospitalization of patients with gastrointestinal bleeding after 24 hours was consistently higher in the Poltava region than in Ukraine (in Ukraine – 36.13% versus 43.16% in the Poltava region) (р<0.05). The rate of postoperative mortality in these patients in Ukraine increased (from 5.02% to 6.30%) (р<0.05)with gradual inhibition (the growth rate decreased). In the Poltava region, the level of the indicator exceeded the national level and the leveling of the dynamic series had a downward trend (from 12.4% to 10.38%) (р<0.05). Thus, the problem of gastrointestinal bleeding remains relevant at the present time, as it continues to remain one of the severe urgent surgical diseases, both in Ukraine as a whole and in its individual regions, in particular in the Poltava region. Peptic ulcer disease of the stomach and duodenum continues to remain the first nosology that causes gastrointestinal bleeding. Postoperative mortality remains high and ranges from 5% to 12%. The time of hospitalization from the onset of the disease to hospitalization is consistently higher in the Poltava region than in Ukraine (the average level in Ukraine is 36.13% versus 43.16% in Poltava region) (р<0.05).

Key words: acute gastrointestinal bleedings, emergency medical care, epidemiology, statistical study

1. Breznytskyi YaS, Sulyma VP, Yaroshenko KO. [Selection of the method of endoscopic hemostasis in acute gastrointestinal bleeding]. Shpytalna khirurhiia. Zhurnal imeni L.Ya. Kovalchuka. 2016;(2):108-11. Ukrainian.
2. Siau K, Chapman W, Sharma N, Tripathi D, Iqbal T, Bhala Management of acute upper gastrointestinal bleeding: an update for the general physician. J R Coll Physicians Edinb. 2017 Sep;47(3):218-30. doi: https://doi.org/10.4997/jrcpe.2017.303
3. DiGregorio AM, Alvey H. Gastrointestinal Blee­ding. 2022 Jun 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.[cited 2023 Apr 01]. doi: https://doi.org/10.1353/ner.2022.0074
4. Uysal Y, Babus SB, Kose A, Ates F, Biricik S, Er­dogan S, et al. The prognostic significance of the risk scores at upper gastrointestinal bleeding. Niger J Clin Pract. 2019 Aug;22(8):1099-1108. doi: https://doi.org/10.4103/njcp.njcp_193_18
5. LiakhovskyiVI, Liulka OM, Kravtsiv MI, Zaiets  [Ways to prevent recurrence of gastrointestinal bleeding]. Klin khirurhiia. 2014;4:8-10. Ukrainian.
6. PerehinetsIB, redaktor.[Indicators of population health and use of health care resources in Ukraine for 2013-2014]. Kyiv; 2015. 325 Ukrainian
7. ZabolotkoVM, redaktor. [Indicators of surgical activity of health care institutions of the Ministry of Health of Ukraine]. Kyiv; 2022. 59 p. Ukrainian
8. Antomonov MY. [Mathematical processing and ana­lysis of medical-biological data]. Kiev: Publishing house "Malii Druk", 2006. 558 p.
9. Tham J, Stanley A. Clinical utility of pre-endos­copy risk scores in uppergastrointestinal bleeding. Expert Rev Gastroenterol Hepatol. 2019 Dec;13(12):1161-7. doi: https://doi.org/10.1080/17474124.2019.1698292
10. Saade MC, Kerbage A, Jabak S, Makki M, Bara­da K, Shaib Y. Validation of thenew ABC score for pre­dicting 30-day mortality in gastrointestinal bleeding. BMC Gastroenterol. 2022 Jun 21;22(1):301. doi: https://doi.org/10.1186/s12876-022-02374-y
11. Trofimov NV, Kryshen VP, Barannik SI, Chu­kh­ryenko AV, ChabanenkoGN, Gayterov AN. [Clinical and statistical aspects of gastrointestinal bleeding course in pa­tients with cardiovascular system pathology]. Med. perspekt. [In­ternet]. 2019 Apr 12 [cited 2023Jan28];24(1):35-9. Russian.
    doi: https://doi.org/10.26641/2307-0404.2019.1.162176
12. LaursenSB, Oakland K, Laine L, Bieber V, Mar­mo R, Redondo-Cerezo E, et al. ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multi­centre  Gut. 2021 Apr;70(4):707-16. doi: https://doi.org/10.1136/gutjnl-2019-320002
13. FeleshtynskyiYP, Oparin SO, Sorokin BV, Boiar­skaia MG, Lutsenko  Endoscopic hemostasis in ulcera­tive gastroduodenal bleeding using high-frequency biolo­gi­cal welding electroligation. Wiad Lek. 2021;74(9 cz 1):2159-62. doi: https://doi.org/10.36740/WLek202109123
14. Yaroshenko RA, Panasenko SI, Chorna IO, Liho­nenko OV. [Evolution of blood loss assessment methods]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu. 2022;7(3):43-51. Ukrainian. doi: https://doi.org/10.26693/jmbs07.03.043
15. StanleyAJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R, et  Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017 Jan 4;356:i6432. doi: https://doi.org/10.1136/bmj.i6432
16. KawaguchiK, Yoshida A, Yuk T, Shibagaki K, Ta­naka H, Fujishiro H, et al. A multicenter prospective study of the treatment and outcome of patients with gastroduodenal peptic ulcer bleeding in Japan. Medicine (Baltimore). 2022;101(49):e32281. doi: https://doi.org/10.1097/MD.0000000000032281
17. Marks I, Janmohamed IK, Malas S, Mavrou A, Banister T, Patel N, et al. Derivation and validation of a novel risk score to predict need for haemostatic in­tervention in acute upper gastrointestinal bleeding (London Haemostat Score). BMJ Open Gastroenterology. 2023 Mar;10(1):e001008. doi: https://doi.org/10.1136/bmjgast-2022-001008

Look through:

Yaroshenko R.A. Poltava state medical university, Poltava, Ukraine
https://orcid.org/0000-0002-5948-1916

Panasenko S.I. Poltava state medical university, Poltava, Ukraine
https://orcid.org/0000-0003-2952-1670

Chorna I.O. Poltava state medical university, Poltava, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0002-0371-8072

Khorosh M.V. Poltava state medical university, Poltava, Ukraine
https://orcid.org/0000-0002-2083-1333

Ligonenko O.V. Poltava state medical university, Poltava, Ukraine
https://orcid.org/0000-0002-2772-2244

Yaroshenko R.A., Panasenko S.I., Chorna I.O., Khorosh M.V., Ligonenko O.V.  Epidemiology of gastrointestinal bleedings compared in Ukraine and in the Poltava region. Medicni perspektivi. 2023;28(3):198-204. DOI: https://doi.org/10.26641/2307-0404.2023.3.289227  

Epidemiology of gastrointestinal bleedings compared in Ukraine and in the Poltava region

The aim of the reserch was to investigate the genotype of the pathogen in a patient with Lyme carditis and to analyze the course of the disease in the process of etiotropic treatment. The article describes a clinical case of infectious myocarditis associated with Lyme disease in a 49-year-old patient. The value of modern diagnostics technologies in diagnosis determination was described. The course of the disease and the results of treatment of the patient were analyzed. The severe rhythm and conduction disorders were revealed with the method of Holter monitoring: AV-block of the first degree, transient AV-block of the II degree (Mobitz 2) and III degree, polytopic extrasystoles. The morphological changes in the heart were diagnosed with ultrasonography and cardiac MRI in order to confirm the diagnosis and to monitor the patient's subsequent course. Total antibodies to antigens of the B. burgdorferi sensu lato complex in blood serum were determined by the ELISA method with test systems Euroimmun AG (Germany). At the second stage, the immunoblot method was applied using the EUROLINE Borrelia RN-AT test system. Due to timely diagnosis, including serological, prescribed etiotropic antibacterial treatment, the patient achieved a significant improvement in both clinical condition and positive serological and ECG dynamics with improved AV conduction. The most frequent ECG changes in Lyme carditis are conduction disorders with development of blockades of various stages. The application of the modern technologies in patients with myocarditis made it possible to determine the etiological factor of the disease with the establishment of genotypes, which caused Lyme carditis.

Key words: Lyme disease, myocarditis, AV-block, serological testing, Holter monitoring, ultrasonography, magnetic resonance imaging

1. Socarras KM, Haslund-Gourley BS, Cramer NA, Comunale MA, Marconi RT, Ehrlich GD. Large-Scale Se­quencing of Borreliaceae for the Construction of Pan-Ge­nomic-Based Diagnostics. Genes (Basel). 2022;8,13(9):1604. doi: https://doi.org/10.3390/genes13091604
2. Andreichyn M, Shkilna M, Korda M. Dvoetapna diahnostyka Laim-boreliozu v pratsivnykiv lisovykh hospodarstv. Two-stage diagnosis of Lyme borreliosis in forestry workers. J of the NAMSU. 2019;25:71-6.
3. Shen RV, McCarthy CA. Cardiac Manifestations of Lyme Disease. Infectious Disease Clinics of North America.2022;36(3):553-61. doi: https://doi.org/10.1016/j.idc.2022.03.001
4. Andreychyn MA, Korda MM, Shkilna MI, Iva­khiv OL, et al. [Lyme borreliosis]. Ternopil: TNMU; 2021. 376 p. Ukrainian.
5. Mozzini C, Cominacini L, Casadei A, Schia­vone C, Soresi M. Ultrasonography in Heart Failure: A Story that Matters. Current problems in cardiology. 2019;44(4):116-36. doi: https://doi.org/10.1016/j.cpcardiol.2018.05.003
6. Yeung C, Baranchuk A. Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week. J Am Coll 2019;73(6):717-26. doi: https://doi.org/10.1016/j.jacc.2018.11.035
7. Sanchez T, Thavendiranathan P, Udell J, Seid­man M, Hanneman K. Cardiac MRI Assessment of No­nischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination. Radiology. Cardiothoracic imaging.2021;3(6):e210252. doi: https://doi.org/10.1148/ryct.210252 
8. Ammirati E, Veronese G, Bottiroli M, Wang D, Cipriani M, Garascia A, et al. Update on acute myocarditis. TrendsCardiovasc  2020;20:1050-738. doi: https://doi.org/10.1016/j.tcm.2020.05.008
9. Radesich C, Del Mestre E, Medo K, Vitrella G, Man­ca P, Chiatto M, et al. Lyme Carditis: From Patho­physiology to Clinical Management. Pathogens. 2022;11(5):582. doi: https://doi.org/10.3390/pathogens11050582
10. Matshela MR. The role of echocardiography in acute viral myocarditis. Cardiovascular journal of Africa. 2019;30(4):239-44.
    doi: https://doi.org/10.5830/CVJA-2018-069
11. Brown E, Lindner J. Ultrasound Molecular Ima­ging: Principles and Applications in Cardiovascular Medicine. Current cardiology reports. 2019;21(5):30. doi: https://doi.org/10.1007/s11886-019-1117-9
12. Fuster L, Gul E, Baranchuk A. Electrocardio­graphic progression of acute Lyme disease. Am J Emerg Med.2017;35(7):1040.e5-01040.e6. doi: https://doi.org/10.1016/j.ajem.2017.02.052
13. Polte CL, Bobbio E, Bollano E, Bergh N, Polte C, Him­melman J, et al. Cardiovascular Magnetic Resonance in Myocarditis. Diagnostics (Basel, Swit­zerland).2022;2(2):399. doi: https://doi.org/10.3390/diagnostics12020399 
14. Tseng W, Su M, Tseng Y. Introduction to Cardio­vascular Magnetic Resonance: Technical Principles and Clinical Applications. Acta Cardiologica Sinica. 2016;32(2):129-44. doi: https://doi.org/10.6515/acs20150616a
15. Scheffold N, Herkommer B, Kandolf R, May A. Lyme carditis--diagnosis, treatment and prognosis. Deutsches Arzteblatt international. 2015;112(12):202-8. doi: https://doi.org/10.3238/arztebl.2015.0202
16. Lytvyn HO, Basa NR. [Infectious diseases, Lyme disease in children at the modern stage]. Infektsiini khvoroby.2021;2(104)73-83.  doi: https://doi.org/10.11603/1681-2727.2021.2.11797
17. Popovych OO. [Lyme-borreliosis: a modern prob­lem of infectology (clinical lecture)]. Aktualna infek­tolohiia.2016;3(12):114-22.  doi: https://doi.org/10.22141/2312-413x.3.12.2016.81725
18. Błaut-Jurkowska J, Olszowska M, Kaźnica-Wiatr M.P. Lyme carditis. Podolec Pol Merkur Lekarski. 2015;39(230):111-5. doi: https://doi.org/10.20418/jrcd.vol3no3.266
19. Zadorozhna VI, Rudenko AO, Klius VYu. [Lyme-borreliosis is a particularly dangerous infection. Threats and risks]. Veterynarna medytsyna. 2017;103:30-2. Ukrainian.
20. Steinbrink A, Brugger K, Margos G, Kraiczy P, Klimpel S. The evolving story of Borrelia burgdorferi sensu lato transmission in Europe. Parasitol Res. 2022;121(3):781-803. doi: https://doi.org/10.1007/s00436-022-07445-3
21. Kostić T, Momčilović S, Perišić Z, Apostolović S, Cvetković J, Jovanović A, et al. Manifestations of Lyme carditis.Intern J  2017;232:24-32. doi: https://doi.org/10.1016/j.ijcard.2016.12.169
22. Young S, Arshad O, Arikan Y, Mirzanejad Y. Lyme carditis: A can’t miss diagnosis. BCMJ Clinical Articles. 2020;62(10):368-72.
23. Radesich C, Del Mestre E, Medo K, Vitrella G, Manca P, Chiatto M, et Lyme Carditis: From Patho­physiology to Clinical Management. Pathogens. 2022;11(5):582. doi: https://doi.org/10.3390/pathogens11050582
24. Nebohatkin IV, Shulhan AM. [Epidemiological and epizootic features of Lyme disease in 2019 in Ukraine]. Aktualna infektolohiia. 2020;8(5-6):57-61. Ukrainian.
25. Caine JA, Coburn J. A short-term Borrelia burg­dorferi infection model identifies tissue tropisms and bloodstream survival conferred by adhesion pro­teins. Infect 2015;83:3184-94. doi: https://doi.org/10.1128/IAI.00349-15
26. Pietruszka K, Reagan F, Stążka J, Kozioł MM. Serologic Status of Borrelia burgdorferi sensu lato in Patients with Cardiovascular Changes. International Jour­nal of Environmental Research and Public Health. 2023;20(3):2239. doi: https://doi.org/10.3390/ijerph20032239
27. Al-Akchar M, Shams P, Kiel J. Acute Myocar­ditis. 2022 Nov 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. [cited 2022 Nov 21]. PMID: 28722877.

Look through:

Myndziv K.V. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine
https://orcid.org/0000-0003-1025-973X

Yarema N.I. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine
https://orcid.org/0000-0002-4378-1084

Vereshchahina N.Ya. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine
https://orcid.org/0000-0002-5569-1334

Bondarchuk V.I. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine, 
e-mail: bondarchykvi@This email address is being protected from spambots. You need JavaScript enabled to view it..This email address is being protected from spambots. You need JavaScript enabled to view it..ua 
https://orcid.org/0000-0001-6906-2494

Hevko U.P. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine
https://orcid.org/0000-0001-5265-2842

Vayda O.V. I. Horbachevsky Ternoil National Medical University, Ternopil, Ukraine
https://orcid.org/0000-0002-2476-7850

Myndziv K.V., Yarema N.I., Vereshchahina N.Ya., Bondarchuk V.I., Hevko U.P., Vayda O.V. Application of diagnostic methods in the verification of Lyme carditis (clinical case). Medicni perspektivi. 2023;28(3):205-212. DOI: https://doi.org/10.26641/2307-0404.2023.3.289228 

Application of diagnostic methods in the verification of Lyme carditis (clinical case)

According to current statistics, the incidence of type 2 diabetes has increased significantly over the past few years. The number of drugs prescribed to correct carbohydrate metabolism is also increasing, and new groups of hypoglycemic drugs are appearing. This prompts a more detailed study and analysis of the possible side effects of the prescribed therapy. One of the modern groups of medications f  or treating type 2 diabetes are analogues of glucagon-like peptide-1 receptor agonists, which, in addition to correcting carbohydrate metabolism, have a beneficial effect on the risk of developing cardiovascular events. Despite this, there is evidence that their use may be associated with the development of undesirable adverse effects from the pancreas, particularly acute pancreatitis, pancreatopathy, or asymptomatic hyperenzymemia. The aim of our work was the analysis of a clinical case of an asymptomatic increase in the level of pancreatic enzymes (Gullo's syndrome) in a patient with type 2 diabetes, who used a glucagon-like peptide-1 receptor analogue for treatment according to the usual scheme (dulaglutide 0.75 mg subcutaneously once a week during 2 years). As a result, the patient developed a side effect that could be related to taking this medicine. This did not lead to the withdrawal of the drug but required a more thorough examination of the patient and regular further screening for the timely detection of the development of possible organic pathology of the pancreas in the future. So, after analyzing this clinical case, it is possible to see the possibility of developing asymptomatic pancreatic hyperenzymopathy during the treatment of type 2 diabetes mellitus with glucagon-like peptide-1 receptor agonist analogues, which should be taken into account when determining the treatment tactics.

Key words: asymptomatic pancreatic hyperenzymemia, glucagon-like peptide-1, type 2 diabetes

1. Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, et al.
2. Glucagon-like peptide 1 (GLP-1) [Internet]. Mol Metab. 2019 Dec [cited 2023 Mar 24];30:72-130. doi: https://doi.org/10.1016/j.molmet.2019.09.010
3. Kuhre RE, Deacon CF, Holst JJ, Petersen N. What Is an L-Cell and How Do We Study the Secretory Mecha­nisms of the L-Cell? [Internet]. Frontiers in Endocrinology. 2021[cited 2023 Mar 24];12. doi: https://doi.org/10.3389/fendo.2021.694284
4. Gilbert MP, Pratley RE. GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials [Internet]. Front Endocrinol (Lausanne). 2020 Apr 3 [cited 2023 Mar 24];11:178. doi: https://doi.org/10.3389/fendo.2020.00178
5. Costa A, Ai M, Nunn N, Culotta I, Hunter J, Boudjadja MB, et al. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation [Internet]. Molecular Metabolism. 2022 Jan [cited2023 Mar 24];55:101407. doi: https://doi.org/10.1016/j.molmet.2021.101407
6. Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art [Internet]. Molecular Metabolism. 2021 Apr [cited2023 Mar 24];46. doi: https://doi.org/10.1016/j.molmet.2020.101102
7. Scheen AJ. Dulaglutide (Trulicity®), a new once-weekly agonist of glucagon-like peptide-1 receptors for type 2 diabetes [Internet]. Rev Med Liege. 2016 Mar [cited 2023 Mar 24];71(3):154-60. PMID: 27311248
8. Amaro A, Sugimoto D, Wharton S. Efficacy and safety of semaglutide for weight management: evidence from the STEP program [Internet]. Postgrad Med. 2022 Jan[cited 2023 Mar 24];134(Sup 1):5-17. doi: https://doi.org/10.1080/00325481.2022.2147326
9. Cabral Lopes A, Roque F, Lourenço O, Her­deiro MT, Morgado M. Gastrointestinal disorders poten­tially associated with Semaglutide: an analysis from the Eudravigilance Database [Internet]. Expert Opinion on  Drug Safety. 2023 Feb [cited 2023 Mar 24]2;1-7. doi: https://doi.org/10.1080/14740338.2023.2172159
10. Mehta P, Reddivari A. A Case Report of Benign Pancreatic Hyperenzymemia (Gullo’s Syndrome) [Inter­net]. Cureus. 2020 May [cited 2023 Mar 24];12(5):e8143. doi: https://doi.org/10.7759/cureus.8143
11. Warshaw AL, Lee KH. Macroamylasemia and other chronic nonspecific hyperamylasemias: chemical od­dities or clinical entities? [Internet]. Am J Surg. 1978 Apr[cited 2023 Mar 24];135(4):488-93. doi: https://doi.org/10.1016/0002-9610(78)90025-9
12. Gullo L. Chronic nonpathological hyperamy­lasemia of pancreatic origin. [Internet]. Gastroenterology. 1996 Jun [cited 2023 Mar 24];110(6):1905-8. doi: https://doi.org/10.1053/gast.1996.v110.pm8964417
13. Gullo L. Benign pancreatic hyperenzymemia [In­ternet]. Dig Liver Dis. 2007 Jul [cited 2023 Mar 24];39(7):698-702. doi: https://doi.org/10.1016/j.dld.2007.03.005
14. Rycyk A, Furtak P, Mądro A, Kasztelan-Szczer­bińska B, Cichoż-Lach H. Gullo’s syndrome – what do we know? [Internet]. Gastroenterology Rev. 2021 [cited 2023 Mar 24];16(3):181-3. doi: https://doi.org/10.5114/pg.2020.101133
15. Huberhritz NB, Belyaeva NV, Lukashevich HM, Mozhyna TL. [Secrets, riddles, and mysteries of macro­amylasemia]. Visnyk klubu pankreatolohiv. 2020;2:12-22. Russian. doi: https://doi.org/10.33149/vkp.2020.01.02

Look through:

Sanina N.A. Dnipro State Medical University, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
https://orcid.org/0000-0001-6603-0219

Hondulenko N.O. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0001-5683-7836

Panina S.S. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0003-1080-7185

Shulha V.S. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0001-7287-0046

Sanina N.A., Hondulenko N.O., Panina S.S., Shulha V.S. A clinical case of asymptomatic pancreatic hyperenzymemia on the background of taking a Glucagon-like peptide-1 analogue (GLP-1). Medicni perspektivi. 2023;28(3):213-217. DOI: https://doi.org/10.26641/2307-0404.2023.3.289229 

A clinical case of asymptomatic pancreatic hyperenzymemia on the background of taking a Glucagon-like peptide-1 analogue (GLP-1)

Pigmented villonodular synovitis is a rare proliferative disease of the synovial membrane, which most often affects the knee joints. Being a benign disease, at the same time, this pathology is often aggressive, and in some cases spreads to the soft tissues outside the joint. There are two forms of monoarticular damage: localized and diffuse. The diffuse form gives frequent relapses. To date, there are no standards for the management of this disease, just as there are no early markers for the detection of pigmented villonodular synovitis. This joint lesion has a long asymptomatic course, or it has symptoms of non-specific recurrent arthritis, so the patients can later be referred for magnetic resonance imaging, which is the only non-invasive method of diagnosing this pathology. At the same time, in modern conditions, most patients with recurrent synovitis will undergo an ultrasound examination of the joint according to the diagnostic standards. Ultrasonography made for abovementioned synovitis is insufficiently described in the medical literature. The aim of our study was to highlight the current data on the diagnosis and management of patients with pigmented villonodular synovitis and to describe our own clinical case. A feature of our clinical case was the detection of characteristic symptoms using ultrasonography. Irregular thickening of the synovial membrane with nodular forma­tions and villous growths, with the length of villi up to 7 mm near the patella with single loci of blood flow, was revealed by ultrasound examination and power Doppler mapping. Shear wave elastometry of the synovial membrane was performed. It demonstrated a significant increase in the stiffness of the synovial membrane, which can be a patho­gnomonic symptom of this pathology. The diagnosis of villonodular synovitis was confirmed histologically after surgical treatment. Subsequently, the patient had a recurrence of the pigmented villonodular synovitis, which was also detected by ultrasound diagnostics. Thus, pigmented villonodular synovitis of the knee joint is a rather rare pathology that requires differential diagnosis with inflammatory joint diseases. The final diagnosis is based on histological exa­mination. MRI and ultrasound diagnostics are non-invasive methods that can detect this pathology with high accuracy. The advantage of ultrasonography is its availability and non-invasiveness. The increase in stiffness of the synovial membrane along with its proliferation, which we found, can serve as an additional criterion of villonodular synovitis, and, according to the data available to us, has not been described in the literature so far.

Key words: villonodular synovitis, ultrasound diagnostics, synovial membrane, elastometry

1. Asaad SK, Salih KM, Kakamad FH, Salih AM, Mohammed SH. Pigmented villonodular synovitis asso­ciated with developmental dysplasia of the hip: A case report. International journal of surgery case reports. 2020;74:260-2. doi: https://doi.org/10.1016/j.ijscr.2020.07.078
2. Zadeh C, Henrichsen J, Fatemi N, Westermann R. Intra-labral pigmented villonodular synovitis: a rare case in two adult patients. Skeletal Radiol. 2023;52:1409-13. doi: https://doi.org/10.1007/s00256-022-04227-x
3. Spierenburg G, Suevos Ballesteros C, Stoel BC, Navas Cañete A, Gelderblom H, van de Sande MAJ, et al. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response asses­sment. Insights 2023;14(1):22. doi: https://doi.org/10.1186/s13244-023-01367-z
4. Sugandhi A, Kondaveeti SK, Sunder A. A Case of Pigmented Villonodular Synovitis. Cureus. 2022;14(6):e25957. doi: https://doi.org/10.7759/cureus.25957
5. Nelakurti DD, Rossetti T, Husbands AY, Pet­reaca RC. Arginine Depletion in Human Cancers. Cancers (Basel).2021;13(24):6274. doi: https://doi.org/10.3390/cancers13246274
6. Bernthal NM, Ishmael CR, Burke ZD. Manage­ment of Pigmented Villonodular Synovitis (PVNS): an Or­thopedic Surgeon’s Perspective. Curr Oncol Rep. 2020;22:63. doi: https://doi.org/10.1007/s11912-020-00926-7
7. Zhamardiy V, Shkola O, Tolchieva H, Saienko V. Fitness technologies in the system of physical qualities development by young students. Journal of Physical Edu­cation and Sport. 2020;20(1):142-9.
8. Fang Yushun, Zhang Qingsong. Recurrence of pigmented villonodular synovitis of the knee: A case report with review of literature on the risk factors causing recurrence. Medicine.2020;99(16):e19856. doi: https://doi.org/10.1097/MD.0000000000019856
9. Koutalos AA, Ragias D, Rizniotopoulos E, Tsana­dis K, Xydias E, Tsoukalas N, et al. Diffuse pigmented villonodular synovitis of the knee joint: 3-year follow-up of a case report. Radiat Oncol J. 2022;40(4):270-5. doi: https://doi.org/10.3857/roj.2022.00122
10. Zhdan VM, Lebid VG, Ivanytskyi IV, Tkachen­ko MV, Isheykana YuO. [Effectiveness of treatment accor­ding to elastometry of the synovial membrane in patients with rheumatoid arthritis.] Aktualni problemy suchasnoy mediciny: Visnyk ukrainskoi medichnoi stomatologichnoi akademii. 2020;4(72):34-9. Ukrainian. doi: https://doi.org/10.31718/2077-1096.20.4.40
11. Коstogryz YО. [Pigmented villonodular synovitis of the knee joint: current state of the problem]. Visnyk ortopedii, travmatologii ta protezuvannya. 2018;1:57-63. Ukrainian.
12. Margad O, Boukhris J, Azriouil O, Daoudi M, Mortaji A, Koulali K. Villonodular synovitis of the knee: about 20 cases. Pan Afr Med J. 2017;28:86. doi: https://doi.org/10.11604/pamj.2017.28.86.9507
13. Sahin MS. Localized Pigmented Villonodular Synovitis of the Knee Joint: A Case Report. J Orthop Case Rep. 2022;12(4):44-8. doi: https://doi.org/10.13107/jocr.2022.v12.i04.2760
14. Luo D, Yu L, Yang L, Zhu Q, Ren H, Liu H. Aty­pical and bilateral pigmented villonodular synovitis of wrist in an adolescent patient: case report and literature review. Int J Clin Exp Pathol. 2021;14(3):383-8. PMID: 33786156; PMCID: PMC7994141
15. Ota T, Nishida Y, Ikuta K, Tsukushi S, Yamada K, Kozawa E, et al. Tumor location and type affect local re­currence and joint damage in tenosynovial giant cell tumor: a multi-center study. Scientific reports. 2021;11(1):17384. doi: https://doi.org/10.1038/s41598-021-96795-6
16. Okamura H, Ishikawa H, Ohno T, Fujita S, Ina­gaki K. Localized Pigmented Villonodular Synovitis of the Bilateral Knee: A Case Report. Journal of orthopaedic case reports. 2022;12(7):18-21. doi: https://doi.org/10.13107/jocr.2022.v12.i07.2898
17. Kissel JA, Leonardelli C. Pigmented villonodular synovitis of the hip in a recreational runner: a case report. The Journal of the Canadian Chiropractic Association. 2021;65(3):344-9.
18. Ivanoski S, Nikodinovska VV. Sonographic asses­sment of the anatomy and common pathologies of clinically important bursae. J Ultrason. 2019;19(78):212-21. doi: https://doi.org/10.15557/JoU.2019.0032
19. Heo S, Park SY, Seo J, et al. Diffuse-Type Tenosy­novial Giant Cell Tumor of the Tendon Sheath in Both Wrists. Taehan Yongsang Uihakhoe Chi. 2021;82(1):250-4. doi: https://doi.org/10.3348/jksr.2020.0055
20. Fernandes TL, Videira LD, Sasaki SU, Natali­no RJ, Almeida AM, Pedrinelli A, et al. Bilateral localized pigmented villonodular synovitis of the knee: case report and review. Acta ortopedica brasileira. 2018;26(3):183-6. doi: https://doi.org/10.1590/1413-785220182603179623
21. Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, et al. Liver fibrosis imaging: A cli­nical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging. 2020;51(1):25-42. doi: https://doi.org/10.1002/jmri.26716
22. Kapustianskyi D, Ivanytskyi I, Ivanytska T, Zha­mardiy V, Donchenko V. Differential diagnosis of soft tissue tumors. Wiadomosci Lekarskie. 2022;LXXV(6):1596-9. doi: https://doi.org/10.36740/WLek202206131
23. Herasymenko SI, Kostohryz OA, Kosto­hryz YuO, Babko AM, Maiko VM. [Results of the surgical treatment of diffuse pigmented villonodular synovitis (diffuse-type tenosynovial giant-cell tumor) of the knee]. Zaporizkyi medychnyi zhurnal. 2021;5(128):656-63. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.5.230164 

Look through:

Zhdan V.M. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0002-4633-5477

Ivanytskyi I.V. Poltava State Medical University, Poltava, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
 https://orcid.org/0000-0002-7234-6356

Babanina M.Y. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0002-6546-9454

Ivanytska T.A. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0002-2556-7658

Kitura Y.M. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0002-2636-4596

Volchenko H.V. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0003-0151-3660

Tkachenko M.V. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0002-0253-8686

Kyrian O.A. Poltava State Medical University, Poltava, Ukraine
 https://orcid.org/0000-0003-4855-4208

Lebid V.H. Poltava State Medical University, Poltava, Ukraine
https://orcid.org/0000-0001-9382-2772

Zhdan V.M., Ivanytskyi I.V., Babanina M.Y., Ivanytska T.A., Kitura Y.M., Volchenko H.V., Tkachenko M.V., Kyrian O.A., Lebid V.H. Possibilities of ultrasonography in the diagnosis of pigmented villonodular synovitis. Clinical case. Medicni perspektivi. 2023;28(3):218-226. DOI: https://doi.org/10.26641/2307-0404.2023.3.289260 

Possibilities of ultrasonography in the diagnosis of pigmented villonodular synovitis. Clinical case

The article describes a rare clinical case of meningoencephalitis of Epstein-Barr viral (EBV) etiology in an immunocompetent patient. The purpose of the work was to acquaint practitioners with the problems of diagnosis and treatment of EBV-neuroinfection, features of the course and management of EBV-meningoencephalitis. The woman, 46 years old, was admitted to the intensive care unit with a diagnosis of mushroom poisoning. Based on clinical-laboratory-instrumental examinations the diagnosis of EBV-meningoencephalitis was made. EBV DNA was detected in the cerebrospinal fluid by polymerase chain reaction (PCR) and magnetic resonance imaging (MRI) of the brain showed focal changes in the left temporal-insular region with signs of leptomeningitis. Taking into account the specifics of this case, the authors of the article came to the following conclusions: EBV-meningoencephalitis can occur in people with normal immune status under conditions of psychological and physical stress; delayed diagnosis of meningoencephalitis at the onset of the disease in this case is associated with the prevalence of clinical manifestations of general brain syndrome, mistakenly regarded as symptoms of intoxication and dyspepsia due to food poisoning; meningoencephalitis of EBV-etiology is ac­companied by signs of convulsive, atactic, cognitive and mental syndromes; temporal-insular localization of focal brain changes may be characteristic for EBV-meningoencephalitis; treatment with acyclovir and glucocorticoids may have be­nefits; complicated vascular anamnesis, bed rest and glucocorticoid therapy predict an increased risk of venous thrombosis, which in this patient was realized as acute sural phlebothrombosis; according to MRI the resolution of leptomeningitis and focal brain changes with gliosis formation occurred 3 months after manifestation of the disease; the risk of the following neurological pathologies due to specific localization of gliosis should be considered and requires medical control.

Key words: Epstein–Barr virus, encephalitis, meningoencephalitis, magnetic resonance imaging, acyclovir, glucocorticoids

1. Venkatesan A, Michael BD, Probasco JC, Geoca­din RG, Solomon T. Acute encephalitis in immuno­competent adults. Lancet. 2019;393:702-16. doi: https://doi.org/10.1016/S0140-6736(18)32526-1
2. Andleeb S, Yasir Bari M, Gill I, Urooj S, Nau­sheen S. Incidence of Encephalitis in the Intensive Care Unit, a Tertiary Care Hospital, Pakistan: A 5-Year Retrospective Study. Turk J Anaesthesiol Reanim. 2020;48(4):288-93. doi: https://doi.org/10.1016/S0140-6736(18)32526-1
3. Payal B Patel. BMJ Best Practice. Encephalitis. London: BMJ Publishing Group Ltd; 2023 [last updated: 2022 Aug 16].130 p. Available from: https://bestpractice.bmj.com/topics/en-gb/436/pdf/436/Encephalitis.pdf
4. Huang L, Zhang X, Fang X. Case report: Epstein–Barr virus encephalitis complicated with brain stem hemor­rhage in an immune-competent adult. Frontiers in immunology.2021;12:618830. doi: https://doi.org/10.3389/fimmu.2021.618830
5. Rudenko AO, Muravska LV, Diachenko PA, Par­khomets BA, Klius VJ. [Clinical peculiarities of nervous system defeats in patients with EBV monoinfection and in assotiation with other herpesvirus in their reactivation and persistence]. Actual Infectology. 2017;5(6):260-4. Ukrainian.
   doi: https://doi.org/10.22141/2312-413x.5.6.2017.122136
6. Maltsev DV. [Herpesvirus neuroinfections in cli­nical cases]. Kyiv: Interservice; 2021. 224 p. Ukrainian.
7. Song DL, Wang JS, Chen LL, Wang Z. Chronic acti­ve Epstein-Barr virus infection treated with PEG-aspargase: A case report. World J Clin Cases. 2021;16;9(26):7845-9. doi: https://doi.org/10.12998/wjcc.v9.i26.7845
8. Cohen JI. Optimal treatment for chronic active Eps­tein-Barr virus disease. Pediatr Transplant. 2009;13(4):393-6. doi: https://doi.org/10.1111/j.1399-3046.2008.01095.x
9. Zarlasht F, et Encephalitis treatment–a case report with long-term follow-up of EBV PCR in cere­brospinal fluid. Int J of Gen Med. 2017;10:371-3. doi: https://doi.org/10.2147/IJGM.S143335
10. Tsuruyama Y, Mori N, Yoshida S, Hayashi T. Ep­stein-Barr virus-related encephalitis in a young woman: A case report. Journal of Infection and Chemotherapy. 2020;26(7):741-4. doi: https://doi.org/10.1016/j.jiac.2020.02.005 

Look through:

Popovych O.O. National Pirogov Memorial Medical University, Vinnytsya, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
  https://orcid.org/0000-0001-6278-6094

Moroz L.V. National Pirogov Memorial Medical University, Vinnytsya, Ukraine
 https://orcid.org/0000-0002-7111-3155

Chabanov F.A. Municipal non-profit enterprise “Vinnytsia City Clinical Hospital No. 1”, Vinnytsya, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 
 https://orcid.org/0000-0001-9307-3679

Androsova O.S. National Pirogov Memorial Medical University, Vinnytsya, Ukraine
 https://orcid.org/0000-0003-3702-5589

Kulias S.M. National Pirogov Memorial Medical University, Vinnytsya, Ukraine
https://orcid.org/0009-0007-4336-8373

Chichirelo-Konstantynovych K.D. National Pirogov Memorial Medical University, Vinnytsya, Ukraine
 https://orcid.org/0000-0002-7403-636X

Plotytsia L.P. Municipal non-profit enterprise “Vinnytsia City Clinical Hospital No. 1”, Vinnytsya, Ukraine

Popovych O.O., Moroz L.V., Chabanov F.A., Androsova O.S., Kulias S.M., Chichirelo-Konstantynovych K.D., Plotytsia L.P. Clinical case of meningoencephalitis of Epstein-Barr viral etiology in an immunocompetent patient. Medicni perspektivi. 2023;28(3):226-233. DOI: https://doi.org/10.26641/2307-0404.2023.3.289264 

Clinical case of meningoencephalitis of Epstein-Barr viral etiology in an immunocompetent patient

Manifestations of сoronavirus disease 2019, caused by SARS-CoV-2 virus, are diverse and can vary from asymptomatic infection to respiratory failure needing intensive care. Vaccines against SARS‐CoV‐2 focusing on the spike glycoprotein have shown promise in diminishing the spread of Covid‐19. Adverse effects, however, are associated with every vaccination. Currently, there are literature reports of some cases of lichen planus eruption following COVID-19 vaccine injection. Oral lichen planus is a relatively common immune-mediated dermatologic disorder that can occur isolated or associated with cutaneous lichen planus. Postvaccination lichen planus has previously been reported in the literature as a rare adverse event following various vaccinations, especially hepatitis A and B, influenza, and varicella. The majority of patients presented with classic cutaneous lichen planus, although some reports highlighted primarily mucosal involvement. Herein we describe two rare cases of erosive-ulcerous oral lichen planus among SARS-CoV-2 vaccine recipients. The first is a case of a 67-year-old male who developed mucocutaneous lichen planus 5 days after administration of the single-dose of Ad26.COV2.S COVID-19 vaccine. In the second case, a 56-year-old female presented with reactivation of oral lichen planus after receiving a first dose of Pfizer COVID-19 vaccination 2 days earlier. The mechanism of the association between vaccines and lichen planus is not known, it is attributed to cell-mediated autoimmunity. Although there is currently no evidence of a causal relationship between SARS-CoV-2 vaccination and lichen planus, these clinical observations suggest that the COVID-19 vaccine is a possible key initiating event leading to the development or recurrence of this disease. 

Key words: COVID-19, oral lichen planus, SARS-CoV-2 vaccine, case report 

1. Virah MV, Rogach IM, Palko AI, Slyvka YI. [Analysis of current data on vaccination against COVID-19 and prospects for vaccination of the population of Ukraine]. Ukraina. Zdorovia natsii. 2021;1(63):56-62. Ukrainian.
   doi: https://doi.org/10.24144/2077-6594.1.1.2021.227155
2. Chernyshova LI, Chernyshov AV. [ Comparative characteristics of vaccines against COVID-19]. Aktualna infektolohiia.2021;9(2):5-9.  doi: https://doi.org/10.22141/2312-413Х.9.2.2021.236218  
3. Mavrutenkov VV, Revenko HO. [Vaccine pro­phylaxis: achievements, problems, perspectives of deve­lopment]. Medicni perspektivi. 2016;3:56-60. doi: https://doi.org/10.26641/2307-0404.2016.3.82025
4. Sinha A, Kumar R, Singh AR. Implication of mass COVID-19 vaccination on dermatology practice in 2021. Dermatol 2021 Mar;34(2):e14765. doi: https://doi.org/10.1111/dth.14765
5. Bozhik SO. [Clinical characteristics of the den­tal status of patients with oral lichen planus]. Medytsyna sohodni i zavtra. 2021;90(3):82-90. Ukrainian. doi: https://doi.org/10.35339/msz.2021.90.3.boz  
6. Hasiuk NV, Cherniak VV, Klitynska OV, et al. [Additional methods of examination in dentistry]. Terno­pil: Palianytsia; 2017:44-47. Available from: http://repository.pdmu.edu.ua/bitstream/123456789/8780/1/Additional_methods.pdf
7. Rotaru DI, Sofineti D, Bolboacă SD, Bul­boacă AE. Diagnostic Criteria of Oral Lichen Planus: A Narrative Review. Acta Clin Croat. 2020 Sep;59(3):513-22. doi: https://doi.org/20471/acc.2020.59.03.16
8. Svyatenko ТV, Litus АI, Kаdenko ОА, Svis­tu­nov IV. Manifestative Papular Dermatoses: Lichen Ruber Planus of the Mucous Membrane of Oral Cavity. J Clin Investigat 2016;4(2):4. doi: https://doi.org/10.13188/2373-1044.1000026
9. Shavit E, Hagen K, Shear N. Oral lichen planus: a novel staging and algorithmic approach and all that is essential to know. F1000Res. 2020 Mar 24;9:F1000. doi: https://doi.org/12688/f1000research.18713.1
10. Mutafchieva MZ, Draganova-Filipova MN, Za­gor­chev PI, Tomov GT. Oral Lichen Planus – Known and Unknown: a Review. Folia Med. 2018 Dec 1;60(4):528-35. doi: https://doi.org/2478/folmed-2018-0017
11. Nosratzehi T. Oral Lichen Planus: an Overview of Potential Risk Factors, Biomarkers and Treatments. Asian Pac J Cancer Prev. 2018 May 26;19(5):1161-7. doi: https://doi.org/22034/APJCP.2018.19.5.1161
12. Lai YC, Yew YW. Lichen planus and lichenoid drug eruption after vaccination. Cutis. 2017 Dec;100(6):E6-E20. PMID: 29360907.
13. Troeltzsch M, Gogl M, Berndt R, Troeltzsch M. Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S). Oral Dis. 2021Sep 30:14025. doi: https://doi.org/10.1111/odi.14025 
14. Picone V, Fabbrocini G, Martora L, Martora F. A Case of New-Onset Lichen Planus after COVID-19 Vac­cination. Dermatol Ther (Heidelb). 2022 Feb 15;12(3):801-5. doi: https://doi.org/10.1007/s13555-022-00689-y
15. Babazadeh A, Miladi R, Barary M, et al. COVID-19 vaccine-related new-onset lichen planus. Clin Case Rep. 2022 Feb 2;10(2):e05323. doi: https://doi.org/1002/ccr3.5323
16. Alrawashdeh HM, Al-Habahbeh O, Naser AY, et al. Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature. Cureus. 2022 Feb 27;14(2):e22669. doi: https://doi.org/7759/cureus.22669
17. Hertel M, Schmidt-Westhausen AM, Wendy S, et al. Onset of Oral Lichenoid Lesions and Oral Lichen Planus Following COVID-19 Vaccination: A Retro­spective Analysis of about 300,000 Vaccinated Patients. Vaccines(Basel). 2022 Mar 20;10(3):480. doi: https://doi.org/10.3390/vaccines10030480  
18. Kaomongkolgit R, Sawangarun W. Oral lichen planus following mRNA COVID-19 vaccination. Oral Dis. 2022 Nov:10.1111/odi.14182. doi: https://doi.org/1111/odi.14182
19. McMahon DE, Kovarik CL, Damsky W, et al. Cli­nical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022 Jan;86(1):113-21. doi: https://doi.org/10.1016/j.jaad.2021.09.002

Look through:

Samoilenko A.V. Dnipro State Medical University, Dnipro, Ukraine,
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
https://orcid.org/0000-0003-1758-6442

Oryshchenko V.Yu. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0002-9372-2218

Strelchenia T.M. Dnipro State Medical University, Dnipro, Ukraine
https://orcid.org/0000-0002-6638-8859

Samoilenko A.V., Oryshchenko V.Yu., Strelchenia T.M. Oral lichen planus post COVID-19 vaccination: report of two cases. Medicni perspektivi. 2023;28(3):234-240. DOI: https://doi.org/10.26641/2307-0404.2023.3.289265 

Oral lichen planus post COVID-19 vaccination: report of two cases